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Welcome to the Perinatal Mortality in Ireland 
Biennial Report 2018/2019 from the National 
Perinatal Epidemiology Centre (NPEC). This 
is the eighth report of the national clinical au-
dit on perinatal mortality using the NPEC data 
collection tool and classification system. The 
reason for undertaking a 2 year report is based 
on difficulties completing the data for 2018 
due to staffing at the centre and we decided 
with the support of our governance groups to 
compile a 2 year report; further delay arose 
with the Covid-19 pandemic, delaying comple-
tion of the 2019 data in 2020. The change in 
the legal setting following Repeal of the Eighth 
amendment, and the subsequent Health (Reg-
ulation of Termination of Pregnancy) Act 2018, 
is reflected in this report with termination of 
pregnancy becoming legal in January 2019.
The NPEC appreciates the provision of data 
to the audit in the first place but also the im-
portance of feedback and discussion with 
the units to enhance the system learning and 
understand how this data can be used to as-
sess/improve the care they provide. I sincerely 
thank all my colleagues in the maternity ser-
vices in Ireland who continue to engage with 
the NPEC and produce data of which we are 
all proud. The NPEC actively encourages the 
use of data in the units through individual hos-
pital reports and the use of the national data 
set. This report also shows, for the first time, 
the maternity service commitment to trans-
parency with the identification of individual 
units in the report.
Knowledge is the insight achieved from pro-
cessing that data, providing intelligence to en-
sure the maternity services in Ireland continue 
to improve care. Developing this knowledge 
is not the ultimate aim; it is one step to the 
continuous improvement in care and health 
outcomes. For this to happen, the knowledge 
generated must be translated into action. The 
NPEC have always strategically aimed to close 
the audit loop and since the establishment of 
the National Women and Infants Health Pro-
gramme (NWIHP) in January 2017, a number 
of the NPEC recommendations have been 
progressed. The NPEC works in collaboration 
with the NWIHP and acknowledges the key 
relationship that is evolving between the two 
organisations. We are also grateful to our col-
leagues in the National Office of Clinical Au-
dit (NOCA) to whose standards our audits are 
aligned and who provide us with constructive 
feedback and support.
Inevitably we can enhance the knowledge we 
have by integrating knowledge from beyond 
our own system, learning from other health 
colleagues who investigate the death of ba-
bies in their care. International comparison 
of these outcomes can enhance our learning. 
Such comparison is difficult when we are not 
comparing like with like, where definitions dif-
fer. In this report we raise the need for a dis-
cussion about the case definitions we use in 
the Republic of Ireland and why we should 
consider assessing a similar cohort of babies 
in a similar way to other developed countries.
Lastly, I would like to thank the staff in the 
NPEC for their ongoing dedication to the mis-
sion of the Centre and our audit Governance 
group for their guidance and intellectual in-
put; together assessing the outcomes of care, 
learning from the data and working with all the 
stakeholders involved, the NPEC continues its 
mission to improve the care of mothers and 
babies in Ireland. 
Richard	A	Greene,	Director,	NPEC
National Perinatal Epidemiology Centre,
5th Floor, Cork University Maternity Hospital,
Wilton, Cork, Ireland.
Email: npec@ucc.ie
Tel: +353 (21) 420 5017 
Foreword 
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Figure	I:	Sections	of	this	Perinatal	Mortality	in	Ireland	Biennial	Report	2018/2019
This is the eighth report of the national clinical 
audit on Perinatal Mortality in the Republic of Ire-
land (ROI), using the NPEC data collection tool 
and classification system. It provides information 
on perinatal deaths arising from births occurring 
in the ROI for the reporting years 2018 and 2019.
Since 2009, the NPEC, in collaboration with the 
multidisciplinary Perinatal Mortality Group (see 
Appendix B), has conducted a national clinical au-
dit of Perinatal Mortality annually. The fundamen-
tal aim of this clinical audit is to provide a nation-
al review of perinatal deaths, to identify quality 
improvement initiatives and make recommenda-
tions for the improvement of care for mothers 
and babies in Ireland. It is acknowledged that 
ongoing monitoring of quality and safety data is 
essential to continually drive improvements in the 
maternity services. The information provided in 
this report contributes to a body of evidence that 
will guide future clinical practice; the counselling 
of bereaved parents; public-health interventions; 
and inform policy makers within the health ser-
vices. The report is divided into seven sections 
(Figure I) with additional information provided in 
the Appendices. 
For the first time in this 2018-2019 audit report, 
the maternity units are identified in the Funnel 
plots detailing perinatal mortality rates across 
units. This development aims to facilitate great-
er transparency in the maternity services and 
follows engagement with all maternity units, the 
NPEC Governance Committees and the National 
Office of Clinical Audit (NOCA).
Following the Repeal of the Eighth amendment 
and the subsequent Health (Regulation of Ter-
mination of Pregnancy) Act 2018; termination of 
pregnancy became legal in the Republic of Ire-
land (ROI) in January 2019. Limited information 
is provided on perinatal deaths (as defined in this 
audit) arising from births in 2019 following termi-




•  National and international comparison of 
Perinatal Mortality Rates (PMR) and the 
impact of in-utero transfer on individual 
unit’s PMR.
•  Distribution of Perinatal Deaths by the 
Robson Ten Group Classification System.
•  Maternal characteristics impacting on 
adverse perinatal outcomes.
•  Management of delivery in women 
experiencing perinatal loss.
•  Infant characteristics impacting on 
adverse perinatal outcomes.
•  Perinatal mortality following termination 
of pregnancy. 




•  “The contribution of Twin Pregnancy to 








• Early neonatal deaths.
•  Perinatal deaths associated with intrapartum 
events.
• Late neonatal deaths.
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Executive Summary 
This is the eighth report of the national clin-
ical audit on Perinatal Mortality in Ireland, 
using the NPEC data collection tool and 
classification system on cause of death. It 
is a biennial report, providing data on per-
inatal deaths arising from births occurring 
in the ROI for the reporting years 2018 and 
2019. All 19 Irish maternity units reported 
anonymised data on 325 deaths arising 
from 61,298 births occurring in 2018, and 
360 deaths arising from 59,574 births oc-
curring in 2019, of at least 500g birthweight 
or at least 24 weeks gestation. 
For the reporting year 2018, stillbirths and 
early-neonatal deaths accounted for 217 
(66.8%) and 108 (33.2%) of the 325 deaths 
respectively. The Perinatal Mortality Rate 
(PMR) was 5.30 deaths per 1,000 births; 
corrected for congenital anomaly, the rate 
was 3.20 per 1,000 births; the stillbirth rate 
was 3.54 per 1,000 births; and the early 
neonatal death rate was 1.77 per 1,000 live 
births. There were a further 30 late neonatal 
deaths reported in 2018.
For the reporting year 2019, stillbirths and 
early-neonatal deaths accounted for 242 
(67.2%) and 118 (32.8%) of the 360 deaths, 
respectively. The PMR was 6.04 deaths per 
1,000 births; corrected for congenital anom-
aly, the rate was 3.73 per 1,000 births; the 
stillbirth rate was 4.06 per 1,000 births; and 
the early neonatal death rate was 1.99 per 
1,000 live births. There were a further 32 late 
neonatal deaths reported in 2019.
Compared to 2018, the number of women/
families experiencing the loss of a baby, 
based on the criteria of birthweight ≥500g 
or gestational age ≥24 weeks, increased 
in 2019. There were an additional 25 still-
births and 10 early neonatal deaths in 2019. 
While not statistically significant (rate ratio, 
RR=1.17, 95%CI=0.96-1.41), this represent-
ed a 17% percent increase in the corrected 
PMR in 2019 compared to 2018. Similarly, 
there was an increase in the uncorrected 
perinatal mortality rate, stillbirth rate and 
neonatal rate in 2019 compared to 2018, 
none of these increases were statistically 
significant. The variation of rates between 
2019 and 2018 are within the limits of ex-
pected year-to-year fluctuations. Of note, 
the overall rate of perinatal mortality has 
remained flat for a number of years, in con-
trast to the decreasing rates observed in 
the decade prior to 2012. While reductions 
in perinatal mortality rates are not easy to 
achieve, other countries have made signifi-
cant reductions in in PMR, particularly still-
births, in recent years.
The care of pregnant mothers was trans-
ferred in utero to another maternity unit in 
15.1% and 11.9 % of the cases associated with 
perinatal deaths in 2018 and 2019 respec-
tively, most commonly to a tertiary referral 
maternity unit. 
The level of variation of PMR across mater-
nity units was higher in 2019 than 2018. The 
PMR for some of the large maternity units 
appeared to be higher than the national 
rate. However, when adjusted for in-utero 
transfers, the PMR in the large tertiary ma-
ternity units are similar to the national rate. 
While one small unit was above the national 
corrected PMR in 2018, none of the 19 ma-
ternity units met the criteria of ‘outlier’, as 
defined by the National Office of Clinical 
Audit (NOCA), in 2018 or 2019.
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For the first time since the inception of this 
audit, hospitals are identified in the funnel 
plots. This is a step towards greater trans-
parency in the Irish maternity services.
Among mothers experiencing perinatal 
death, the proportion of women attending 
their first antenatal visit at 20 weeks ges-
tation or later was slightly lower in 2019 
(5.5%) compared to 2018 (10.2%) and 2017 
(7.7%).
The rate of autopsy uptake in 2019 (49.2%) 
is slightly higher compared to 2018 (42.0%). 
In both 2018 and 2019, the autopsy uptake 
rate in stillbirths (2018; 46.7% and 2019; 
52.1%) continues to be higher than in cas-
es of early neonatal death (2018; 32.0% and 
2019; 43.1%).
Major congenital anomaly was the most 
common cause of stillbirths in both 2018 
and 2019 (2018; 30.9% and 2019; 30.6%). 
This is in contrast to findings in 2017 when 
specific placental conditions were the most 
common cause of death. In 2018, for twenty 
percent of stillbirths the cause of death was 
unexplained. This is higher than the propor-
tion in 2017 (11.1%) and 2019 (9.5%), the lat-
ter year having the lowest rate since 2014.
Low birthweight continues to be associat-
ed with perinatal deaths, particularly with 
stillbirths. 
Major congenital anomaly was also the most 
common cause of early neonatal death in 
both 2018 and 2019 (2018; 57.4 % and 2019; 
54.2%) followed by respiratory disorder 
(2018; 23.1% and 2019; 23.7%), most com-
monly associated with severe pulmonary 
immaturity.
An association between maternal age and 
perinatal mortality was identified. Com-
pared to mothers aged between 25-29 
years, women aged greater than 40 years 
had a higher rate of perinatal mortality 
(2018; 66% and 2019; 35% higher).
In terms of ethnicity and occupation, while 
the numbers involved were small, ethnic mi-
norities and the unemployed were over-rep-
resented in the mothers who experienced 
perinatal deaths in 2018 and 2019. This is 
similar to findings in previous years.
An association between increased BMI and 
perinatal mortality was identified. Obese 
women had more than twice the risk of per-
inatal mortality compared to women who 
gave birth in 2019 with a healthy BMI.
Despite a steady year-on decline in the 
overall birth rate, Ireland has among the 
highest twin and higher-order multiple 
pregnancy birth rates in Europe. Perinatal 
deaths from multiple births accounted for 
12.9% and 9.7% of all perinatal deaths in 
2018 and 2019 respectively. This is over 3.85 
times the proportion of multiples among all 
births in the reporting years 2018 and 2.85 
times the number in 2019.
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Key findings in 2018 and 2019 
Perinatal Mortality Rate (PMR)
•  The PMR was 5.30 per 1,000 births in 2018 and 6.04 per 1,000 births in 2019.
•  Corrected for congenital anomaly, the PMR was 3.20 per 1,000 births in 2018 
and 3.73 per 1,000 births in 2019.
•  There was a 17% increase in the corrected PMR in 2019 compared to 2018. How-
ever, this was not statistically significant.
•  The overall rate of perinatal mortality has remained flat for a number of years, in 
contrast to the decreasing rates observed in the decade prior to 2012.
•  Variation in the rate of PMR was identified between maternity units. However, 
when adjusted for major congenital anomaly and in-utero transfers, no materni-
ty unit was considered an outlier as defined by NOCA.
Stillbirths: Accounted for 66.8% and 67.2% of perinatal deaths in 2018 and 2019 
respectively.
•  Major congenital anomaly was the most common cause of death in both 2018 
and 2019 followed by specific placental conditions. 
Early	neonatal	deaths: Accounted for 33.2 % and 32.8 % of perinatal deaths in 
2018 and 2019 respectively.
•  Major congenital anomaly was the most common cause of neonatal death in 
both 2018 and 2019. Severe pulmonary immaturity was the second most com-
mon cause of early neonatal death in both years.
Late	Neonatal	deaths:	There were 30 and 32 late neonatal deaths in 2018 and 
2019 respectively.
•  Major congenital anomaly was the most common cause of late neonatal death 
in both years.
Low	birth	weight:	As in previous years, low birthweight was associated with per-
inatal deaths in 2018 and 2019, particularly stillbirths.
Multiple	Births:	Perinatal death from multiple births accounted for 12.9% and 9.7% 
of all perinatal deaths in 2018 and 2019 respectively.
Autopsy	Rates: The rate of autopsy uptake continues to be higher in stillbirths 
compared to neonatal deaths.
Maternal	factors:	Maternal age (greater than 40years) and high BMI was associ-
ated with a higher risk of perinatal mortality.
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Recommendations
Recommendations	 from	 previous	 reports	 being	 progressed	 by	 the	 National	
Women’s	and	Infants	Health	Programme:
•  Anonymised histology reports on perinatal death should be submitted to the 
NPEC as part of this audit; this would facilitate standardised interpretation and 
classification of placental conditions.
•  The Hospital Groups should examine the allocation of funding for the perinatal 
pathology service to ensure that a structured approach is taken to recruit staff 
in a timely manner. This has now being progressed by the NWIHP with a number 
of perinatal pathology posts being filled and funding is being sought to com-
plete the plan for a networked perinatal pathology service.
Based	on	the	findings	of	this	and	previous	reports,	the	NPEC	Perinatal	Mortal-
ity	Advisory	Group	makes	the	following	recommendations:
•  Robust clinical audit of perinatal outcomes in all maternity units in Ireland is vital 
for quality patient care. Funding should be provided to ensure protected time 
for clinical audit and implementation of its findings. Owner; the Health Service 
Executive (HSE).
•  The establishment of an enquiry for stillbirth and neonatal deaths should be 
considered in order to enhance the lessons which may improve care. This could 
take the format of a standardised review of specific cohorts, such as:
 – unexpected intrapartum related deaths
 – multiple pregnancies
 – term stillbirths (in normally formed babies) 
These cohorts could be reviewed on a rolling basis. Owner; the National Women 
and Infants Health Programme (NWIHP) and the Institute of Obstetrics and Gy-
naecology (IOG). 
•  Standardised approach to improved antenatal detection of fetal growth restric-
tion (FGR) with timely delivery is a preventative strategy to reduce perinatal 
mortality.1 
 –  One option, as used previously and in other centres, is the generation of cus-
tomized birth weight centile charts for every woman during pregnancy and 
concomitantly, staff should be trained in risk assessment, plotting of symphysial 
fundal height (SFH) and scan weight estimates in order to reduce stillbirths in 
Ireland. Owner; the NWIHP.
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 –  Based on feedback to the NPEC, other methodologies could be considered. 
A multidisciplinary working group should be developed to address a national 
standardised approach to the detection of FGR. A national approach should 
also evaluate the use of a standard growth curve across all Irish maternity units. 
Owner; the NWIHP and the IOG. 
•  Consideration should be given to the establishment of a national working group 
to include Obstetricians, Neonatologists, Midwives and Allied Health Profession-
als whose remit is to look at the problem of preterm birth (PTB) in Ireland at a 
national level and how it is best addressed. Owner; the NWIHP.
•  Valuable considerations around clinical practice and education in the manage-
ment of twin pregnancy is outlined in chapter two of this report. These could be 
included in an update of the 2012 ‘Clinical Practice Guideline, Management of 
Multiple Pregnancy’. Owner; the NWIHP. 
•  Further engagement with the Coroner Society of Ireland to explore the time-
liness of autopsy reports reported to maternity units is warranted. Owner; the 
NWIHP.
• Defining and auditing perinatal loss.
  (a) To allow for international comparison of stillbirths, a move towards collect-
ing data on fetal deaths >22 weeks and < 24 weeks should be considered in the 
audit of perinatal mortality in Ireland.2
  (b) A national working group should be convened to review the definition of 
perinatal mortality in the Republic of Ireland (ROI). This working group should 
include the NWIHP, NPEC, the General Registers Office (GRO), the Institute of 
Obstetrics and Gynaecology, the National Clinical Programme for Paediatrics 
and Neonatology and the Department of Health. Owner; the NPEC.
Areas	for	potential	research	identified	in	the	findings	of	this	report.
•  A public health education programme on perinatal deaths and modifiable risk 
factors should be developed.3, 4 Owner; Public Health agencies in the HSE and 
Department of Health. 
1  Clinical Practice Guideline No 29 (2014). Fetal Growth Restriction Guideline - Recognition, Diagnosis and 
Management: Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate 
of Strategy and Clinical Programmes, Health Service Executive.
2  Kelly K et al. A review of stillbirth definitions: A rationale for change. European Journal of Obstetrics & 
Gynaecology and Reproductive Health. 256 (2021) 235-245
3 Nuzum D, Meaney S, O’Donoghue K. The public awareness of stillbirth: an Irish population study.  
BJOG 2018;125:246–252
4 O’Keeffe LM, Dahly DL, Murphy M, et al Positive lifestyle changes around the time of pregnancy: a cross-sectional 
study BMJ Open 2016;6:e010233. doi: 10.1136/bmjopen-2015-010233 
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Figure	II:	Map	of	maternity	units	and	hospital	groups	in	the	Republic	of	Ireland.	
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Methods
Data	collection	and	management 
In 2018 and 2019, there were 19 maternity units in 
Ireland. Within each maternity, unit coordinators 
with the responsibility of submitting perinatal 
mortality data to the NPEC have been identified. 
Pseudonymised data on perinatal deaths from 
births that occurred between January 1 2018 and 
December 31 2019 were submitted to the NPEC 
by all 19 units using a standardised notification 
dataset either electronically, via the secure online 
NPEC database, or alternatively by paper format 
(see Appendix E). The notification dataset is com-
pleted using data on fetal and maternal charac-
teristics recorded in the clinical records. Imple-
mented nationally in 2011, the NPEC notification 
dataset was based on the validated Centre for 
Maternal and Child Enquiries (CMACE) Perinatal 
Death Notification Form5 and has been endorsed 
by the Clinical Advisory Group at the Institute of 
Obstetrics and Gynaecology, the Faculty of Paedi-
atrics and the HSE National Obstetric Programme 
Working Group.
Figure III illustrates the NPEC data collection and 
management processes. There has been a steady 
improvement in the overall quality of data report-
ed by all maternity units since the implementation 
of the NPEC perinatal mortality notification data-
set in 2011. To ensure completeness and accuracy 
of information, all data is validated directly with 
the respective maternity units. The NPEC also un-
dertakes extensive reconciliation of its annual per-
inatal mortality dataset with that of the National 
Perinatal Reporting System (NPRS). This consoli-
dation with the NPRS is in response to recommen-
dations by the Chief Medical Officer6 and ensures 
that both agencies’ datasets represent the most 
accurate record of perinatal mortality annually.
As previously acknowledged, this report comes 
from the efforts of many people and among the 
most important are the coordinators at the mater-
nity hospitals. At unit level, there is an enormous 
amount of work done by these individuals, some 
working alone, some with colleagues. When we 
get data in the NPEC, we often must verify facts 
about the cases and follow up about outstanding 
reports, etc. We are aware that many coordinators 
are doing this work in their own time and often 
after hours. We know they sometimes want calls 
after hours so they can focus on this work. Audit is 
5 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
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a very important component of health services, it 
is our way of checking what we are doing, can we 
improve, where is there variance. It is an area that 
is recognised as being very important in all strate-
gic documents, but it is rarely supported in spec-
ified resources. There are multiple demands for 
data in the maternity services and indeed some 
duplication; there needs to be a review of the data 
requirements and a streamlining in keeping with 
good data governance and indeed the HIQA data 
quality framework.7 It is difficult to fund resources 
for audit when the frontline is under pressure for 
resources, however its value is not less important, 
and it needs support. As in previous reports we 
again make a recommendation in this area.
•	 Recommendation:	 Robust clinical audit 
of perinatal outcomes in all maternity units 
in Ireland is vital for quality patient care. 
Funding should be provided to ensure pro-
tected time for clinical audit and implemen-
tation of its findings. Owner; the Health Ser-
vice Executive (HSE) 
The	2018/2019	birth	cohort
In this 2018/2019 biennial report, perinatal deaths 
are presented for births from 1 January 2018 to 
31 December 2019. This allows neonatal deaths of 
December 2018 births which occurred in January 
2019 to be included, and likewise this allows neo-
natal deaths of December 2019 births which oc-
curred in January 2020 to be included. The NPEC 
have been reporting on the perinatal mortality for 
a birth cohort in both the 2015 and 2016 perinatal 
mortality reports. This method of reporting peri-
natal mortality for a birth cohort allows more ac-
curate estimates of mortality rates to be produced 
as appropriate denominators are available. The 
MBRRACE-UK Perinatal Mortality Surveillance Re-
ports are based on perinatal mortality for a birth 
cohort also.8 The NPEC Perinatal Mortality Reports 
for the years 2011-2014 were based on deaths in a 
calendar year. Therefore, in this 2018/2019 report, 
2011-2014 figures have been revised to adjust for 
this.
Rate	calculations
To assess perinatal mortality, overall and unit-spe-
cific perinatal mortality rates (PMRs) per 1,000 
births and corresponding 95% confidence inter-
vals were derived. For incidence rates, 95% confi-
dence intervals were calculated using exact Pois-
son confidence limits unless stated otherwise. 
Stillbirth, neonatal and corrected PMRs, which ex-
clude deaths associated with or due to a congen-
ital anomaly, were also calculated. Denominator 
data on the number of live births and stillbirths in 
both 2018 and 2019 was provided directly by the 
Irish Healthcare Pricing Office.9, 10
Perinatal deaths are included in a maternity unit’s 
rate if the baby was delivered in the maternity 
unit or if the unit was the intended place of de-
livery, but the baby was born before arrival. In the 
event of a neonatal death, the perinatal death is 
assigned to the maternity unit where the baby 
was delivered regardless of where the baby died 
(includes post-natal transfers to tertiary maternity 
units/paediatric centres). 
Rate	ratios
Further analysis was conducted to assess varia-
tion in incidence rates between years, maternal 
age groups, body mass index categories and nul-
liparous and multiparous women. This analysis in-
volved using Poisson regression which calculates a 
rate ratio (for example, the rate in one year divided 
by the rate in the previous year). Rate ratios have 
the advantage of being easy to interpret. They 
are interpreted against the rate to which they are 
being compared (the reference group/reference 
rate). A rate ratio is greater than one if a rate is 
greater than the rate to which it is being compared. 
For example, a rate ratio of 1.25 indicates the rate 
being examined is 25% higher than (or 1.25 times) 
the rate to which it is being compared. Converse-
ly, a rate ratio will be less than one if a rate is less 
than the rate to which it is being compared. For 
example, a rate ratio of 0.80 indicates that the rate 
7  Health Information and Quality Authority.(HIQA) Guidance on a data quality framework for health and social care. Health Information and 
Quality.2018. Available from: https://www.hiqa.ie/sites/default/files/2018-10/Guidance-for-a-data-quality-framework.pdf
8  Draper ES, Gallimore ID, Kurinczuk JJ, Smith PW, Boby T, Smith LK, Manktelow BN, on behalf of the MBRRACE-UK Collaboration. MBRRACE-UK 
Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 2016. Leicester: The Infant Mortality and Morbidity 
Studies, Department of Health Sciences, University of Leicester. 2018.
9  Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press]
10  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press]
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being examined is equivalent to 80% of the rate to 
which it is being compared, i.e. it is 20% lower. The 
Poisson regression analysis provides a 95% confi-
dence interval for the rate ratio and the associated 
p-value, both of which indicate whether the rate 
difference is in line with what might be expected 
due to chance. A rate difference is considered to 
be beyond what might be expected by chance, i.e. 
statistically significant, if the 95% confidence inter-
val for the rate ratio does not include the value one. 
This is equivalent to the p-value derived from the 
analysis being less than 0.05. If the p-value is less 
than 0.001 then the rate difference may be consid-
ered highly statistically significant.
Funnel	plots
Variations in PMRs between maternity units could 
potentially be due to random chance or reflect 
differences in baseline characteristics of the child-
bearing population. For this reason, funnel plots 
were used to assess performance outcomes for 
individual units in comparison to the overall aver-
age.11 In brief, the plot is a scatter diagram of in-
dividual maternity unit mortality rates against the 
number of births within that unit. The national rate 
is indicated by the solid straight line. The 95% con-
fidence interval is indicated by the curved dashed 
line. The dashed lines represent the limits within 
which 95% of units are expected to lie (i.e. with-
in two exact binomial standard errors). The 99.8% 
confidence interval for the national rate is plot-
ted using solid lines. These solid lines represent 
the limits within which 99.8% of units are expect-
ed to lie (i.e. within three exact binomial stand-
ard errors). The width of the confidence interval 
is adjusted to allow for meaningful comparison 
between unit-specific rates and the national rate. 
The confidence interval is wider for smaller units 
reflecting the lack of precision in rates calculated 
based on small numbers. The confidence interval 
narrows for larger maternity units, giving the dia-
gram a ‘funnel’ shape. Maternity unit rates outside 
the 95% and 99.8% confidence interval are statis-
tically significantly different from the national rate. 
In general, one in 20 units would be expected to lie 
outside the 95% confidence limits by chance alone 
whereas an observation outside the 99.8% confi-
dence limits is especially rare, i.e. there is a 0.2% 
chance of this happening (Figure IV).
Birthweight	centile
As with previous reports, we have produced charts 
to highlight the issue of failure of fetal growth in 
utero in relation to the stillbirths and early neo-
Figure	IV:	Diagram	outlining	the	interpretation	of	a	Funnel	Plot	
11  Spiegelhalter D. (2002) Funnel plots for institutional comparison. Quality and Safety in Health Care; 11(4):390-91.
99.8% confidence interval (CI). 
Rates above the 99.8% CI are 
markedly higher than the national 
rate.
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natal deaths that occurred in Ireland in 2018 and 
2019. To do so, we used the Gestation Related Op-
timal Weight (GROW) software12 and coefficients 
derived from the multiple regression analysis of 
data on 11,072 births in six maternity units in Dub-
lin, Galway, Limerick and Belfast in 2008-2009.13
The regression analysis determined the Term (i.e. 
40 weeks) Optimal Weight (TOW) in Ireland to be 
3,490.7g. The normal range (i.e. the range from 
the 10th centile weight to the 90th centile weight) 
around the TOW was then calculated and the rec-
ommended proportionality growth function was 
applied to the TOW, the 10th centile term weight 
and the 90th centile term weight in order to de-
termine the optimal weight and normal range at 
all gestations (21-44 weeks for the stillbirths and 
early neonatal deaths in Ireland in 2018 and 2019). 
These steps are described in detail in the GROW 
documentation.
Customised birthweight centiles were also de-
rived using the GROW software. There was miss-
ing data for maternal height (2018 n=47 of 325, 
14.5% and 2019 n=102 of 360, 28.3%) and weight 
(2018 n=40 of 325, 12.3% and 2019 n=79 of 360, 
21.9%). For these cases, we used the median 
height and weight of the mothers with complete 
data. The GROW software also provides estimat-
ed customised birthweight centiles in cases with 
missing data. Ultimately, customised birthweight 
centiles were calculated for 316 of the 325 perina-
tal in deaths in 2018 and for 356 of the 360 peri-
natal in deaths in 2019.
Classification	of	abnormal	placental	his-
tology
Abnormal placental findings have been classified 
and presented under the following broad catego-
ries: maternal vascular malperfusion, fetal vascu-
lar malperfusion, cord pathology, cord pathology 
with distal disease, delayed villous maturation de-
fect, chorioamnionitis, villitis and ‘other placental 
condition’ (Appendix F). This is in keeping with 
recommendations in a publication from an inter-
national consensus meeting of pathology.14 It is 
envisaged that this will optimise classification of 
placental conditions causing or contributing to 
perinatal loss.
Classification	of	death
The NPEC data collection form requests contrib-
utors to identify maternal, fetal and neonatal con-
ditions, using specific categories, which caused or 
were associated with the death. The unit contrib-
utor is also requested to assign the principal cause 
of death with reference to the post mortem and 
placental pathology if performed. Guidance and 
definitions for completing specific categories are 
described in Appendix G. Briefly described, cat-
egories include both pathophysiological entities 
and clinical conditions present at time of death 
including placental pathology and Intra-Uterine 
Growth Restriction (IUGR). Classification of still-
births was made using the NPEC maternal and fe-
tal classification system. In the case of neonatal 
deaths, the NPEC neonatal classification system 
was used to attribute the main neonatal cause of 
death and the NPEC maternal and fetal classifica-
tion system was used to identify the underlying 
obstetric condition/sentinel event associated with 
the death. 
Robson	Ten	Group	Classification	System
In 2018 (16 of the 19) and 2019, (17 of the 19 units) 
units participated in the perinatal mortality audit 
also provided data on all deliveries classified ac-
cording to the Ten Group Classification System 
(TGCS) (Appendix H).15 This facilitated perina-
tal deaths to be classified according to the Ten 
Groups for these units. 
Definitions	and	terminology
While individual units define perinatal cases simi-
larly, there is some variation. To allow for compar-
ison across all units the NPEC used the following 
definitions for the current report:
Stillbirth:	 The NPEC seeks to apply a definition 
of stillbirth in accordance with the Irish Stillbirths 
Registration Act, which specifies stillbirth as a child 
born weighing 500 grams or more or having a ges-
tational age of 24 weeks or more who shows no 
sign of life.16 Cases of intrauterine death diagnosed 
12  Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
13  Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. The customized 
fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
14  Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab Med.
15  Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/S0965539501000122
16  Stillbirth Registration Act, 1994. Available at: http://www.irishstatutebook.ie/eli/1994/act/1/enacted/en/print 
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before 24 gestational weeks with a birthweight 
<500g are not considered to have reached a ges-
tational age of 24 weeks or more and thus are not 
included as stillbirths in this audit.
Early	neonatal	death: Death of a live born baby 
occurring within 7 completed days of birth. 
Late	 neonatal	death: Death of a live born baby 
occurring after the 7th day and within 28 com-
pleted days of birth. 
Live	 birth: Live birth refers to the complete ex-
pulsion or extraction from its mother of a product 
of conception, irrespective of the duration of the 
pregnancy, which, after such separation, breathes 
or shows any other evidence of life - e.g. beating 
of the heart, pulsation of the umbilical cord or 
definite movement of voluntary muscles - wheth-
er or not the umbilical cord has been cut or the 
placenta is attached. Each product of such a birth 
is considered live born.17
Total	births:	For the purpose of calculating per-
inatal mortality rates, the denominator used was 
the number of births (live birth and stillbirths) 
from 24 weeks gestation or birthweight >500g. 
Stillbirth	 rate: Number of stillbirths per 1,000 
births (live births and stillbirths from 24 weeks 
gestation or weighing >500g). The reporting 
guideline used by the Irish Healthcare Pricing Of-
fice perinatal statistics report on stillbirths uses 
the criterion of birthweight >500g.18, 19 For consist-
ency, we also report the stillbirth rate using the 
criterion of birthweight >500g.
Neonatal	 death	 rate: Number of early neona-
tal deaths per 1,000 live births (from 24 weeks 
gestation or weighing >500g). The Irish Health-
care Pricing Office perinatal statistics report on 
early neonatal deaths with a birthweight >500g. 
For consistency, we also report the early neona-
tal death rate using the criterion of birthweight 
>500g.
Perinatal	 mortality	 rate	 (PMR): Number of still-
births and early neonatal deaths per 1,000 births 
(live births and stillbirths from 24 weeks gestation 
or weighing >500g). Neonatal deaths occurring in 
babies with a birthweight < 500g and delivered 
before 24 weeks are not included in the PMR. 
However, the collation of data on these perinatal 
events by the NPEC provides vital information sur-
rounding adverse pregnancy outcomes in all reg-
istered live births. Again, for consistency with the 
Irish Healthcare Pricing Office reporting of peri-
natal statistics, we also report the neonatal death 
rate using the criterion of birthweight >500g. Late 
neonatal deaths are not included in the PMR.
Corrected	PMR:	Perinatal mortality rate excluding 
perinatal deaths associated with or due to a major 
congenital malformation.
Booking:	Some data sought by the NPEC Perinatal 
Death Notification Form relate to the time of book-
ing. Booking in this regard relates to the mother’s 
first antenatal visit at the maternity unit.
In	utero	 transfer:	From January 2016, the NPEC 
Perinatal Death Notification Form contains a spe-
cific question on whether the obstetric care of the 
mother was transferred to another maternity unit 
with the fetus in utero. The identity of the trans-
ferring unit and gestational age at time of in-utero 
transfer are also captured.
Parity: The number of completed pregnancies, 
whether live birth or stillbirth, of at least 24 weeks 
gestation or with a birthweight ≥500g. We refer 
to parity prior to the pregnancy that resulted in a 
perinatal loss.
Gravida:	 The number of times the mother has 
been pregnant, irrespective of duration. We refer 
to gravida prior to the pregnancy that resulted in 
a perinatal loss.
Termination	of	pregnancy	(TOP):	The NPEC Per-
inatal Death Notification Form contains a specific 
question on whether the perinatal loss occurred 
following Termination of Pregnancy (TOP). TOP 
refers to all cases where the pregnancy is medi-
cally ended, with the expected outcome of fetal 
or early neonatal death, in either of the following 
events: in the interest of the maternal health OR 
in cases of fatal fetal malformation. Within this re-
port perinatal deaths, as defined in this audit, fol-
lowing TOP are reported from January 2019. 
17  World Health Organisation. Available at: http://www.who.int/healthinfo/statistics/indmaternalmortality/en/
18  Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press]
19  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press]
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20  Health Information and Quality Authority. Guidance on a data quality framework for health and social care 2018. : HIQA; 2018 
[cited 2019]. Available from: https://www.hiqa.ie/sites/default/files/2018-10/Guidance-for-a-data-quality-framework.pdf 
Data Quality Statement
In the National Perinatal Epidemiology Centre the maintenance of data at high quality 
standards is a priority. The purpose of this data quality statement is to support the in-
terpretation and quality of the information contained in this report.
This quality statement, presented in Appendix I, has been developed in line with the 
Health Information and Quality Authority (HIQA) guidance on data quality framework 
for health and social care.20 The statement describes the quality of the data according 
to five data quality dimensions as defined by HIQA: 
1. Relevance 
2. Accuracy and reliability 
3. Timeliness and punctuality 
4. Coherence and comparability 
5. Accessibility and clarity
The National Clinical Audit of Perinatal Mortality adheres to following national and 
international legislation and standards: 
• The European Union General Data 
• Protection Regulation 2016 
• The Data Protection Act 1988 and the 
• Data Protection (Amendment) Act 2003
• Data Protection Act 2018 (Section 36(2)) (Health Research) Regulations 2018
• Information Management Standards for National Health and Social Care Data (2017)
• National Office of Clinical Audit Standards for National Clinical Audit 
• National Standards for Safer Better Healthcare (2012) 
• FAIR (Findable, Accessible, Interoperable, and Re-usable) Data Principles. 
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1. Main findings
Perinatal	mortality	rate
This section of the report provides details of the 
perinatal mortality rate (PMR), maternal and in-
fant characteristics and autopsy uptake. In line 
with previous reports, the findings provided in 
this section relate to stillbirths and early neonatal 
deaths only. Separate sections are then provided 
for stillbirths, early neonatal deaths and late neo-
natal deaths describing clinical management and 
the main cause of death based on the NPEC Clas-
sification System.
In 2018, the 19 Irish maternity units reported 61,298 
births with a birthweight >500g or gestational age 
of ≥ 24 weeks. Of these 61,298 births, 325 met the 
criteria and were classified as perinatal deaths. 
Stillbirths and early neonatal deaths accounted for 
217 (66.8%) and 108 (33.2%) of the 325 deaths re-
spectively. There were a further 30 late neonatal 
deaths in 2018. In 2019, the 19 Irish maternity units 
reported 59,574 births with a birthweight >500g 
or gestational age ≥ 24 weeks. Of these 59,574 
births, 360 were subsequently classified as peri-
natal deaths. Stillbirths and early neonatal deaths 
accounted for 242 (67.2%) and 118 (32.8%) of the 
deaths, respectively. There were a further 32 late 
neonatal deaths in 2019.
The reporting guideline used by the Irish Health-
care Pricing Office (HPO) in their publication of 
national perinatal statistics, uses the criterion of 
birthweight >500g. In 2018, there were 61,258 ba-
bies born weighing >500g. Of these 61,258 babies, 
302 met the criteria and were classified as peri-
natal deaths. Stillbirths and early neonatal deaths 
accounted for 197 (65.2%) and 105 (34.8%) of the 
302 deaths, respectively. A further 30 babies met 
the criteria and were classified as late neonatal 
deaths in 2018. In 2019, there were 59,536 babies 
born weighing >500g. Of these 59,536 babies, 
339 met the criteria and were classified as peri-
natal deaths. Stillbirths and early neonatal deaths 
accounted for 223 (65.8%) and 116 (34.2%) of the 
339 deaths respectively. A further 32 babies met 
the criteria and were classified as late neonatal 
death in 2019.
As detailed in Table 1.1, in 2018 the stillbirth rate 
associated with the criteria of birthweight >500g 
or gestational age >24 weeks was 3.54 per 1,000 
births and the early neonatal death rate using the 
same criteria was 1.77 per 1,000 live births com-
pared respectively to 3.22 and 1.72 per 1,000 births 
based on birthweight >500g. In 2018, the overall 
PMR was 5.30 deaths per 1,000 births and when 
corrected for congenital anomaly was reduced to 
3.20 whereas the respective rates based on birth-
weight >500g were 4.93 and 2.92 per 1,000 births. 
In 2019 the stillbirth rate associated with the cri-
teria of birthweight >500g or gestational age >24 
weeks was 4.06 per 1,000 births and the early neo-
natal death rate using the same criteria was 1.99 per 
1,000 live births compared respectively to 3.75 and 
1.96 per 1,000 births based on birthweight >500g. 
In 2019, the overall PMR was 6.04 deaths per 1,000 
births and when corrected for congenital anomaly 
was reduced to 3.73 whereas the respective rates 






























































Note: BWT=Birthweight; Rate per 1,000 births; 95% CI=95% Poisson confidence interval;  
Corrected perinatal deaths exclude deaths due to a congenital anomaly. 
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European	comparison	of	the	rate	of	still-
birth
In 2018, Euro-Peristat published a report entitled, 
the ‘European Perinatal Health Report’ which com-
pared the stillbirth rate across countries in Europe 
in 2015.21 The criterion for the stillbirth rate was 
gestational age ≥28 weeks. Based on this criteri-
on, Figure 1.1 illustrates the 2018 and 2019 Irish total 
stillbirth rate and the corrected Irish stillbirth rate, 
which excludes cases due to a congenital anomaly 
in comparison to the reported stillbirth rate for the 
other countries in Europe. 
Figure	1.1:	Irish	stillbirth	rate	in	2018/2019	compared	to	the	stillbirth	rate	in	other	countries	in	Europe
Note: Rates based on stillbirths among births with ≥28 completed weeks of gestation. The Irish stillbirth rate, when 
corrected by excluding cases due to a congenital anomaly, is adjusted to 2.1 per 1,000 births in 2018 and 2019.
21  Euro-Peristat Project. European Perinatal Health Report. Core indicators of the health and care of pregnant 
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Comparison	 of	 perinatal	 mortality,	
2013-2019
Table 1.2 compares the perinatal mortality out-
comes for 2018 and 2019, based on the criteria 
of birthweight ≥500g or gestational age ≥24 
weeks, with those of the previous five years. 
Compared to 2018, the number of women/fam-
ilies experiencing the loss of a baby, based on 
the above criteria, increased in 2019. There were 
an additional 25 stillbirths and 10 early neonatal 
deaths in 2019. While not statistically significant 
(rate ratio, RR=1.17, 95%CI=0.96-1.41), this repre-
sented a 17% percent increase in the corrected 
PMR in 2019 compared to 2018. Similarly, there 
was an increase in the uncorrected perinatal 
mortality rate, stillbirth rate and neonatal rate in 
2019 compared to 2018, none of these increas-
es were statistically significant (uncorrected 
PMR RR=1.14, 95%CI=0.98-1.32, stillbirth RR=1.15, 
95%CI=0.96-1.38 and early neonatal deaths 
RR=1.12, 95%CI=0.87-1.46). The overall finding of 
the not statistically significant increased rates in 
2019 versus 2018 indicates that these increases 
are within the limits of expected year-to-year 
fluctuations. Furthermore, 2018 was the year 
with the lowest national perinatal mortality rates 
recorded in Republic of Ireland by the NPEC to 
date.
Table	1.2:	Comparison	of	perinatal	statistics,	2013-2019
2013 2014 2015 2016 2017 2018 2019 RR	(95%	CI)
Total	births N 69,146 67,663 65,904 64,133 62,076 61,298 59,574
Stillbirths
n 294 324 287 250 235 217 242
1.15 (0.96-1.38)
rate 4.3 4.8 4.4 3.9 3.8 3.54 4.06
Early	neonatal	
deaths
n 162 142 166 124 111 108 118
1.12 (0.87-1.46)
rate 2.4 2.1 2.5 1.9 1.8 1.77 1.99
Perinatal	deaths
n 456 466 453 374 346 325 360
1.14 (0.98-1.32)
rate 6.6 6.9 6.9 5.8 5.6 5.30 6.04
Corrected	
perinatal	deaths
n 296 315 279 228 220 196 222
1.17 (0.96-1.41)
rate 4.3 4.7 4.2 3.6 3.5 3.20 3.73
Note: Rates are per 1,000 births; RR=Rate ratio comparing rate in 2019 versus rate in 2018; 95% CI=Exact Poisson 95% confidence 
intervals; Corrected perinatal deaths exclude deaths due to a congenital anomaly.
Figure	1.2:	Trend	in	perinatal	mortality	rates	in	Ireland,	2012-2019
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The time trend in each of the perinatal mortality 
rates is illustrated in Figure 1.2. The overall rate of 
perinatal mortality has remained flat for a num-
ber of years, in contrast to the decreasing rates 
observed in the decade prior to 2012.22 While re-
ductions in perinatal mortality rates (PMR) are 
not easy to achieve, other countries have made 
significant reductions in recent years. In the UK, 
a 20% reduction in stillbirths and a 5.1% reduction 
in neonatal deaths was achieved.23 A similar ap-
proach in New Zealand has led to an 11% reduction 
in stillbirths.24 The Netherlands have shown the 
highest rate of decrease in stillbirths of 48 coun-
tries, at 6.2% per year.25 In this report, Ireland was 
17th on an equivalent PMR and 10th in terms of a 
reduction in rate. The reductions in the different 
countries have been achieved through the use of 
various care bundles, with the greatest reductions 
been found in stillbirths. NHS England has ‘Saving 
Babies Life Care Bundle’: 1. Reducing smoking in 
pregnancy 2. Risk assessment and surveillance for 
fetal growth restriction 3. Raising awareness of re-
duced fetal movement 4. Effective fetal monitor-
ing during labour and in the new version 2, (2019) 
have added Reduction of preterm labour.26 Sim-
ilar approaches are undertaken in New Zealand: 
The National Maternity Monitoring Group (NMMG) 
was established in 2012 as part of the Maternity 
Programme to oversee and review national ma-
ternity standards and highlight areas in need of 
improvement. The Netherlands have prioritised 
the implementation of learning points from audits, 
and a programme has been developed to help lo-
cal teams with the implementation process.27 
While the NWIHP are progressing a number of 
the recommendations from previous NPEC re-
ports, a coordinated approach including other 
agencies such as the IOG and the Healthy Ireland 
Programme (Department of Health and Wellbeing 
in the HSE) should allow a care bundle approach 
towards kick starting further improvement. Imple-
mentation of the recommendations in this report 
and perhaps packaging them with those such as 
CTG interpretation/ risk assessment, as recom-
mended in the Therapeutic Hypothermia Report 
2019,28 would assist the maternity services in Ire-
land to achieve a further reduction in the perinatal 
mortality and morbidity rates. 
Variation	by	maternity	unit
Based on birthweights ≥500g and/or gestation at 
delivery ≥24 weeks, in 2018 the uncorrected PMR 
across the Irish maternity units ranged from 2.82 
to 7.50 per 1,000 births and the corrected PMR 
ranged from 1.03 to 5.98 per 1,000 births (Table 
1.3). In 2019, the uncorrected PMR across the Irish 
maternity units ranged from 1.37 to 9.12 per 1,000 
births and the corrected PMR ranged from 0.84 to 
5.34 per 1,000 births. This level of variation across 
units is higher in 2019 compared to 2018. There 
was little or no correlation between the unit-spe-
cific corrected PMR in 2018 and 2019.
As reported earlier, there was an increase in the 
corrected PMR at the national level from 3.20 
per 1,000 births in 2018 to 3.73 per 1,000 births 
in 2019, this increase was not statistically signifi-
cant (P=0.118). It must be noted that year-to-year 
changes at the level of individual units are volatile 
due to the smaller numbers involved. Moreover, 
the profile of mothers delivered may differ across 
Irish maternity units and this may explain varia-
tion in perinatal mortality rates. However, to es-
tablish this requires more detailed information on 
all mothers delivered at Irish maternity units than 
is currently available. 
22  Healthcare Pricing Office. (2016) Perinatal Statistics Report 2014. Dublin:
23  NHS England. Better Births Four Years On: A Review of Progress.; 2020 https://www.england.nhs.uk/wp content/
uploads/2020/03/better-births-four-years-on-progress-report.pdf.
24  PMMRC. Twelfth Annual Report of the Perinatal and Maternal Mortality Review Committee Reporting Mortality 2016.; 2018
25 Flenady V, Wojcieszek AM, Middleton P, et al. Stillbirths: Recall to action in high-income countries. Lancet. 2016;387(10019):691-702.
26  Saving-Babies-Lives-Care-Bundle-Version-Two-Updated-Final-Version.pdf (england.nhs.uk). 
27  www.actiontoolkit.nl.
28  Neonatal Therapeutic Hypothermia in Ireland, Annual Report 2019. Cork. Available at: https://www.ucc.ie/en/media/research/
nationalperinatalepidemiologycentre/annualreports/Published2019AnnualReportv1.pdf 




2018 2019 2018 2019
Cavan (CGH) 3.30 (1.07-7.70) 5.08 (2.05-10.45) 1.32 (0.16-4.77) 3.63 (1.18-8.45)
Coombe (CWIUH) 5.04 (3.63-6.8) 5.92 (4.35-7.87) 3.36 (2.23-4.85) 4.16 (2.86-5.83)
Cork (CUMH) 5.28 (3.77-7.18) 8.32 (6.36-10.7) 3.03 (1.92-4.55) 4.72 (3.27-6.58)
Drogheda (OLOL) 3.26 (1.56-5.98) 4.06 (2.1-7.09) 2.28 (0.92-4.69) 2.71 (1.17-5.33)
Galway (UHG) 3.50 (1.68-6.43) 3.87 (1.94-6.92) 2.10 (0.77-4.56) 1.06 (0.22-3.09)
Kerry (UHK) 3.19 (0.87-8.15) 1.68 (0.2-6.04) 1.59 (0.19-5.75) 0.84 (0.02-4.66)
Kilkenny (SLHK) 5.69 (2.61-10.78) 1.37 (0.17-4.96) 3.80 (1.39-8.24) 1.37 (0.17-4.96)
Letterkenny (LUH) 5.24 (2.4-9.93) 3.04 (0.99-7.09) 2.33 (0.64-5.95) 2.43 (0.66-6.22)
Limerick (UMHL) 4.51 (2.75-6.95) 4.09 (2.39-6.54) 2.03 (0.93-3.85) 2.65 (1.32-4.73)
Mayo (MUH) 7.30 (3.65-13.03) 5.84 (2.67-11.06) 5.98 (2.74-11.31) 1.95 (0.4-5.68)
Mullingar (RHM) 3.58 (1.44-7.36) 6.54 (3.48-11.15) 1.53 (0.32-4.47) 4.02 (1.74-7.91)
National Maternity (NMH) 7.31 (5.55-9.44) 9.12 (7.15-11.45) 4.03 (2.76-5.69) 5.00 (3.57-6.8)
Portiuncula (PUH) 7.50 (3.88-13.06) 5.23 (2.26-10.28) 4.37 (1.76-8.99) 3.27 (1.06-7.61)
Portlaoise (MRHP) 2.82 (0.77-7.22) 4.03 (1.48-8.74) 1.41 (0.17-5.09) 4.03 (1.48-8.74)
Rotunda (RH) 6.57 (4.96-8.52) 8.07 (6.27-10.22) 4.10 (2.86-5.7) 5.34 (3.90-7.14)
Sligo (SUH) 2.95 (0.80-7.53) 2.93 (0.8-7.47) 2.95 (0.8-7.53) 2.19 (0.45-6.40)
South Tipperary (STGH) 3.10 (0.64-9.02) 5.65 (1.84-13.13) 1.03 (0.03-5.74) 4.52 (1.23-11.53)
Waterford (UHW) 5.00 (2.29-9.47) 4.63 (2.00-9.10) 3.33 (1.22-7.24) 2.89 (0.94-6.74)
Wexford (WGH) 7.13 (3.69-12.42) 1.81 (0.37-5.28) 5.94 (2.85-10.90) 1.21 (0.15-4.35)
National Maternity (NMH) 5.30 (4.74-5.91) 6.04 (5.44-6.70) 3.20 (2.77-3.68) 3.73 (3.25-4.25)
Note: Rates per 1,000 births based on birthweights ≥500g or gestational age ≥24 weeks; PMR=perinatal mortality rate;  
Corrected PMR excludes deaths due to a congenital anomaly. 
In	utero	transfer
In Ireland, women with high risk pregnancies may 
be transferred to the care of tertiary maternity 
units with facilities for specialist fetal medicine 
and high-level neonatal intensive care. Of the 
325 perinatal deaths in 2018, there were 49 cases 
(15.1%) where the care of the pregnant woman was 
transferred in utero. These 49 in utero transfers 
resulted in 16 stillbirths (32.7%) and 33 early neo-
natal deaths (67.3%). All but two of the 49 in utero 
transfer cases in 2018 were transferred to one of 
the country’s four large maternity hospitals.
The solid horizontal line in Figure 1.3 represents 
the national PMR in 2018 (5.3 deaths per 1,000 
births) and the lettered square markers represent 
each unit’s PMR. The dashed curves represent the 
95% confidence limits around the national rate 
and the full curves represent the 99.8% confidence 
limits. For maternity units with a PMR equivalent 
to the national rate, there is a 5% chance that a 
unit’s observed PMR will be outside the 95% confi-
dence limits and a one-in-500 or 0.2% chance that 
a unit’s observed PMR will be outside the 99.8% 
confidence limits. One large tertiary maternity unit 
had an uncorrected PMR above the national rate 
and between the upper 95% confidence limit and 
the upper 99.8% confidence limit. 
25< CONTENTS PAGE BIENNIAL REPORT 2018/2019
Figure	1.3:	Funnel	plot	of	the	perinatal	mortality	rate	(PMR)	for	Irish	maternity	units,	2018
Three units (C, D and F) have similar rates as do three other units (E, H, I) (represented by the overlapping lettered square markers. 
A – South Tipperary (STGH); 
B – Kerry (UHK); 
C – Sligo (SUH); 
D – Portlaoise (MRHP); 
E – Mayo (MUH); 
F – Cavan (CGH);
G – Kilkenny (SLHK); 
H – Portiuncula (PUH); 
I – Wexford (WGH); 
J – Letterkenny (LUH); 
K – Waterford (UHW); 
L – Mullingar (RHM); 
M – Galway (UHG); 
N – Drogheda (OLOL); 
O – Limerick (UMHL); 
P – Cork (CUMH); 
Q – National Maternity (NMH);
R – Coombe (CWIUH);
S – Rotunda (RH).
In Figure 1.3, the red square markers represent 
each unit’s PMR in 2018 if these in utero transfers 
had not happened, i.e. if all mothers who expe-
rienced perinatal loss after their care was trans-
ferred in utero had instead experienced perinatal 
loss in the care of the maternity unit where she in-
tended to deliver at the time of her first antenatal 
visit. Without these in utero transfer cases, almost 
all of the country’s small maternity units would 
have had a higher PMR while the PMR for the four 
large maternity hospitals, considered together, 
would have been 20.9% lower. This impact varied 
across the four large maternity hospitals, as illus-
trated in Figure 1.3. Without these in utero trans-
fers, the PMR in 2018 would have been 7.5% lower 
for one hospital, 19.0% lower for another hospital, 
19.6% lower for the third hospital and 32.8% lower 
for the fourth hospital. With this adjustment, the 
PMR for these large tertiary maternity hospitals 
would have been very similar to the national rate.
Of the 360 perinatal deaths in 2019, there were 
43 cases (11.9%) where the care of the pregnant 
woman was transferred in utero. These 43 in utero 
transfers resulted in 15 stillbirths (34.9%) and 28 
early neonatal deaths (65.1%). All but one of the 
43 women had her care transferred to one of the 














































Total births in unit (≥500g or ≥24 weeks), 2018
Unit rate National rate 95% Limits 99.8% Limits
26 PERINATAL MORTALITY IN IRELAND < CONTENTS PAGE
Figure	1.4:	Funnel	plot	of	the	perinatal	mortality	rate	(PMR)	for	Irish	maternity	units,	2019	
The solid horizontal line in Figure 1.4 represents 
the national PMR in 2019 (6.0 deaths per 1,000 
births). One large maternity hospital had a PMR 
higher that the national rate and above the upper 
99.8% confidence limit. Another two large mater-
nity hospitals had a PMR that was higher than the 
national rate and between the upper 95% confi-
dence limit and the upper 99.8% confidence limit. 
In contrast, all but one of the 15 smaller maternity 
units had a PMR that was lower than the national 
rate.
The red square markers represent each unit’s PMR 
in 2019 if these in utero transfer had not hap-
pened, i.e. if the 43 mothers who experienced per-
inatal loss after their care was transferred in utero 
had instead experienced perinatal loss in the care 
of the maternity unit where delivery was intend-
ed at the time of the first antenatal visit. Without 
these in utero transfer cases, almost all of the 
country’s small maternity units would have had 
a higher PMR and, for most, it would have been 
similar to the national rate. The uncorrected PMR 
for the four large maternity hospitals would have 
been lower, 16.1% lower if considered together, but 
this varied by hospital, as illustrated in Figure 1.4. 
Without the 43 in utero transfers, the PMR in 2019 
would have been 8.3% lower for one large mater-
nity hospital, 10.6% lower for another maternity 
hospital, 14.7% lower for the third large materni-
ty hospital and 27.4% lower for the fourth large 
maternity hospital. With this adjustment, the PMR 
for these hospitals would have been between the 
95% confidence limits. This shows the impact on 
perinatal mortality rates for these large materni-
ty hospitals associated with in utero transfer. As 
previously mentioned, in Ireland, women with high 
risk pregnancies may be transferred to the care 
of tertiary maternity units with facilities for spe-
cialist fetal medicine and high-level neonatal in-
tensive care. These transfers are undertaken in the 
best interest of the mother and her baby/babies 
to allow appropriate care for preterm deliveries, 



















































Total births in unit (≥ 500g or ≥ 24 weeks ), 2019
Unit rate National rate 95% Limits 99.8% Limits
A – South Tipperary (STGH); 
B – Kerry (UHK); 
C – Sligo (SUH); 
D – Portlaoise (MRHP); 
E – Mayo (MUH); 
F – Cavan (CGH);
G – Kilkenny (SLHK); 
H – Portiuncula (PUH); 
I – Wexford (WGH); 
J – Letterkenny (LUH); 
K – Waterford (UHW); 
L – Mullingar (RHM); 
M – Galway (UHG); 
N – Drogheda (OLOL); 
O – Limerick (UMHL); 
P – Cork (CUMH); 
Q – National Maternity (NMH);
R – Coombe (CWIUH);
S – Rotunda (RH).
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Corrected	perinatal	mortality	rate
The solid horizontal line in Figure 1.5 represents 
the national corrected PMR in 2018 (3.2 deaths per 
1,000 births) based on the 196 perinatal deaths 
not due to congenital anomaly. 
Twenty-one (10.7%) of the 196 perinatal deaths 
were associated with cases where the care of the 
pregnant woman was transferred in utero. As in-
dicated by the red markers in Figure 1.5, the cor-
rected PMR of most small maternity units would 
have been higher if these in utero transfers did not 
occur and the corrected PMR of three of the four 
large maternity hospitals would have been lower. 
One small maternity hospital had a corrected PMR 
(5.94 per 1,000 births) higher than the nation-
al rate and just above the upper 95% confidence 
limit. There were no in utero transfers associated 
with this small maternity hospital that might have 
influenced its corrected PMR. This unit was not in 
this range in 2017 or 2019 and as such does not 
meet the criteria for the National Office of Clinical 
Audit (NOCA) escalation process which defines a 
statistical outlier as results that fall “two standard 
deviations on or above the expected value across 
two consecutive reporting periods or above three 
standard deviations on or above the expected val-
ue in one or more reporting period”.29
Figure	1.5:	Funnel	plot	of	the	corrected	perinatal	mortality	rate	for	Irish	maternity	units,	2018	
Two units (D and F) have similar rates (represented by the overlapping lettered square markers. 
A – South Tipperary (STGH); 
B – Kerry (UHK); 
C – Sligo (SUH); 
D – Portlaoise (MRHP); 
E – Mayo (MUH); 
F – Cavan (CGH);
G – Kilkenny (SLHK); 
H – Portiuncula (PUH); 
I – Wexford (WGH); 
J – Letterkenny (LUH); 
K – Waterford (UHW); 
L – Mullingar (RHM); 
M – Galway (UHG); 
N – Drogheda (OLOL); 
O – Limerick (UMHL); 
P – Cork (CUMH); 
Q – National Maternity (NMH);
R – Coombe (CWIUH);
S – Rotunda (RH).
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The solid horizontal line in Figure 1.6 represents 
the national corrected PMR in 2019 (3.7 deaths per 
1,000 births) based on the 222 perinatal deaths of 
normally formed infants. Nineteen (8.6%) of the 
222 perinatal deaths were associated with cases 
where the care of the pregnant woman was trans-
ferred in utero.
As indicated by the red markers in Figure 1.6, the 
corrected PMR of some small maternity units 
would have been higher and the corrected PMR 
of the maternity hospitals would have been lower 
if these in utero transfers did not occur. One large 
maternity hospital had a corrected PMR (5.34 per 
1,000 births) higher than the national rate and 
above the upper 95% confidence limit. However, 
there were three in utero transfers to this mater-
nity hospital. Without these cases, the corrected 
PMR would have been 4.99 per 1,000 births and 
just under the upper 95% confidence limit. An-
other smaller maternity unit had a corrected PMR 
(1.06 per 1,000 births) that was lower than the na-
tional rate and below the lower 95% confidence 
limit. The corrected PMR would have been twice 
as high (2.11 per 1,000 births) and within the 95% 
confidence limits if in utero transfer cases that 
resulted in perinatal death not due to congenital 
anomaly had stayed in the care of the hospital. 
Stillbirth	and	early	neonatal	death	rate
In Figure 1.7, the solid horizontal line represents 
the annual national stillbirth rate of 3.8 per 1,000 
births based on cases reported for 2018 and 2019. 
Two of the four large maternity hospitals had a 
stillbirth rate equal to or just above the upper 95% 
confidence limit. As shown in the previous funnel 
plots, deaths due to congenital anomaly or follow-
ing in utero transfer were associated with elevat-
ing the rate of perinatal deaths in the country’s 























































Total births in unit (≥ 500g or ≥ 24 weeks ), 2019
Unit rate National rate 95% Limits 99.8% Limits
A – South Tipperary (STGH); 
B – Kerry (UHK); 
C – Sligo (SUH); 
D – Portlaoise (MRHP); 
E – Mayo (MUH); 
F – Cavan (CGH);
G – Kilkenny (SLHK); 
H – Portiuncula (PUH); 
I – Wexford (WGH); 
J – Letterkenny (LUH); 
K – Waterford (UHW); 
L – Mullingar (RHM); 
M – Galway (UHG); 
N – Drogheda (OLOL); 
O – Limerick (UMHL); 
P – Cork (CUMH); 
Q – National Maternity (NMH);
R – Coombe (CWIUH);
S – Rotunda (RH).
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Figure	1.7:	Funnel	plot	of	the	stillbirth	rate	for	Irish	maternity	units,	2018/2019	
Three units (C,F,G) have similar rates (represented by the overlapping lettered square markers). 
A – South Tipperary (STGH); 
B – Kerry (UHK); 
C – Sligo (SUH); 
D – Portlaoise (MRHP); 
E – Mayo (MUH); 
F – Cavan (CGH);
G – Kilkenny (SLHK); 
H – Portiuncula (PUH); 
I – Wexford (WGH); 
J – Letterkenny (LUH); 
K – Waterford (UHW); 
L – Mullingar (RHM); 
M – Galway (UHG); 
N – Drogheda (OLOL); 
O – Limerick (UMHL); 
P – Cork (CUMH); 
Q – National Maternity (NMH);
R – Coombe (CWIUH);













































Total births in unit (≥500g or ≥24 weeks), 2018/2019
Unit 2018/2019 Stillbirth rate National Stillbirth rate 95% Limits 99.8% Limits
The solid horizontal line in Figure 1.8 represents the 
annual national early neonatal death rate of 1.88 per 
1,000 live births based on cases reported for 2018 
and 2019. Two of the four large maternity hospitals 
had a rate higher than the national rate; the rate 
for one large maternity hospital was above the up-
per 99.8% confidence limit and for another the rate 
was between the upper 95% confidence limit and 
the upper 99.8% confidence limit. As shown in ear-
lier funnel plots, deaths due to congenital anomaly 
or following in utero transfer were associated with 
elevating the rate of perinatal deaths in these large 
tertiary maternity hospitals.




















































Total live births in unit (≥500g or ≥24 weeks), 2018/2019
2018/2019 ENND rate National ENND  rate 95% Limits 99.8% Limits
Figure	1.8:	Funnel	plot	of	the	early	neonatal	death	rate	for	Irish	maternity	units,	2018/2019
Six units (C, D, H, J, I and K) have similar rates (represented by the lettered square markers). 
A – South Tipperary (STGH); 
B – Kerry (UHK); 
C – Sligo (SUH); 
D – Portlaoise (MRHP); 
E – Mayo (MUH); 
F – Cavan (CGH);
G – Kilkenny (SLHK); 
H – Portiuncula (PUH); 
I – Wexford (WGH); 
J – Letterkenny (LUH); 
K – Waterford (UHW); 
L – Mullingar (RHM); 
M – Galway (UHG); 
N – Drogheda (OLOL); 
O – Limerick (UMHL); 
P – Cork (CUMH); 
Q – National Maternity (NMH);
R – Coombe (CWIUH);
S – Rotunda (RH).
Distribution	of	Perinatal	Deaths	by	
Robson	Ten	Group	Classification	System
The Robson Classification, also referred to as the 
Ten Group Classification System (TGCS), is a classi-
fication system providing a common starting point 
for further detailed analysis within which all peri-
natal outcomes can be measured and compared.30 
The system classifies all pregnant women into one 
of 10 categories that are mutually exclusive and, as 
a set, totally comprehensive.31
The categories are based on five basic obstetric 
characteristics that are routinely collected for all 
maternities: parity, gestational age, onset of la-
bour, foetal presentation, and number of foetuses. 
In cases of antepartum stillbirth, the baby is usu-
ally delivered following induction of labour or by 
pre-labour caesarean section. This places the vast 
majority of women who experience antepartum 
stillbirth into Group 2 or Group 4, depending on 
parity. It thereby causes these groups to have rel-
atively high perinatal mortality rates compared to 
groups 1 and 3, which is a consequence of care 
after the perinatal loss event rather than reflecting 
valid differences in risk. To address this issue, we 
report perinatal mortality data for Groups 1 and 
2 combined and Group 3 and 4 combined. The 
TGCS allows for further investigation of Perina-
tal Mortality by group. Treating Groups 1 & 2 and 
Groups 3 & 4 as single cohorts allows focus on the 
principal groups of nulliparous and multiparous 
30 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/
S0965539501000122
31  Robson M et al. The 10-Group Classification System (Robson classification), induction of labor, and cesarean delivery. 
International Journal of Gynecology and Obstetrics 131 (2015) S23–S27
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women, irrespective of mode of delivery.32
For the reporting years 2018 and 2019, 16 and 17 
of the 19 Irish maternity units respectively collated 
data on all births using the TGCS. The number of 
deliveries of infants in these units (n=106,401) con-
stituted 89% of the total number of deliveries in 
Ireland in the combined reporting years 2018 and 
2019. The numbers in the table include congeni-
tal anomalies. These units accounted for a similar 
proportion of the country’s 686 perinatal deaths 
in 2018 and 2019 (n=617, 89%) and their overall 
Perinatal Mortality Rate (PMR) was 5.80 per 1,000 
deliveries. Groups One through Five accounted 
for 87.6% of the deliveries (n= 93,263) but repre-
sented 24.9% of the perinatal deaths (n= 154).
Higher perinatal mortality rates are expected in 
groups 8 and group 10 considering the range of 
complications associated with both multiple preg-
nancy and prematurity. Prematurity is strongly 
associated with perinatal mortality. This is made 
especially clear by the TGCS. Group Ten contains 
all single cephalic pregnancies delivered preterm. 
This group contained 4% of the maternities, it had 
the highest PMR and contributed 2.4 per 1,000 ba-
bies delivered to the overall PMR of 5.8 per 1,000 
babies delivered. 
The incidence of perinatal mortality varies across 
the groups. The Robson TGCS highlights the 
groups and reasons that contribute to the over-
all PMR and allows more focussed interventions 
to improve clinical care. The TGCS reinforces the 
need for close monitoring of multiple pregnancy 
and other pregnancies at risk of premature birth.
32  O’Farrell IB, Manning E, P Corcoran, Greene RA, on behalf of the Perinatal Mortality Group. Perinatal Mortality in Ireland Annual 














N Rate N Rate N Rate
All* 106401 414 3.89 203 1.91 617 5.80 5.80
1 Nulliparous, singleton, 
cephalic, >37/40, 
spontaneous labour
36019 40 1.11 16 0.44 56 1.55 0.53
2 Nulliparous, singleton, 
cephalic, >37/40 
induced or elective CS
3 Multiparous (excluding 
previous CS), singleton, 
cephalic, >37/40, 
spontaneous labour
41010 49 1.19 28 0.68 77 1.88 0.72
4 Multiparous (excluding 
previous CS), singleton, 
cephalic, >37/40 
induced or elective CS
5 Previous CS, singleton, 
cephalic, >37/40, 
induced or elective CS
16234 13 0.80 8 0.49 21 1.29 0.20
6 All nulliparous deliveries 
with a single breech 
pregnancy
4884 105 21.50 36 7.37 141 28.87 1.33
7 All multiparous breech 
(including previous CS)
8 All women with a single 
pregnancy with a 
transverse or oblique lie, 
including women with 
previous uterine scars
9 All multiple pregnancies 
(including previous CS)
3756 27 7.19 40 10.65 67 17.84 0.63
10 All singleton, cephalic, 
<37/40 (including 
previous CS)
4498 180 40.02 75 16.67 255 56.69 2.40
*Note: Rate is per 1,000 babies delivered 95% CI=Exact Poisson 95% confidence intervals. CS=Caesarean section. 
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Maternal	characteristics
The findings presented below relate to character-
istics of mothers of stillbirths and early neonatal 
deaths born with a birthweight ≥500g or having 
achieved a gestational age ≥24 weeks.
Age
The age of mothers experiencing perinatal loss was 
known for 323 of the 325 perinatal deaths in 2018 
(99.4%) (Table 1.5a). The mothers who experienced 
perinatal loss in 2018 ranged in age from teenage 
years (the youngest 15 years of age) through to fifty. 
Their age distribution broadly reflected that of the 
population of mothers who gave birth in Ireland in 
2018. Half of the population (51.3%) who gave birth 
in 2018 were aged 25-34 years, whereas a slightly 
lower proportion of mothers who experienced per-
inatal loss were in this age group (48.6%). The age 
profile of mothers who experienced a stillbirth was 
similar to that of mothers who experienced early 
neonatal death. 
The age of mothers experiencing perinatal loss 
was known for all 360 perinatal deaths in 2019 (Ta-
ble 1.5b). The mothers who experienced perinatal 
loss in 2019 ranged in age from teenage years (the 
youngest 16 years of age) through to mid-forties 
(46 years of age). Their age distribution broadly 
reflected that of the population of mothers who 
gave birth in Ireland in 2019. Half of the population 
(51.0%) who gave birth in 2019 were aged 25-34 
years, whereas a slightly lower proportion of moth-
ers who experienced perinatal loss were in this age 
group (48.6%). The age profile of mothers who ex-
perienced a stillbirth was similar to that of mothers 
who experienced early neonatal death. 
An association between maternal age and perinatal 
mortality was found. Compared to mothers aged 
between 25-29 years, women aged greater than 
40 years had 66% higher rate of perinatal mortality 
(p=0.019) in 2018. (Table 1.6a) In 2019, a broadly sim-
ilar pattern was found, compared to mothers aged 
between 25-29 years, women aged greater than 
40 years had 35% higher rate of perinatal mortality, 















<25yrs 9.8% 35(10.8) 20(9.3) 15(14)
25-29yrs 17.1% 50(15.5) 35(16.2) 15(14)
30-34yrs 34.2% 94(29.1) 62(28.7) 32(29.9)
35-39yrs 31.2% 107(33.1) 75(34.7) 32(29.9)
>40yrs 7.6% 37(11.5) 24(11.1) 13(12.1)














<25yrs 9.3% 33(9.2) 19(7.9) 14(11.9)
25-29yrs 16.8% 66(18.3) 40(16.5) 26(22)
30-34yrs 34.2% 117(32.5) 77(31.8) 40(33.9)
35-39yrs 31.7% 102(28.3) 78(32.2) 24(20.3)
>40yrs 7.9% 42(11.7) 28(11.6) 14(11.9)
Note: Values are shown as n (%) unless otherwise stated.
33  Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press]
34  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press]







<25yrs 5.81 (4.04-8.08) 1.22 (0.79-1.88) 0.37
25-29yrs 4.77 (3.54-6.28) 1.00 (reference)  
30-34yrs 4.48 (3.62-5.48) 0.94 (0.67-1.32) 0.724
35-39yrs 5.6 (4.59-6.77) 1.18 (0.84-1.64) 0.346
>40yrs 7.91 (5.57-10.91) 1.66 (1.09-2.54) 0.019







<25yrs 5.95 (4.1-8.36) 0.9 (0.6-1.37) 0.637
25-29yrs 6.58 (5.09-8.37) 1.00 (reference)  
30-34yrs 5.74 (4.75-6.88) 0.87 (0.65-1.18) 0.377
35-39yrs 5.39 (4.4-6.55) 0.82 (0.6-1.12) 0.208
>40yrs 8.91 (6.42-12.04) 1.35 (0.92-1.99) 0.125
Note: 95% CI=Exact Poisson 95% confidence intervals. 
Ethnicity
Assessment of risk of perinatal loss associated 
with ethnic group is impeded by the absence of 
national data on ethnicity for the pregnant pop-
ulation in Ireland. In both 2018 and 2019 the ma-
jority of mothers who experienced perinatal loss 
were of white Irish ethnicity (2018, 71.7% and 2019 
69.2% (Table 1.7). 
This is close to the proportion of white Irish wom-
en in the female population aged 15-49 years enu-
merated by the National Census 2016. While the 
numbers involved were small, Irish Traveller, Asian 
and Black ethnicities were overrepresented in 
the mothers who experienced perinatal deaths in 
2018 (12.9%) and 2019 (11.9%) compared to 5% of 








White Irish 233(71.7) 249(69.2) 77.1
Irish Traveller 7(2.2) 10(2.8) 0.7
Other white background 48(14.8) 62(17.2) 13.3
Asian/Asian Irish 18(5.5) 12(3.3) 1.6
Black/Black Irish 10(3.1) 8(2.2) 2.7
Other/Mixed 7(2.2) 13(3.6) 1.8
Not recorded/Missing 2(0.6) 6(1.7) 2.7
Note: Values are shown as n (%) unless otherwise stated. Population data from the National Census 2016. 









Home duties 47(15.6) 16.0
Student 7(2.3) n/a
Others not in labour force 6(2.0) n/a
Note: Data not known on employment status for 23 perinatal deaths.  









Home duties 47(13.8) 15.0
Student 12(3.5) n/a
Others not in labour force 6(1.8) n/a
Note: Data not known on employment status for 20 perinatal deaths.  
*Employment status was not stated or not classifiable for 7.2% of all births in 2019.
Employment Status
Lower socio-economic status has been shown to 
be associated with poor pregnancy outcomes.35 In 
the NPEC national clinical audit, data on the moth-
er’s and father’s employment status at booking 
was sought. Data was not recorded for 34 (9.8%) 
of the 346 women who experienced perinatal loss, 
this was slightly higher than the proportion of un-
recorded employment status in 2016 (8.6%). Table 
1.8a and Table 1.8b provides a high-level overview 
of the data that were provided on mother’s occu-
pation alongside data available for the most com-
parable occupation categories for mothers of all 
births in Ireland (from the 2018 and 2019 Perinatal 
Statistics Report).36, 37
Employment status was specified for 92.9% of the 
mothers for whom data were recorded in 2018 
(Table 1.8a). A slightly higher proportion of the 
mothers experiencing perinatal loss were unem-
ployed (7.3%) compared to 4.9% of all mothers. 
The proportion of mothers engaged in home du-
ties who experienced perinatal loss (15.6%) was 
similar to the percentage of all women engaged in 
home duties who gave birth (16.0%) in 2018.
Employment status was specified for 94.4% of the 
mothers for whom data were recorded in 2019 
(Table 1.8b). A higher proportion of the mothers 
experiencing perinatal loss were unemployed 
(9.4%) compared to 4.3% of all mothers. The pro-
portion of mothers engaged in home duties who 
experienced perinatal loss (13.8%) was slightly 
lower than the percentage of all women engaged 
in home duties who gave birth (15.0%) in 2019.
35  Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
36 Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press]. 
37  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press].
38  Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press]. 
39  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press]. 
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Gestation at booking
Gestation at the time of the mother’s first antena-
tal visit to the maternity hospital was not record-
ed for 41 cases of perinatal death in 2018 (12.6%). 
Of those with data, less than thirty percent (27.1%) 
booked into hospital before 12 weeks gestation, 
almost sixty percent (59.5%) attended for antena-
tal care between 12 and 19 weeks gestation (Table 
1.9a). In 2018, the median gestational age at book-
ing was 13 weeks.
Gestation at the time of the mother’s first ante-
natal visit to the maternity hospital was not re-
corded for 31 cases of perinatal death in 2019 
(8.6%), this was slightly lower compared to 2018. 
Of those with data, over twenty percent (22.2%) 
booked into hospital before 12 weeks gestation, 
almost seventy percent (69.9%) attended for an-
tenatal care between 12 and 19 weeks gestation 
(Table 1.9b). In 2019, the median gestational age 
at booking was 12 weeks. The proportion of wom-
en presenting for first antenatal visit at 20 weeks 
gestation or later was slightly lower in 2019 (5.5%) 








Less than 12 Weeks 58(28.7) 19(23.2) 77(27.1)
12-19 Weeks 121(59.9) 48(58.5) 169(59.5)
20 Weeks or Later 18(8.9) 11(13.4) 29(10.2)
Not Booked 5(2.5) 4(4.9) 9(3.2)








Less than 12 Weeks 51(21.9) 22(22.9) 73(22.2)
12-19 Weeks 164(70.4) 66(68.8) 230(69.9)
20 Weeks or Later 12(5.2) 6(6.3) 18(5.5)
Not Booked 6(2.6) 2(2.1) 8(2.4)
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Anatomy scan
Since 2017, the NPEC have collected data on 
whether a woman underwent an anatomy scan. As 
recommended by the Institute of Obstetrics and 
Gynaecology, second trimester fetal anomaly ul-
trasound scanning should be universally available 
for all pregnant women in Ireland. 
Data on whether a woman received an anatomy 
scan was recorded for 318 of 325 woman who ex-
perienced perinatal loss in 2018. Of these 318 wom-
en, almost ninety percent (n=286, 89.9%) received 
an anatomy scan. 
Data on whether a woman received an anatomy 
scan was recorded for 356 of 360 woman who 
experienced perinatal loss in 2019. Of these 356 
women, ninety percent (n=321, 90.2%) received an 
anatomy scan. 
Fertility treatment 
Currently in Ireland there is no national data on the 
number of births as a result of fertility treatment. 
The NPEC Notification Form contains a specific 
question on whether the pregnancy resulting in 
perinatal loss was the result of fertility treatment. In 
2018, information was available for 289 of the 325 
(88.9=%) cases of perinatal death. In 19 of these 
289 cases (6.6%) the pregnancy was reported to 
be the result of fertility treatment (n=10 of 186 still-
births, 5.4%; n=9 of 103 early neonatal deaths, 8.7%). 
Eight of these 19 pregnancies (42.1%) were associ-
ated with multiple births ending in perinatal loss of 
one or more infants. The method of treatment was 
specified for 17 of the 19 (89.5%) pregnancies re-
sulting from fertility treatment. In order of frequen-
cy, the methods were: in vitro fertilisation (including 
egg donation and Intracytoplasmic Sperm Injection 
(ICSI) and other types) (n=16), and ovulation induc-
tion with Clomiphine Citrate (n=1). 
In 2019, information was available for 316 of the 360 
(87.8%) cases of perinatal death. In 33 of these 316 
cases (10.4%) the pregnancy was reported to be the 
result of fertility treatment (n=21 of 203 stillbirths, 
10.3%; n=12 of 113 early neonatal deaths, 10.6%). Sev-
en of these 33 pregnancies (21.2%) were associat-
ed with multiple births ending in perinatal loss of 
one or more infants. The method of treatment was 
specified for 32 of the 33 (97.0%) pregnancies re-
sulting from fertility treatment. In order of frequen-
cy, the methods were: in vitro fertilisation (including 
egg donation and Intracytoplasmic Sperm Injection 
(ICSI) and other types) (n=24), fertility drug thera-
py (n=5) and Intrauterine Insemination (IUI) (n=3).
Body mass index
Increased maternal Body mass index (BMI) has 
been associated with an increased risk of congen-
ital anomaly and stillbirth.40, 41 The recording of BMI 
in maternity records is a key recommendation of 
the Obesity and Pregnancy Clinical Practice Guide-
line. While this may be common practice in mater-
nity units, no national data on the BMI of the preg-
nant population are available.42 In this report, data 
on maternities by BMI were obtained for 31,476 
women who gave birth or booked to give birth in 
one of the country’s four large maternity hospitals 
in 2019, this data was then extrapolated to produce 
national estimates.
Body mass index (BMI) was available for 263 of the 
325 (80.9%) of women who experienced perinatal 
loss in 2018, and for 257 of 360 women (71.4%) in 
2019 (Table 1.10a). In 2018, the BMI of 41.4% of these 
mothers was in the healthy range (18.5-24.9kg/
m2), which is similar to the previous years, whereas 
in 2019 it is slightly lower (37.0%). Overall, women 
in the healthy BMI category were underrepresent-
ed among women who experience perinatal loss 
compared to the population of women who gave 
birth in 2019. 
As shown in Table 1.10b, women in the obese cate-
gory who experienced perinatal loss in 2019 were 
overrepresented relative to the population of wom-
en who gave birth in 2019. This was reflected in the 
perinatal mortality rate of 7.44 per 1,000 for obese 
women. Thus, obese women had more than twice 
the risk of perinatal mortality compared to women 
who gave birth in 2019 with a normal BMI. 
40  Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis.  
Am J Obstet Gynecol 2008;198:611-9
41  Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, et al. Maternal obesity and risk of stillbirth: a metaanalysis.  
Am J Obstet Gynecol 2007;197:223-8.
42  Clinical Practice Guideline No 2 (2011). Obesity and Pregnancy: Institute of Obstetricians and Gynaecologists, Royal College of 
Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.




















Underweight (<18.5) 5(1.2) 6(1.8) 2(0.6) 1(0.4) 6(2.3) (1.5%)
Healthy (18.5-24.9) 179(43.8) 140(42.0) 135(43.3) 109(41.4) 95(37.0) (48.2%)
Overweight (25.0-29.9) 128(31.3) 114(34.2) 103(33) 77(29.3) 72(28.0) (30.9%)
Obese (≥ 30.0) 97(23.7) 73(21.9) 72(23.1) 76(28.9) 84(32.7) (19.5%)
Note: Values are shown as n(%) unless otherwise stated; Percentage refers to the total 263 cases for which BMI was obtained 
in 2018 and 257 cases in 2019. *Data on maternities by BMI were obtained for 31,476 women who gave birth or booked to give 
birth in one of the country’s four large maternity hospitals in 2019. This is 54.3% of the 57,983 women who gave birth in hospital 
in 2019, according to HIPE data. We multiplied the BMI data on 31,476 women by 1.84 (i.e. 100%/54.3%) in order to estimate the 








Underweight (<18.5) 7.11 (2.61-15.47) 2.09 (0.92-4.77) 0.08
Healthy (18.5-24.9) 3.40 (2.75-4.16) 1.00 (reference) -
Overweight (25.0-29.9) 4.02 (3.14-5.06) 1.18 (0.87-1.6) 0.288
Obese (≥ 30.0) 7.44 (5.93-9.21) 2.19 (1.63-2.93) 0.000
RR=Rate ratio, comparing rate ratio in women who experience perinatal loss in 2019 versus women who gave birth in 2019. 
Smoking and substance misuse
Smoking status of the mothers at their time of 
booking was recorded for 293 (90.2%) of the 325 
women in 2018. Of these, 40 (13.7%) were smokers 
at the time of booking. Data on the number of cig-
arettes smoked was known for 34 of the 40 cases. 
Twenty-one were smoking between one and nine 
cigarettes per day (n=21 of 34, 61.8%) and thir-
teen were smoking more than 10 cigarettes per 
day (n=13 of 34, 38.2%). In 2019, smoking status of 
the mothers at their time of booking was record-
ed for 328 (91.1%) of the 360 women. Of these, 53 
(16.2%) were smokers at the time of booking. Data 
on the number of cigarettes smoked was known 
for 39 of the 53 cases. Seventeen were smoking 
between one and nine cigarettes per day (n=17 of 
39, 43.6%) and twenty-two were smoking more 
than 10 cigarettes per day (n=22 of 39, 56.4%).
In 2018, information on smoking in late pregnancy 
was available for 25 of the 40 smokers (62.5%) 
and only one case (4.0%) stopped smoking during 
pregnancy. In 2019, information on smoking in late 
pregnancy was available for 46 of the 53 smok-
ers (86.8%) and nine cases (19.6%) had stopped 
smoking during pregnancy. The prevalence of 
smoking during pregnancy or in the last trimester 
is not routinely known for all Irish pregnancies but 
rates of 12%, 15%, 16% and 19% have been report-
ed for England, Northern Ireland, Wales and Scot-
land, respectively.43 
In 2018, three women had a documented histo-
ry of alcohol misuse prior to pregnancy and one 
woman had a documented history of alcohol mis-
use during pregnancy. Four women had a docu-
mented history of drug misuse prior to pregnan-
cy and one woman had a documented history of 
drug misuse during pregnancy in 2018. 
In 2019, no woman had a documented history of 
alcohol misuse prior to pregnancy or had a doc-
umented history of alcohol misuse during preg-
nancy. Four women had a documented history of 
drug misuse prior to pregnancy and two women 
had a documented history of drug misuse during 
pregnancy in 2019. 
43  EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com














Previous caesarean delivery 64(19.3) 71(22.1) 69(26.1) 52(22.6) 41(16.8) 41(16.8)
Pre-term birth or mid-trimester loss 29(8.7) 24(7.5) 24(9.1) 13(5.7) 18(7.4) 18(7.4)
Three or more miscarriages 16(4.8) 24(7.5) 21(8) 7(3.0) 12(4.9) 12(4.9)
Baby with congenital anomaly 7(2.1) 10(3.1) 7(2.7) 7(3.0) 5(2.0) 5(2.0)
Infant requiring intensive care 14(4.2) 13(4) 11(4.2) 6(2.6) 8(3.3) 8(3.3)
Stillbirth 7(2.1) 12(3.7) 9(3.4) 5(2.2) 7(2.9) 7(2.9)
Neonatal death 6(1.8) 3(0.9) 5(1.9) 5(2.2) 3(1.2) 3(1.2)
Pre-eclampsia 18(5.4) 8(2.5) 11(4.2) 5(2.2) 9(3.7) 9(3.7)
Placental abruption 4(1.2) 4(1.2) 3(1.1) 2(0.9) 1(0.4) 0(0)
Placenta praevia 2(0.6) 1(0.3) 2(0.8) 1(0.4) 2(0.8) 2(0.8)
Post-partum haemorrhage requiring transfusion 4(1.2) 5(1.6) 5(1.9) 1(0.4) 5(2.0) 5(2)
Other 46(13.9) 35(10.9) 43(16.3) 26(11.3) 30(12.3) 30(12.3)






















Nulliparous 172(38) 135(36.2) 147(42.5) 123(37.8) 156(43.5) 38.9% 39.0%
Para 1 148(32.7) 128(34.3) 91(26.3) 88(27.1) 96(26.7) 34.5% 34.9%
Para 2 84(18.5) 62(16.6) 69(19.9) 61(18.8) 69(19.2) 17.3% 17.4%
Para 3+ 49(10.8) 48(12.9) 39(11.3) 53(16.3) 38(10.6) 9.2% 8.7%
Previous pregnancy 
Seventy percent of mothers who experienced 
perinatal loss in 2018 had at least one previous 
pregnancy (gravida > 0; 230 of 325, 70.8%). Sim-
ilarly, in 2019 over two thirds of mothers who ex-
perienced perinatal loss had at least one previous 
pregnancy (gravida > 0; 244 of 360, 67.8%)
In 2018, of the 230 women who had a previous 
pregnancy, 44.3% (n=102) were reported to have 
had a previous pregnancy-related problem. In 
2019, of the 244 women who had a previous preg-
nancy, 38.9% (n=95) were reported to have had a 
previous pregnancy-related problem. In both 2018 
and 2019, caesarean section delivery was the most 
common previous pregnancy-related problem 
(Table 1.11). Pre-term birth or mid-trimester loss 
was the second most common pregnancy-related 
problem. 
In terms of parity, women who experienced peri-
natal loss in 2018 and 2019 were broadly similar to 
the population of women who gave birth in 2018 
and 2019 although there was an over-representa-
tion of women with at least three previous deliv-
eries among those who experienced perinatal loss 
(Table 1.12). The risk of perinatal death increased 
with increasing parity, for example, in 2018, wom-
en who had three or more previous deliveries had 
2.25 fold increased risk of perinatal death com-
pared to women who had one previous delivery. 
(Table 1.13a). In 2019 a similar pattern was found; 
the risk of perinatal mortality was 1.59 times higher 
in women who had three or more previous deliver-
ies (Table 1.13b).
44  Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press].
45  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press].








Nulliparous 5.17 (4.29-6.16) 1.24 (0.94-1.63) 0.121
Para 1 4.16 (3.34-5.13) 1.00 (reference)  
Para 2 5.76 (4.4-7.39) 1.38 (1.00-1.92) 0.052
Para 3+ 9.37 (7.02-12.26) 2.25 (1.60-3.17) 0.000








Nulliparous 6.74 (5.72-7.88) 1.46 (1.13-1.88) 0.004
Para 1 4.63 (3.75-5.65) 1.00 (reference)  
Para 2 6.67 (5.19-8.45) 1.44 (1.06-1.96) 0.020
Para 3+ 7.36 (5.21-10.11) 1.59 (1.09-2.32) 0.015
Note: 95% CI=Exact Poisson 95% confidence intervals. 
Pre-existing medical problems
Information about pre-existing medical conditions 
was available for all women who experienced per-
inatal loss in 2018 and 2019. In 2018, thirty percent 
of women had a pre-existing medical problem 
(n=100, 30.8%). Similarly, in 2019 slightly over thirty 
percent of women also had a pre-existing medical 
problem (n=118, 32.8%).
In 2018, the most common type of pre-existing 
medical problems were psychiatric disorders with 
5.2% of mothers (n=17 of 325 women) suffering 
from conditions of this type (Table 1.15). This was 
followed by endocrine disorders which had sec-
ond the highest percentage of occurrence in 2018 
(n= 16, 4.9%). In 2019, the most common type of 
pre-existing medical problems were endocrine 
disorders with 6.4% of mothers (n=23 of 360 
women) suffering from conditions of this type. In 
both 2018 and 2019, under the “Other” category 
a wide range of problems were captured, such as 

















Psychiatric disorder 24(5.5) 34(7.7) 31(7.0) 40(11.5) 27(8.0) 17(5.2) 19(5.3)
Endocrine disorder 17(3.9) 30(6.8) 24(5.4) 26(7.5) 22(6.5) 16(4.9) 23(6.4)
Diabetes 13(3.0) 16(3.6) 16(3.6) 8(2.3) 7(2.1) 8(2.5) 13(3.6)
Cardiac disease 11(2.5) 9(2.0) 6(1.4) 6(1.7) 6(1.8) 6(1.8) 2(0.6)
Hypertension 7(1.6) 10(2.3) 13(2.9) 9(2.6) 6(1.8) 11(3.4) 8(2.2)
Renal disease 5(1.2) 7(1.6) 4(0.9) 3(0.9) 4(1.2) 1(0.3) 2(0.6)
Haematological disorder 3(0.7) 8(1.8) 5(1.1) 9(2.6) 4(1.2) 4(1.2) 1(0.3)
Inflammatory disorder 3(0.7) 6(1.4) 17(3.9) 3(0.9) 2(0.6) 4(1.2) 1(0.3)
Epilepsy 4(0.9) 1(0.2) 5(1.1) 1(0.3) 0 2(0.6) 4(1.1)
Other 90(20.7) 105(23.6) 65(14.7) 62(17.9) 61(18.1) 54(16.6) 75(20.8)
* Any pre-existing  
medical problem
143(32.9) 175(39.4) 138(31.3) 123(35.4) 107(31.8) 100(30.8) 118(32.8)
*Note: n(%) represents the number of women who had ‘any pre-existing medical problem’; more than one medical problem may 
apply per woman. 
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Delivery
In 2018, labour was induced in over sixty percent of 
women who experienced a stillbirth (n=139 of 217, 
64.1%) and 13.2% of those who experienced a neo-
natal death (n=14 of 106, unknown for two cases). 
In 2019, labour was induced in over three quarters 
women who experienced a stillbirth (n=185 of 242, 
76.4%) and 22.9% of those who experienced a ne-
onatal death (n=27 of 118). 
In 2018 and 2019 the type of care received at de-
livery was known for all of the mothers who ex-
perienced perinatal loss. In both years, the vast 
majority of the babies were delivered under ob-
stetric-led care which is the predominant model 
of care in Ireland (2018; n=315 of 325, 96.9% and 
2019; n=349 of 360, 96.6%). Ten babies both in 
2018 and 2019 were born before arrival at the ma-
ternity unit. One baby was delivered under mid-
wifery-led care in 2019.
Presentation at delivery was known for all but two 
cases in 2018 (n=323 of 325, 99.4%) and for all but 
one case in 2019 (n=359 of 360, 99.7%). In 2018 
and 2019, over seventy percent of presentations at 
delivery were vertex presentations (2018; n=238 of 
323, 73.7% and 2019; n=261 of 359, 72.7%). One in 
four presentations were breech in 2018 and 2019 
(2018; n=78 of 323, 24.1% and 2019; n=91 of 359, 
25.3%). In 2018, the presentation was compound 
in seven cases (n=7 of 323, 2.2%), and in five cases 
in 2019 (n=5 of 359, 1.4%). In 2019 there was one 
case with a brow presentation and another case 
with a face presentation. 
Mode of delivery was known for all but one case 
in 2018 (n=324 of 325, 99.7%) and for all moth-
ers who experienced perinatal loss in 2019 (Table 
1.15a and Table 1.15b). In 2018, spontaneous vag-
inal cephalic delivery was the mode of delivery 
for over sixty percent of stillbirths (n=135 of 216, 
62.5%) and for one third of the babies who died 
in the early neonatal period (n=36 of 108, 33.3%). 
In 2018, over fifty percent of the deliveries in cas-
es of neonatal death involved caesarean section 
(n=57, 52.8%), usually pre-labour (n=37). Eighteen 
percent of stillbirths involved caesarean section 
(n=39, 18.0%), again predominantly pre-labour 
(n=29). Among stillbirths delivered by caesarean 
section in 2018, one third of the mothers (n=13 of 
39, 33.3%) had a previous caesarean delivery.
In 2019, spontaneous vaginal cephalic delivery was 
the mode of delivery for over sixty percent of still-
births (n=155 of 242, 64.0%) and for almost half 
of the babies who died in the early neonatal peri-
od (n=56 of 118, 47.5%). In 2019, under forty per-
cent of the deliveries in cases of neonatal death 
involved caesarean section (n=43, 36.4%), usually 
pre-labour (n=30). Approximately eight percent 
of stillbirths involved caesarean section (n=19, 
7.8%), again predominantly pre-labour (n=16). 
Among stillbirths delivered by caesarean section 
in 2019, over thirty percent of the mothers (n=6 of 













Spontaneous vaginal cephalic 135(62.5) 36(33.3) 171(52.8) Vaginal birth
51.5%Spontaneous vaginal breech 36(16.7) 8(7.4) 44(13.6)
Pre-labour caesarean section 29(13.4) 37(34.3) 66(20.4)
Caesarean section
34.3%Caesarean section after the  
onset of labour
10(4.6) 20(18.5) 30(9.3)
Assisted breech 6(2.8) 4(3.7) 10(3.1) 0.5%
Ventouse 0(0) 2(1.9) 2(0.6) 10.7%
Forceps 0(0) 1(0.9) 1(0.3) 3.0%
Note: Values are n(%) unless otherwise stated.
46  Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press].













Spontaneous vaginal cephalic 155(64.0) 56(47.5) 211(58.6) Vaginal birth
51.3%Spontaneous vaginal breech 53(21.9) 10(8.5) 63(17.5)
Pre-labour caesarean section 16(6.6) 30(25.4) 46(12.8)
Caesarean section
34.8%Caesarean section after the  
onset of labour
3(1.2) 13(11.0) 16(4.4)
Assisted breech 10(4.1) 3(2.5) 13(3.6) 0.5%
Ventouse 1(0.4) 3(2.5) 4(1.1) 10.0%
Forceps 4(1.7) 3(2.5) 7(1.9) 3.4%
The type of caesarean section was known for all 
stillbirth cases delivered by caesarean section in 
2018 (n=39 of 39). Elective caesarean section deliv-
ery was the most common type of caesarean deliv-
ery in stillbirths in 2018 (n=18 of 39, 46.2%). Urgent 
(maternal or fetal compromise which is not imme-
diately life threatening) caesarean delivery was the 
most common type of caesarean delivery in neo-
natal deaths (n=24 of 57, 42.1%) in 2018. 
The type of caesarean section was known for all 
but one stillbirth case delivered by caesarean sec-
tion in 2019 (n=18 of 19). Elective caesarean sec-
tion delivery was the most common type of cae-
sarean delivery in stillbirths in 2019 (n=18 of 39, 
38.9%). Emergency caesarean delivery was the 
most common type of caesarean delivery in neo-
natal deaths (n=20 of 43, 46.5%) in 2019. 
47  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press].
For women who experienced perinatal loss in 
2018, 7.7% were admitted to a high dependency 
unit (HDU) (n=25 of 325) and seven cases (n=7 
of 325, 2.2% ) were admitted to an intensive care 
unit (ICU). Similar admission rates were reported 
in 2019, with 6.4% of cases being admitted to a 
HDU (n=23 of 360) and five cases (n=5 of 360, 
1.4%) being admitted to an ICU (Table 1.16). In 2018 
and 2019, admission to a HDU for the mother was 
more common in cases associated with early ne-
onatal death.
Deliveries by emergency caesarean section were 
associated with high levels of admission to the 
HDU. Within the cohort of women experiencing 
perinatal mortality, over one in four deliveries by 
emergency caesarean section were admitted to 
the HDU in 2018 (n=9 of 34 cases of this type of 
caesarean section, 26.5%). In 2018, of these nine 
cases that were delivered by emergency caesar-
ean section and were subsequently admitted to 
the HDU, six were early neonatal deaths and three 
were stillbirths. 
In 2019, over twenty percent of deliveries by emer-
gency caesarean section were admitted to the 
HDU (n=6 of 27 cases of this type of caesarean 
section, 22.1%). In 2019, of these six cases that 
were delivered by emergency caesarean section 
and were subsequently admitted to the HDU, five 
were early neonatal deaths and one case was a 
stillbirth. 






























Admitted to HDU 13(3.8) 8(3.7) 17(15.7) 25(7.7) 10(4.1) 13(11.0) 23(6.4)
Admitted to ICU 1(0.3) 4(1.8) 3(2.8) 7(2.2) 4(1.7) 1(0.8) 5(1.4)
Note: Values are n(%) unless otherwise stated. For the first time in this report, location of post-delivery maternal care in HDU and 
ICU is presented separately for women experiencing stillbirths and neonatal deaths.
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Infant	characteristics
The findings presented below are based on stillbirths and early neonatal deaths born with a birthweight 
≥500g or having achieved a gestational age ≥24 weeks.
Sex 
There were eight perinatal deaths for which the sex of the baby was indeterminate in 2018 and six cases 
such cases in 2019 (Table 1.17a and Table 1.17b). In 2018 and 2019 a higher proportion of deaths occurred 
in males (2018; 52.3% and 2019; 51.7%). Male babies outnumbered female babies among stillbirths and 










Male 107(49.3) 63(58.3) 170(52.3) 51.35
Female 104(47.9) 43(39.8) 147(45.2) 48.63
Indeterminate 6(2.8) 2(1.9) 8(2.5) 0.02
48 Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press].
While the NPEC data collection form does not 
contain a specific question on the indication for 
admission to HDU/ICU, maternal complications 
and obstetric factors which caused or were asso-
ciated with the perinatal death are identified. 
Of the eight women delivering stillbirths who were 
admitted to HDU, placental abruption was the 
cause of death in six of the eight cases, with three 
of the women also experiencing a hypertensive dis-
order of pregnancy. A further two HDU admissions 
were associated with uterine rupture and maternal 
collapse respectively. Similarly, the majority (n=3) 
of the 4 women admitted to ICU following delivery 
of a stillbirth experienced a placental abruption 
with maternal infection being associated with the 
fourth admission. In 2019, of the ten women ad-
mitted to HDU, the majority (n=6) experienced a 
placental abruption. Antepartum haemorrhage of 
unknown cause, infection and pre-eclampsia were 
associated with another three admissions. Of the 
four women admitted to ICU following delivery 
of a stillbirth, two were associated with placental 
abruption and one case had an associated an-
tepartum haemorrhage of unknown cause.
In contrast, of the seventeen women experiencing 
an early neonatal death, maternal / obstetric com-
plications associated with HDU admission in 2018 
included chorioamnionitis (n=4), placenta praevia 
(n=2), placental abruption (n=1) and hypertensive 
disorder of pregnancy (n=4). In six cases, a ma-
ternal complication was not associated with the 
neonatal death. In 2019, of the thirteen women ad-
mitted to HDU who experienced an early neonatal 
death, maternal complications associated with the 
death included infection (n=2), placental abrup-
tion with hypertensive disorders of pregnancy 
(n=1), pre-existing maternal disorders (n=2). In 
eight cases, a maternal complication was not as-
sociated with the neonatal death. Maternal com-
plications associated with ICU admissions includ-
ed eclampsia, placental abruption, and maternal 
infection for women experiencing neonatal death 
in 2018. In the one case admitted to ICU in 2019, 
ascending infection following premature rupture 
of membranes was an associated factor in the 
cause of neonatal death. 
Maternal	complications	associated	with	HDU	and	ICU	admission	
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Multiple births 
As with previous years, an increased risk of perinatal mortality associated with multiple pregnancy com-
pared to singleton pregnancy was found in both 2018 and 2019. In 2018, there were 42 perinatal deaths 
from multiple births, making up 12.9% of all perinatal deaths in 2018 (Table 1.18a). In 2018, the perina-
tal mortality rate associated with multiple pregnancy was 3.85 times higher at 18.45 per 1,000 births 
(p<0.001) (Table 1.18c). In 2019, there were 35 perinatal deaths from multiple births, making up 9.7% of all 
perinatal deaths in 2019 (Table 1.18b). In 2019, the perinatal mortality rate associated with multiple preg-










Male 125(51.7) 61(51.7) 186(51.7) 51.19
Female 113(46.7) 55(46.6) 168(46.7) 48.79










Singleton 199(91.7) 84(77.8) 283(87.1) Singleton births 96.3%
Twins 14(6.5) 24(22.2) 38(11.7)
Multiple births 3.7%Triplet 4(1.8) - 4(1.2)










Singleton 228(94.2) 97(82.2) 325(90.3) Singleton births 96.4%
Twins 12(5) 18(15.3) 30(8.3)
Multiple births 3.6%Triplet 2(0.8) 3(2.5) 5(1.4)








Singleton 4.79 (4.25-5.39) 1.00 (reference) <0.001
Multiple 18.45 (13.3-24.94) 3.85 (2.78-5.32)  








Singleton 5.66 (5.06-6.31) 1.00 (reference) <0.001
Multiple 16.11 (11.22-22.41) 2.85 (2.01-4.03)  
Note: 95% CI=Exact Poisson 95% confidence intervals.
49  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press].
50  Healthcare Pricing Office. Perinatal Statistics Report 2018. Dublin: Health Service Executive. [in press].
51  Healthcare Pricing Office. Perinatal Statistics Report 2019. Dublin: Health Service Executive. [in press]. 
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Gestation 
Over seventy percent of perinatal deaths in 2018 and 2019 were associated with delivery before 37 weeks 
gestation (n=492 of 680, 72.3%, unknown for five cases). This was the case for 73.4% of stillbirths (n=334 of 
455, unknown for four stillbirths) and 70.2% of early neonatal deaths (n=158 of 225, unknown for one early 
neonatal death). A higher proportion of extremely pre-term delivery (delivery 22-27 weeks gestation) was 
more often associated with cases of early neonatal death than cases of stillbirth (Figure 1.10).
Figure	1.10:	Distribution	of	gestational	age	at	delivery	in	stillbirths	and	neonatal	deaths	in	2018	and	2019



























Gestational age at delivery (weeks)
Stillbirths Early Neonatal Deaths
The 42 perinatal deaths from multiple births in 2018 
comprised of 18 stillbirths and 24 early neonatal 
deaths. The majority (n=10, 41.7%) of the 24 early ne-
onatal deaths from multiple births were due to ma-
jor congenital anomalies. The second most common 
cause of death in the early neonatal deaths were 
due to respiratory disorders (n=7, 29.2%) mainly se-
vere pulmonary immaturity (n=6). The most com-
mon causes of death for the 18 stillbirths from mul-
tiple births were major congenital anomalies (n=3, 
16.7%) specific placental conditions (n=3, 16.7%) and 
infection (n=3, 16.7%).
The 35 perinatal deaths from multiple births in 
2019 comprised of 14 stillbirths and 21 early neona-
tal deaths. The majority (n=13, 61.9%) of the 21 early 
neonatal deaths from multiple births were due to 
respiratory disorders, mainly severe pulmonary im-
maturity (n=12). Major congenital anomalies were 
the second most common cause of death in the 
early neonatal deaths (n=15, 23.8%). The majority 
of the 14 stillbirths from multiple births were due to 
specific placental conditions (n=8, 57.1%).
Chorionicity was reported for all 42 perinatal deaths 
from multiple births in 2018 and for 32 of the 35 
multiple births in 2019. The vast majority were cases 
with dichorionic diamniotic (2018; n=25, 59.5% and 
2019 n=21, 68.8%) and the remaining cases were 
monochorionic diamniotic (2018; n=14, 33.3% and 
2019; n=9, 28.1%) and trichorionic (2018 n=3, 7.1% 
and 2019; n=1, 3.1%). 
In 2018, there were 20 cases where one twin died, 
nine pairs of twins where both twins died, two cas-
es where one triplet died, and one set of triplets 
where two of the three triplets died representing a 
total of 42 perinatal losses. 
In 2019, there were 20 cases where one twin died, 
five pairs of twins where both twins died, two cas-
es where one triplet died, and one set of triplets 
where all three triplets died representing a total of 
35 perinatal losses. 
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In 2018 and 2019, the most represented birthweight in cases of perinatal death was in the range 500-999 
grams (n=199 of 684, 29.1%, unknown for one stillbirth case) (Figure 1.11). In over seventy five percent of 
perinatal deaths (n=510, 74.5%) the birthweight was less than 2,500 grams. For stillbirths, 74.9% had a 
birthweight below 2,500g (n=343 of 458) and 73.8% of neonatal deaths (n=167 of 226) also registered a 
weight below this value. 
Figure	1.11:	Distribution	of	birthweight	in	stillbirths	and	neonatal	deaths	in	2018	and	2019
Note: Data on birthweight was unknown for one stillbirth.
Birthweight 
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Birthweight centiles
An increased risk of perinatal death has been as-
sociated with failure of fetal growth in utero. We 
have produced charts to highlight this issue in re-
lation to the stillbirths and early neonatal deaths 
that occurred in Ireland in 2018 and 2019. To do 
so, we used the Gestation Related Optimal Weight 
(GROW) software52 and coefficients derived from 
the multiple regression analysis of data on 11,072 
births in six maternity units in Dublin, Galway, Lim-
erick and Belfast in 2008-2009.53
The regression analysis determined the Term (i.e. 
40 weeks) Optimal Weight (TOW) in Ireland to be 
3,490.7g. The normal range (i.e. the range from 
the 10th centile weight to the 90th centile weight) 
around the TOW was then calculated and the rec-
ommended proportionality growth function was 
applied to the TOW, the 10th centile term weight 
and the 90th centile term weight in order to de-
termine the optimal weight and normal range at 
all gestations (21-44 weeks for stillbirths and ear-
ly neonatal deaths in Ireland in 2018 and 2019). 
These steps are described in detail in the GROW 
documentation.
The optimal weight and normal range for all ges-
tations are plotted with the actual birthweights 
of the stillbirths in 2018 in (Figure 1.12a) and still-
births in 2019 (1.12b) with the birthweights for cas-
es of early neonatal death in 2018 (Figure 1.13a) 
and cases of early neonatal death in 2019 (Figure 
1.13b). For stillbirths across all gestational ages, a 
high proportion were below the lower limit of the 
normal range (10th centile). In cases of early neo-
natal death, the birthweight was often below the 
normal range for births after 32 weeks gestation. 
However, low birthweight was observed less often 
than for cases of stillbirth.
Figures (1.12a, 1.12b, 1.13a and 1.13b) have the limi-
tation of plotting actual birthweights against the 
optimal weight and normal range adjusted only for 
gestational age. There is no adjustment for oth-
er factors affecting birthweight, namely, maternal 
height, weight, parity and ethnic group and infant 
sex. The use of centiles customised for maternal 
and infant characteristics affecting birthweight 
identifies small babies at higher risk of mortality 
better than population centiles.54 Small-for-ges-
tational-age (SGA) refers to birthweights below 
the 10th centile and severely SGA refers to birth-
weights less than the 3rd centile.55
52 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.7.6.5(IE), 2015 Gestation Network, www.gestation.net
53  Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
54 Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population–
based birthweight standards. BJOG 2001;108:830–4.
55  Royal College of Obstetrics and Gynaecologists. The investigation and management of the small-for-gestational age fetus. 
RCOG Green Top Guideline 2013 (No.31). Available at: www.rcog.org.uk/files/rcog-corp/22.3.13GTG31SGA_ExecSum.pdf
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Figure	1.14a:	Distribution	of	customised	birthweight	centiles	for	stillbirths,	2018
Customised birthweight centiles were derived 
using the GROW software.56 There was missing 
data for maternal height (2018; n=47 of 325, 14.5% 
and 2019; n=102 of 360, 28.3%) and weight (2018; 
n=40 of 325, 12.3% and 2019; n=79 of 360, 21.9%). 
For these cases, we used the median height and 
weight of the mothers with complete data. The 
GROW software also provides estimated custom-
ised birthweight centiles in cases with missing 
data. Ultimately, customised birthweight centiles 
were calculated for 316 of the 325 perinatal in 
deaths in 2018 and for 356 of the 360 perinatal in 
deaths in 2019.
The distribution of customised birthweight cen-
tiles at all gestations is illustrated for stillbirths in 
2018 (Figure 1.14a) and in 2019 (Figure 1.14b) and 
for early neonatal deaths in 2018 (Figure 1.15a) 
and 2019 (Figure 1.15b) . At all gestations, there 
were cases spanning the full range of birthweight 
centiles (i.e. 0-100th) but there was a clear over-
representation of cases below the median and far 
more at or near centile zero than would be ex-
pected in the population of all births.
56  A. Customised Weight Centile Calculator. GROW version 6.7.6.5(IE), 2015 Gestation Network, www.gestation.net
 
Figure 1. 4a: tribution of customised birthweight centiles for stillbirths, 2018 
 
Figure 1.14b: Distribution of customised birthweight centiles for stillbirths, 2019 
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Figure 1.14a: Distribution of customised birthweight centiles for stillbirths, 2018 
 




Figure 1.15a: Distribution of customised birthweight centiles for early neonatal deaths, 2018 
 
Figure 1.15b: Distribution of customised birthweight centiles for early neonatal deaths, 2019 
 
Figure	1.15a:	Distribution	of	customised	birthweight	centiles	for	early	neonatal	deaths,	2018
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Table 1.19 details the number and percentage of 
stillbirths and early neonatal deaths within specif-
ic ranges of customised birthweight centiles. Low 
birthweight was associated with both groups but 
particularly with stillbirths. Forty percent (39.2%) 
of all stillbirths were classified as severely SGA 
(<3rd customised birthweight centile) and over fif-
ty percent (53.7%) were SGA (<10th customised 
birthweight centile) compared to 34.1% and 44.8% 
of the cases of early neonatal death, respectively. 
SGA may be more prevalent among stillborn ba-
bies because they may have died some days or 
weeks before being delivered. We do not record 
whether there was evidence of maceration in cas-
es of stillbirth but there was support for this hy-
pothesis. The customised birthweight centile of 
the stillborn baby was lower when there was more 







< 3rd 176(39.2) 76(34.1)




Note: *Includes cases from the category <3rd Centile. Values are n (%) unless otherwise stated. Centiles could not be calculated 
for ten stillbirths and three early neonatal deaths.
 
Figure 1.15a: Distribution of customised birthweight centiles for early neonatal deaths, 2018 
 
Figure 1.15b: Distribution of customised birthweight centiles for early neonatal deaths, 2019 
 
Figure	1.15b:	Distribution	of	customised	birthweight	centiles	for	early	neonatal	deaths,	2019
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Cases of stillbirth and early neonatal death were at significantly lower birthweight centiles when the 
cause of death was attributed to major congenital anomaly (Table 1.20). Over half of the 138 stillbirths 
due to congenital anomaly (n=78, 56.5%) were severely SGA in comparison to over thirty percent of 
the stillbirths due to other causes (n=98, 31.5%). Similarly, fifty percent of the 124 early neonatal deaths 
due to congenital anomaly (n=62, 50.0%) were severely SGA compared to just fourteen percent (n=14, 













< 3rd 78(56.5) 98(31.5) 62(50.0) 14(14.1)
< 10th* 90(65.2)* 151(48.6)* 77(62.1)* 23(23.2)*
10-49th 21(15.2) 91(29.3) 21(16.9) 39(39.4)
50-89th 12(8.7) 44(14.1) 12(9.7) 29(29.3)
90th+ 15(10.9) 25(8) 14(11.3) 8(8.1)
Note: *Includes cases from the category <3rd Centile. Values are n (%) unless otherwise stated. Centiles could not be calculated 
for ten stillbirths and three early neonatal deaths. 
Diagnosis of fetal growth restriction (FGR)
Data on diagnosis of fetal growth restriction 
(FGR) were recorded for 676 of the 685 perina-
tal deaths in 2018 and 2019. A diagnosis of FGR 
was reported for 179 (26.5%) of the 676 deaths, 
120 (26.4%) stillbirths and 59 (26.7%) early neo-
natal deaths. An antenatal diagnosis of FGR (as 
opposed to diagnosis based on observation at de-
livery or post-mortem) was reported for 124 peri-
natal deaths (18.3%), 50 stillbirths (22.6%) and 74 
early neonatal deaths (16.2%).
For stillbirths and cases of early neonatal death 
that were severely SGA (<3rd customised birth-
weight centile), approximately 41.8% (n=105 of 
251) had an antenatal diagnosis of FGR (Table 
1.21). The level of antenatal diagnosis of FGR was 
lower for stillbirths and early neonatal death that 
were SGA (stillbirths = 29.0%, neonatal deaths = 
43.4%) compared to stillbirths and early neonatal 
death that were severely SGA (stillbirths = 36.9%, 






Severely SGA (<3rd centile) 65 of 176 (36.9%)
SGA (<10th centile)* 70 of 241 (29.0%)*
Neonatal	death
Severely SGA (<3rd centile) 40 of 75 (53.3%)
SGA (<10th centile)* 43 of 99 (43.4%)*
Note: SGA cases include severely SGA cases; *Includes cases from the category <3rd Centile. 
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•		Recommendation: Improved antenatal detection of fetal growth restriction (FGR) with timely delivery 
is a preventative strategy to reduce perinatal mortality. 
–  As used previously and in other centres, the generation of customized birth weight centile charts for 
every woman during pregnancy and concomitantly, staff should be trained in risk assessment, plotting 
symphysial fundal height (SFH) and scan weight estimates in order to reduce stillbirths in Ireland.
–  Based on feedback to the NPEC, other methodologies could be considered. A multidisciplinary work-
ing group should be developed to address a national standardised approach to the detection of FGR. 
A national approach should also evaluate the use of a standard growth curve across all Irish maternity 
units. The Institute of Obstetrics and Gynaecology would be well placed to facilitate this working group.
Perinatal	mortality	following	
termination	of	pregnancy
From January 2019, the change in the Irish legis-
lation following the ‘Repeal of the Eighth amend-
ment’ legalised termination of pregnancy (TOP) 
in the Republic of Ireland (ROI) in certain circum-
stances. Abortion in the ROI is regulated by the 
Health Regulation of Termination of Pregnancy 
Act 2018. Abortion is permitted during the first 
twelve weeks of pregnancy, and later in cases 
where the pregnant woman’s life or health is at 
risk, or in the cases of a fatal fetal abnormality.57
In 2019, eight percent (n=30, 8.3%) of all the 360 
perinatal deaths with a birthweight ≥500g and/or 
gestation at delivery ≥24 weeks reported to NPEC 
resulted from a TOP (stillbirths; n=23, 76.7% and 
neonatal deaths; n=7, 23.3%). Major congenital 
anomaly was associated with all cases of stillbirths 
delivered following TOP (n=23, 100%). The majori-
ty of stillbirths delivered following TOP most com-
monly occurred between the gestational ages of 
22 to 27 weeks (n=18, 78.3%). Major congenital 
anomaly was associated with all but one case of 
neonatal death following TOP (n=6, 86.0%). For 
the remaining one case of early neonatal death, 
chorioamnionitis was the reported underlying ob-
stetric antecedent complication. Early neonatal 
deaths following TOP most commonly occurred 
between the gestational ages of 22 to 27 weeks 
(n=6, 85.7%).
While not included in the calculation of the peri-
natal mortality rates, NPEC ask for notification of 
deaths in the early neonatal period of babies born 
before 24 weeks gestation and weighing less than 
500g. In 2019, ten such deaths following TOP were 
reported to the NPEC. Major congenital anomaly 
was associated with eight of the ten cases and 
chorioamnionitis was the reported underlying ob-
stetric antecedent complication for the other two 
remaining cases. 
57  Health (Regulation of Termination of Pregnancy) Act 2018. Available at: www.irishstatutebook.ie/eli/2018/act/31/enacted/en/html
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Investigations	to	determine	the	cause	of	death
Autopsy
Current practice guidelines recommend that par-
ents should be offered a full post-mortem exam-
ination of the stillborn infant to help explain the 
cause of death. When a cause is found it can cru-
cially influence care in a future pregnancy.58 In 
2018, data on autopsy uptake was reported for 
317 of the 325 perinatal deaths, of which 42.0% 
(n=133) underwent an autopsy. In 2019, data on 
autopsy uptake was reported for 358 of the 360 
perinatal deaths, of which 49.2% (n=176) under-
went an autopsy. The rate of autopsy uptake in 
2019 is slightly higher compared to 2018. The 
trend in the perinatal autopsy rate is illustrated in 
Figure 1.16. The autopsy uptake rate in stillbirths 
continues to be higher than in cases of early neo-
natal death.
In Ireland in 2018, an autopsy was undertaken fol-
lowing 46.7% of stillbirths (n=100 of 214, unknown 
for three cases) and almost one third of early ne-
onatal deaths (n=33 of 103, 32.0%, unknown for 
five cases), see Figure 1.18. In 2019, an autopsy was 
undertaken following 52.1% of stillbirths (n=126 
of 242) and over forty percent of early neona-
tal deaths (n=50 of 116, 43.1%, unknown for two 
cases), These figures are higher than in the Unit-
ed Kingdom as a whole in 2016 (full autopsy for 
44.5% of stillbirths and 26.3% of early neonatal 
deaths).59
Figure	1.16:	Autopsy	uptake	percentage,	2011-2019
58  Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of 
Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
59  Draper ES, Gallimore ID, Kurinczuk JJ, Smith PW, Boby T, Smith LK, Manktelow BN, on behalf of the MBRRACE-UK 
Collaboration. MBRRACE-UK Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 
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The variation in the rate of autopsy across the 19 maternity units for the combined years 2018 and 2019 
is illustrated in the funnel plot (Figure 1.17). This may reflect variation in access to dedicated perinatal 
pathology services across units. There was some variation found across the four large maternity units, 
with rates of 35.1%, 43.4%, 44.2% and 69.7% being found across the four units for the combined reporting 
years 2018 and 2019.
Figure 1.18 details the autopsy-related steps fol-
lowing the 685 perinatal deaths for the combined 
reporting years 2018 and 2019 (autopsy uptake 
unknown for ten cases). A total of 310 (45.9%) 
autopsies were performed on cases of perinatal 
death and there were 365 (54.1%) cases that did 
not receive an autopsy in 2018 and 2019.
As mentioned previously, over half of the perinatal 
deaths did not receive an autopsy (n=365 54.1%). 
Data on whether an autopsy was offered was re-
ported for 356 of these 365 cases. For the majori-
ty of these 356 cases an autopsy was offered and 
presumably declined by parents (n=287, 80.6%). 
Such an offer was made more often in cases of 
stillbirth (189 of 287, 65.9%) than for early neo-
natal deaths (98 of 287, 34.1%). Consequently, for 
the combined years 2018/2019, of the 356 cases 
where data on autopsy uptake were reported, 
there were 69 perinatal deaths for which an au-
topsy was not offered (19.4%). This represents a 
slightly higher proportion than in 2017, when 9.8% 















































2018/2019 Total number of perinatal deaths in unit (≥500g or ≥24 weeks)
Unit-specific rate Overall rate      95% Confidence interval
Figure	1.17:	Funnel	plot	of	autopsy	uptake	in	the	19	Irish	maternity	units	in	2018/2019	(combined)	
A – South Tipperary (STGH); 
B – Kerry (UHK); 
C – Sligo (SUH); 
D – Portlaoise (MRHP); 
E – Mayo (MUH); 
F – Cavan (CGH);
G – Kilkenny (SLHK); 
H – Portiuncula (PUH); 
I – Wexford (WGH); 
J – Letterkenny (LUH); 
K – Waterford (UHW); 
L – Mullingar (RHM); 
M – Galway (UHG); 
N – Drogheda (OLOL); 
O – Limerick (UMHL); 
P – Cork (CUMH); 
Q – National Maternity (NMH);
R – Coombe (CWIUH);
S – Rotunda (RH).
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Figure	1.18:	Flowchart	outlining	autopsy-related	steps	taken	after	385	perinatal	deaths	in	2018	and	2019	combined
Note: *Data on whether autopsy was performed and/or offered was missing for ten cases. **There were nine cases, where it 
was reported that an autopsy was not performed but it was not known whether an autopsy was offered. Values are n (%) unless 
otherwise stated.
The decision not to offer to undertake an autopsy 
may be influenced by the clinical scenario and the 
antenatal diagnosis. There was evidence to sup-
port this in relation to major congenital anomaly. 
The proportion of cases not offered an autopsy 
was higher if the perinatal death was due to a ma-
jor congenital anomaly than if it the death was 
due to another cause (Table 1.22).
For the reporting year 2019, feedback from units 
highlighted a delay in returns of coronial autop-
sy reports; this was exacerbated in 2020 due to 
the impact of the Covid 19 pandemic. Notwith-
standing the latter, further engagement between 
the NWIHP and the coronial system could benefit 
timeliness of autopsy reports to maternity units 













Performed 50(35.5) 176(55.9) 39(33.1) 44(46.3)
Offered 69(48.9) 120(38.1) 54(45.8) 45(47.4)
Not offered 21(14.9) 17(5.4) 25(21.2) 6(6.3)
Note: Data on whether autopsy was performed and/or offered was missing for ten cases, additionally, there were nine other 
cases, where it was reported that an autopsy was not performed but it was not known whether an autopsy was offered.  
Values are n (%) unless otherwise stated.
Recommendation:	Further engagement with the Coroner Society of Ireland to explore the timeliness 
of autopsy reports reported to maternity units is warranted. Owner; the National Women and Infants 
Health Programme (NWIHP) to progress.
 
Figure 1.18: Flowchart outlining autopsy-related steps taken after 385 perinatal deaths in 2018 
and 2018 combined 
Note: *Data on whether autopsy was performed and/or offered was missing for ten cases. **There were nine 
cases, where it was reported that an autopsy was not performed but it was not known whether an autopsy was 
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Placental examination 
The value of placental examination in determining 
cause of perinatal death is well documented.60 In 
2018 and 2019, placental histology examinations 
were conducted for almost all stillbirths (n=446 of 
456, 99.1%, unknown for three cases) and for 97.8% 
of early neonatal deaths (n=207 of 221, 97.8%, un-
known for five cases). These figures are similar to 
those reported in 2017 for stillbirths (99.1%) and 
are slightly higher than those reported for early 
neonatal deaths (92.7%) in 2017. In 2016, levels of 
placental histology examinations were reported 
for stillbirths in the United Kingdom as a whole 
(89.9%).61
Specific placental conditions 
Abnormal placental findings have been classified 
in line with recommendations from the publication 
from the international consensus meeting of pa-
thology.62 These are presented under the following 
broad categories: Maternal vascular malperfusion, 
Fetal vascular malperfusion, Cord pathology, Cord 
pathology with distal disease, Delayed villous mat-
uration, Chorioamnionitis, Villitis, Fetal Vasculitis 
and other. 
Specific placental conditions were generally more 
prevalent among stillbirths than among cases of 
early neonatal death. (Table 1.23). In the case of 
stillbirths in both 2018 and 2019, conditions within 
the maternal vascular malperfusion, fetal vascular 
malpersuion and cord pathology categories were 
most commonly reported.
Submission of anonymised placental histology re-
ports to the NPEC as part of this audit would facil-
itate standardised interpretation and classification 














Fetal vascular malperfusion 58(27.1) 9(8.7) 50(20.7) 13(11.1)
Maternal vascular malperfusion 49(22.9) 14(13.5) 66(27.3) 21(17.9)
Cord pathology 49(22.9) 6(5.8) 58(24) 14(12)
Delayed villous maturation 19(8.9) 4(3.8) 18(7.4) 4(3.4)
Chorioamnionitis 16(7.5) 23(22.1) 22(9.1) 20(16.9)
Cord pathology with distal disease 10(4.7) 0(0) 21(8.7) 5(4.3)
Fetal vasculitis 2(0.9) 14(13.5) 9(3.7) 7(6)
Other placental condition* 29(13.6) 16(15.4) 56(23.1) 21(17.9)
Any placental condition 136(63.6) 48(46.2) 175(72.3) 64(54.7)
Note: More than one placental condition was present for some cases. *Includes conditions such as Placental disease due to 
massive perivillous fibrin deposition, Mesenchymal dysplasia, Diffuse chorionic hemosiderosis and Chronic histocytic intervillositis.
60  Korteweg FJ, Erwich JJ, Timmer A, van der Meer J, Ravise JM, Veeger NJ, Holm JP. Evaluation of 1025 fetal deaths: proposed 
diagnostic workup. Am J Obstet Gynecol 2012 206:53.e1-53.e12
61  Draper ES, Gallimore ID, Kurinczuk JJ, Smith PW, Boby T, Smith LK, Manktelow BN, on behalf of the MBRRACE-UK Collaboration. 
MBRRACE-UK Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 2016. Leicester: 
The Infant Mortality and Morbidity Studies, Department of Health Sciences, University of Leicester. 2018.
62  Khong TY, Mooney EE et al (2016). Sampling and definition of placental lesions. Arch Pathol Lab Med 2016 Jul;140 (7):698-713
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Other examinations performed 
External examinations were performed for over forty percent of the perinatal deaths in 2018 and 2019 
(2018; 41.5% and 2019; 42.8%) compared to forty-six percent (46.4%) in 2017 (Table 1.24). Computerised 
tomography scans (CT scan) and magnetic resonance imaging (MRI) tests were rarely undertaken. X-Ray 
examinations were carried out more often following cases of stillbirth in rather than for cases of early 
neonatal death in 2018 and 2019.
Cytogenetic analysis is an important investigation 
in the diagnosis of chromosomal abnormalities. 
Some abnormalities are potentially recurrent and 
can be tested for in future pregnancies.63 In the 
event of a chromosomal disorder, a specific ques-
tion on the NPEC Perinatal Death Notification 
form (Appendix E) asks how the diagnosis was 
made. In 2018, a chromosomal disorder was the 
most commonly reported major congenital anom-
aly causing death (49 perinatal deaths; 37 still-
births and 12 early neonatal deaths). In over sixty 
percent of these cases in 2018 (n=30 of 49, 61.2%), 
the diagnosis was made by cytogenetic analysis 
(n=22 of 27 stillbirths, 81.5%; n=8 of 12 neonatal 
deaths, 66.7%). Similarly, in 2019 a chromosomal 
disorder was the most commonly reported major 
congenital anomaly causing death (49 perinatal 
deaths; 37 stillbirths and 12 early neonatal deaths). 
In almost three quarters of these cases in 2019 
(n=41 of 55, 74.5%), the diagnosis was made by 
cytogenetic analysis (n=28 of 40 stillbirths, 70.0%; 
n=13 of 15 neonatal deaths, 86.7%).





























External 160(46.4) 87(40.1) 48(44.4) 135(41.5) 112(46.3) 42(35.6) 154(42.8)
X-Ray 139(40.3) 63(29.0) 12(11.1) 75(23.1) 84(34.7) 27(22.9) 111(30.8)
CT scan 5(1.4) 4(1.8) 1(0.9) 5(1.5) 0(0) 0(0) 0(0)
MRI 11(3.2) 0(0) 0(0) 0(0) 0(0) 1(0.8) 1(0.3)
Note: Values are n (%) unless otherwise stated. CT=Computerised tomography, MRI=magnetic resonance imaging. 
63 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of 
Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
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2.  Invited Commentary by Dr Sieglinde Mullers; 
The contribution of Twin Pregnancy to Perinatal 
Mortality
Introduction
The decades spanning the 1980’s to 2000’s wit-
nessed an exponential increase in twin and high-
er-order multiple births worldwide.1 According to 
the economic and social research institute (ESRI) 
and the Euro-Peristat perinatal data, the twinning 
rate in Ireland for 2015 was 18.7 per 1,000 ma-
ternities, representing an increase of 22.1% over 
the preceding decade.2,3 As of 2015, our multiple 
pregnancy birth rate was higher than the U.K. and 
the fifth highest in Europe2 (Figure 2.1). Further-
more, our rates of triplet and higher order multiple 
births are the second highest in the E.U. (0.5 per 
1,000 maternities) after Cyprus with 0.9 per 1,000 
maternities.3
Owing to more stringent use of assisted repro-
ductive techniques (ART), epidemiological data 
now indicate a declining multiple birth rate in the 
U.K. and USA, however this is not the current ex-
perience in Ireland.4 While there has been a signif-
icant decline in total births per annum in Ireland 
since 2012, the rate of twin and higher-order mul-
tiple births has not significantly changed. In 2019 
there were 59,084 infants born, including a total 
of 2,096 twins (1,048 twin-pairs), such that the 
rate of multiple pregnancy births in 2019 was 1.8% 
(17.7 per 1,000 maternities) of all births. This has 
been fairly constant since 2012 (Figure 2.2). Con-
sequently, the ongoing clinical workload generat-
ed from the high-risk nature of these pregnancies 
is undoubtedly felt on-the-ground in maternity 
and neonatal intensive care (NICU) units all over 
the country. Thus, multiple pregnancy remains an 
important issue in the provision of obstetric and 
neonatal services. 
Population based studies indicate a declining 
perinatal mortality (PNM) rate in multiple preg-
nancy.5-7 Despite these promising contemporary 
data, multiple pregnancy continues to dispropor-
tionately contribute to perinatal morbidity and 
mortality, with the risk of stillbirth (SB) and early 
neonatal death (NND) in twins being twice and 
three times that of singletons respectively.5-8 Fur-
thermore, the increased rate of preterm delivery in 
multiple pregnancy confers a four-fold increased 
risk of developing cerebral palsy compared to sin-
gleton pregnancy.9,10
In January 2021, MBRRACE-UK published its inau-
gural report on the Confidential Enquiry into Still-
birth and Neonatal Death in Twin Pregnancies in 
the U.K.11 The report was conducted by 11 separate 
multidisciplinary panels who comprehensively re-
viewed the quality of care in the case of 50 preg-
nancies with 80 twin deaths. The findings indicat-
ed ‘in around 1 in 2 baby deaths, the care was poor, 
and that if the care had been better it may have 
prevented the baby from dying’.11
Recognising the contribution of multiple pregnan-
cy to overall PNM, together with the relatively high 
twin-birth rate in Ireland, this invited commentary 
focuses on twin perinatal mortality in 2019 in re-
lation to trends over the last eight years (2012-
2019). Together with the NPEC audit, the inclusion 
of a more detailed review of twin perinatal mortal-
ity represents a concerted effort to address and 
reduce perinatal mortality in this high-risk group. 
Figure 2.1 shows the rates of twin, triplet and high-
er-order births, expressed as numbers of women 
with twin, triplet or higher-order births per 1,000 
women giving birth to one or more fetuses (adapt-
ed from Euro-Peristat 2015, 2018).3 In 2015, Ireland 
had the fifth and second highest rate of twins and 
higher-order multiple births in the E.U. (18.7/1000 
and 0.5/1,000 maternities, respectively). 
60 PERINATAL MORTALITY IN IRELAND < CONTENTS PAGE
 





































































0 5 10 15 20 25 30
Belgium (120 681)
Bulgaria, 2014 (64 427)
























Sweden, 2014 (113 999)
UK: England and Wales (689 751)
UK: Scotland (23 937)




Twins Triplets or more
Figure	2.1	Multiple	birth	rates	per	1,000	women	with	live	births	or	stillbirths	by	number	of	fetuses	in	2015
(adapted	from	Euro-Peristat	2015,	2018)
Figure 2.2 is derived from HIPE data, and shows a declining overall birth rate in Ireland in the years 
2012-2019. It must be noted that although the overall birth rate has declined during this period, no sig-
nificant reduction in twin or high-order multiple births was shown. Data for twins and other multiples 
represent individual births. 
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Figure 2.2 Births by plurality in  2012-2019 (HIPE data) 
 
Figure	2.2	Births	by	plurality	in	2012-2019	(HIPE	data)
Perinatal Mortality in twins
Perinatal mortality in multiple pregnancy for the purpose of this report is recorded for individual 
deaths in twins. This is based on perinatal deaths (stillbirth (SB) and early neonatal deaths (NND) 
in twins with a birthweight ≥500g or gestational age at delivery ≥24 weeks). Cases of intrauterine 
death diagnosed before 24 gestational weeks with a birthweight <500g are not considered to have 
reached a gestational age of 24 weeks or more and thus are not included as stillbirths. For the pur-
pose of this report, data will be presented as combined PNM or separately as SB or NND associated 
with twin pregnancy. 
In 2019 there were a total of 360 perinatal deaths, of which 35 (9.7%) involved multiple pregnancies 
(Table 2.1). This included 30 cases involving twins and five involving triplets. Regarding the 30 twin 
deaths in 2019, there are five cases where both twins died (three cases involved dichorionic (DC) 
twins and two cases involved monochorionic diamniotic twins (MCDA). Regarding twins, there was 
one case of congenital anomaly associated with SB and five cases associated with NND, thus the 
corrected perinatal mortality rate for twins in 2019 was 5.7 per 1000 twin births. 
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Table	2.1:	Perinatal	deaths	from	singleton,	twin,	triplet	and	other	multiple	births,	2012-2019
2012	(N) 2013	(N) 2014	(N) 2015	(N) 2016	(N) 2017	(N) 2018	(N) 2019	(N)
Singleton 396 411 420 390 341 303 282 325
Twin 43 41 43 60 31 40 38 30
Triplet 1 3 1 3 1 3 4 5
Other Multiple 0 0 0 0 1 0 0 0
Total 440 455 464 453 374 346 324 360
*Perinatal deaths in twins and higher-order multiples refers to individual deaths. 
Comparison of perinatal mortality rate in twins, 2012-2019
Overall, compared with singleton pregnancies, there was a threefold increased risk of perinatal deaths 
among twins from the period spanning 2012-2019 (risk ratio=3.04, 95% CI 2.71-3.41) (Table 2.2). This 
relative risk was 2.79 in 2012-14 and was 3.16 in 2017-19. This is comparable to international perinatal 





Triennium Singletons Twins Singletons Twins Singletons Twins
2012-14 196873 7300 1227 127 6.23 17.40
2013-15 191990 7320 1221 144 6.36 19.67
2014-16 188393 7212 1151 134 6.11 18.58
2015-17 183389 7034 1034 131 5.64 18.62
2016-18 178989 6830 927 109 5.18 15.96
2017-19 174697 6550 911 108 5.21 16.49
The PNM in twins varied significantly by maternal 
age, with the greatest relative risk observed for 
twins of mothers aged < 25 years (Figure 2.3). The 
relative risk for PNM in twins compared with single-
tons decreased with increasing maternal age, be-
ing nearly five times higher in the <25 year old (RR 
4.86, 95% CI 3.4-6.94), four times higher in 25-29 
year-olds (RR 3.90 , 95% CI 2.92-5.22), 3.4 times 
higher risk for twins of 30-34 year-olds (RR 3.39, 
95% CI 2.77-4.16), 2.5 times higher risk for twins of 
35-39 year-olds (RR 2.48, 95% CI 2-3.06), and ap-
proximately twice the risk among twins of mothers 
aged at least 40 years (RR 1.94, 95% CI 2.71-3.41). 
All risk ratios were based on pooled information 
from 2012-2019 and were noted to be highly statis-
tically significant (p <0.001). 
The lower rate of PNM in older mothers expecting 
twin and high-order multiple pregnancies may be 
reflective of the increased prenatal surveillance, 
judicious use of aspirin, and lower thresholds for 
delivery that are likely afforded to this group, ow-
ing to the higher anticipated risk profile. Increasing 
maternal age has been associated with less peri-
natal mortality in twins compared to singletons.15 
One of the key findings from the MBRRACE-UK 
report on twin mortality centered around the rec-
ommendation of prophylactic aspirin for women 
with multiple pregnancy, reporting that in only half 
of eligible women was there documentation of as-
pirin being prescribed.11 Current NICE guidance 
recommends low-dose aspirin for women with 
multiple pregnancy and with additional risk fac-
tors for the development of preeclampsia.16 Thus, 
being a first time mother with a multiple pregnan-
cy already constitutes two moderate risk factors, 
and therefore these women should be prescribed 
aspirin. Preliminary evidence appears to support 
the higher dose of 150mg per day for preeclamp-
sia prevention in multiple pregnancies.17 
The relatively high rate of PNM in twins and high-
er-order multiple pregnancies in our younger 
mothers requires further comprehensive review. 
Of note, where documented, fertility treatment 
featured in 23.3% of perinatal twin deaths, which 
is comparable with published data.18 
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Figure	2.3	Perinatal	mortality	rate	by	plurality	and	maternal	age	(2012-2019)
 
Figure 2.3 Perinatal tality rate by plurality and m ternal age (2012-2019) 
<25 yrs 25-29 yrs 30-34 yrs 35-39 yrs 40+ yrs
Perinatal mortality rate Twins 33.33 20.66 16.76 14.56 17.39
Perinatal mortality rate Other
mutiples 142.86 66.67 20.58 22.22 41.67










Perinatal mortality rate Twins
Perinatal mortality rate Other mutiples
Perinatal mortality rate Singletons
Expon. (Perinatal mortality rate Twins)
Expon. (Perinatal mortality rate Other mutiples)
The relative risk for PNM in twins compared with singletons decreased with increasing maternal age, 
with a four times higher risk for twin PNM in 25-29 year-olds, 3.4 times higher risk for twins of 30-34 
year-olds, 2.5 times higher risk for twins of 35-39 year-olds and approximately twice the risk among 
twins of mothers aged at least 40 years. 
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Figure 2.4 Major congenital anomaly as the main cause of perinatal mortality (stillbirths and early 




Causes of perinatal mortality in twins 
Regarding twin perinatal mortality in 2019, of the 30 perinatal deaths there were 12 cases of SB and 18 
cases of early NND. The main causes of SB and early NND in twins spanning 2012-2019 are outlined in 
Tables 2.3 and 2.4 respectively. Major congenital anomaly is broken down by specific cause/system for all 
perinatal deaths spanning 2012-2019 in Figure 2.4
Stillbirth in twins
Regarding cause of stillbirths (SB) in twins in 2019 
(n=12), a significant number of cases were due to 
specific placental causes (n=12, 58%). These in-
cluded maternal vascular malperfusion (n=3), fetal 
vascular malperfusion (n=2), cord pathology (n=1), 
other (n=1). This highlights the necessity for dedi-
cated perinatal pathologists in the investigation of 
perinatal twin mortality. In two cases the cause of 
stillbirth was noted to be due to specific fetal con-
ditions (namely twin-twin transfusion syndrome, 
TTTS). There was one case each of congenital 
anomaly (gastrointestinal disease), infection (cho-
rioamnionitis) and one case were unexplained. The 
breakdown of infection as a cause of SB in twins, 
2012-2019 is highlighted in Figure 2.2. 
Of note in 2019, maternal disorders including hy-
pertensive disorders, antepartum or intrapartum 
haemorrhage, mechanical factors, other obstet-
ric factors or IUGR did not account for any of the 
stillbirths associated with twins. The increasing use 
of aspirin for preeclampsia prevention in multiple 
pregnancy may partly explain the lack of associa-
tion of maternal hypertensive conditions in perina-
tal death in twins. 
There were a total of eight intrapartum stillbirths in 
twins spanning 2012-2019. This included five cases 
with spontaneous onset of labour at < 24 weeks 
gestation with associated chorioamnionitis, and 
one case each of maternal sepsis and PPROM (< 
24 weeks and >500g), induction of labour at 35 
weeks for TTTS, and spontaneous onset of labour 
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at 25 weeks noted to have TTTS. A key recommen-
dation from the recent MBRRACE-UK report ne-
cessitates senior obstetric input for all women with 
multiple pregnancy presenting to maternity units, 
and throughout labour and delivery.11 Further, indi-
vidual case review may identify deficiencies, if any, 
in intrapartum care in cases of twin intrapartum SB. 
Over the time period 2012-2019 of 29 stillborn ba-
bies whose main cause of death was noted to be 
TTTS, only four cases make a reference to laser 
ablation having been performed in the pregnan-
cy. However, laser ablation is not a specific data 
collection point, therefore data are incomplete-
ly captured in the NPEC audit. TTTS-associated 























Major Congenital Anomaly 6 1 3 9 7 2 3 1 32
Antepartum or intrapartum 
haemorrhage (abruption)
0 1 2 0 0 0 0 0 3
Mechanical 0 1 0 0 2 0 2 0 5
Other cord entanglement or 
knot
0 1 0 0 2 0 0 0 3
Uterine rupture before 
labour
0 0 0 0 0 0 2 0 2
Maternal disorder (obstetric 
cholestasis)
0 0 0 0 0 0 1 0 1
Infection 2 1 3 4 1 0 3 1 15
Specific fetal conditions* 2 4 7 10 1 4 0 2 30
Twin-twin transfusion (TTTS) 2 4 6 10 1 4 0 2 29
IUGR 1 0 0 3 0 0 0 0 4
IUGR Suspected antenatally 0 0 0 3 0 0 0 0 3
IUGR Observed at post 
mortem
1 0 0 0 0 0 0 0 1
Associated Obstetric factors 2 0 0 0 0 1 1 0 4
Prolonged rupture of 
membranes >24 hrs
0 0 0 0 0 1 0 0 1
Other obstetric factors 0 0 0 0 0 0 1 0 1
Spontaneous premature 
labour
2 0 0 0 0 0 0 0 2
Unexplained 2 3 4 3 1 4 2 1 20
No Antecedent or 
Associated Obstetric 
Factors
1 1 3 1 0 2 1 1 10
Unexplained but with 
some reported Antecedent 
or Associated Obstetric 
Factors
1 1 1 1 1 2 1 0 8
Little or nothing known 
about the case
0 1 0 0 0 0 0 0 1
Pending results of 
post-mortem or other 
investigations
0 0 0 1 0 0 0 0 1
Specific placental conditions 6 5 4 4 3 8 2 7* 39
Total 21 16 23 33 15 19 14 12 153
Note: Twin births refer to individual babies born following a twin delivery. *Specific fetal conditions as a cause of stillbirth in twins 
refers almost exclusively to cases of Twin-twin transfusion (TTTS).
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Figure 2.5. Infection as the main cause of stillbirth in 15 twins in 2012-2019  
Note:Infection broken down by specific cause in twin stillbirths, 2012-2019 (refer to table 2.3) 
 
Figure	2.5.	Infection	as	the	main	cause	of	stillbirth	i 	15	twins	in	2012- 019	
Note: Infection broke  own by specifi  cause in twi  s illbirths, 2012-2019 (refer to table 2.3). 
Neonatal death in twins
Regarding early neonatal death (NND) in twins in 2019, the majority (n= 10 of 18, 55.5%) were due to res-
piratory disorders, followed by major congenital anomalies (n=5, consisting of 3 cases each of CNS mal-
formation and 2 cases with multiple anomalies), neurological disorders (n=2, includes IVH and PVL), and 
there was one NND due to specific fetal causes. There were no cases of necrotising enterocolitis (NEC) 
or infection as a cause of NND in twins in 2019. The breakdown of causes of NND in twins is illustrated in 
Table 2.4. The contribution of gestational age at delivery to twin early neonatal mortality will be further 
discussed.






















Major Congenital Anomaly 7 8 6 8 3 7 10 5 54
Central nervous system 1 1 1 1 0 2 1 3 10
Other major congenital anomaly 1 0 0 1 0 2 0 0 4
Cardiovascular system 0 0 1 2 1 0 1 0 5
Urinary tract 0 1 1 2 0 0 2 0 6
Musculo-skeletal system 0 0 0 0 0 0 1 0 1
Multiple anomalies 3 4 1 0 0 0 5 2 15
Chromosomal disorders 2 2 2 2 2 3 0 0 13
Previable 1 0 0 0 0 0 0 0 1
Pre-viable (<22 weeks) 1 0 0 0 0 0 0 0 1
Respiratory Disorders 12 16 11 14 12 12 7 10 94
Severe pulmonary immaturity 6 9 9 13 7 7 6 9 66
Surfactant deficiency lung disease 4 7 1 0 2 1 1 0 16
Pulmonary hypoplasia 0 0 1 1 2 3 0 1 8
Other respiratory disorder 2 0 0 0 1 1 0 0 4
Gastro Intestinal Disease 0 0 0 0 1 0 0 0 1
Necrotising enterocolitis 0 0 0 0 1 0 0 0 1
Neurological Disorder 2 1 0 1 0 2 3 2 11
Hypoxic ischaemic encephalopathy 0 1 0 0 0 1 0 0 2
Intraventricular/periventricular 
haemorrhage
2 0 0 1 0 1 3 2 9
Infection 0 0 3 1 0 0 1 0 5
Sepsis 0 0 3 0 0 0 1 0 4
Pneumonia 0 0 0 1 0 0 0 0 1
Other Specific Causes 0 0 0 0 0 0 0 1 1
Other specific cause 0 0 0 0 0 0 0 1 1
Sudden Unexpected Death 0 0 0 0 0 0 1 0 1
SIDS 0 0 0 0 0 0 1 0 1
Unexplained 0 0 0 3 0 0 2 0 5
Pending results of post mortem or 
other investigations
0 0 0 3 0 0 2 0 5
Total 22 25 20 27 16 21 24 18 173
Twin births refers to individual babies born following a twin delivery. 
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In 2019, of the 30 perinatal deaths in twins (Table 
2.5), over seventy percent were DCDA twins (n=22 
of 30, 73.3%), with eight deaths in MCDA twins (n=8 
of 30, 26.7%). Information regarding national base-
line chorionicity, integral to a discussion on the con-
tribution of chorionicity to twin PNM, is regrettably 
not currently available through HIPE data collection. 
However, given DCDA twins are more common-
ly encountered, the relatively higher contribution 
of DCDA twins to total twin perinatal mortality is 
proportional. The breakdown of perinatal deaths 
in twins by chorionicity, 2012-2019 is shown in Ta-
ble 2.5. Notably, compared to 2012, there has been 
a reduction in PNM in MCDA twins in 2019, with the 
highest contribution to twin PNM in 2014 (n=20 of 
39, 51.3%) and the lowest in 2016 (n=5 of 30, 16.7%). 
It is worth noting there are incomplete data regard-
ing chorionicity for 18 of the 326 perinatal deaths in 























DCDA 26 19 19 33 25 29 25 22 198
MCDA 16 16 20 23 5 8 13 8 109
MCMA 0 1 0 0 0 0 0 0 1
Total 42 36 39 56 30 37 38 30 308
Note: Data unknown/missing for 18 of the 326 deaths in 2012-2019. Twin births refers to individual babies born following a twin 
delivery. Dichorionic diamniotic (DCDA), Monochorionic diamniotic (MCDA) and Monochromic Monoamniotic (MCDA). 
Outcome in twins is largely driven by chorionicity, 
with monochorionicity contributing significantly to 
perinatal mortality at all gestations.19-23 Complica-
tions specific to the shared monochorionic placen-
ta include selective intrauterine growth restriction 
(SIUGR), twin-twin transfusion syndrome (TTTS), 
twin-anaemia polycythaemia syndrome (TAPS), and 
the situation of single twin demise with the signif-
icant risk of death (12%) or neuro-morbidity in the 
surviving twin (25%).24 According to the recent 
MBRRACE-UK report, mortality in twins was signifi-
cantly influenced by chorionicity.11 Of the 50 individ-
ual twin deaths, both babies died in all three of the 
reviewed monoamniotic (MA) twins, in 15 of 22 cas-
es of MCDA pairs, and in 12 of 25 dichorionic (DC) 
twins. 
Early determination of chorionicity, with empha-
sis on identifying the less common monochorionic 
pairs, and adherence to internationally recommend-
ed ultrasound monitoring of twins (monthly for DC 
twins and 2-weekly from 16 weeks in MCDA twins) 
is critical in minimising the perinatal disease burden 
in twins.19-21 According to the recent MBRRACE-UK 
report, frequency of ultrasound surveillance failed to 
follow guidance for monochorionic pregnancies with 
a total of 20% of eligible women not undergoing the 
recommended sonographic surveillance in twins.11 
Although assignment of chorionicity was high at 
98% compliance, there were additional areas within 
ultrasound surveillance that fell beneath the stand-
ard of care, for example incorrect labelling of twins, 
lack of reporting of percentage intertwin growth dis-
cordance, and failing to act on abnormal ultrasound 
findings in twins or referral for specialist input. These 
are auditable outcomes in twin pregnancies for all 
obstetric units. Furthermore, in a concerted effort to 
minimise late perinatal mortality in twins, contem-
porary recommendations regarding the timing of 
delivery in uncomplicated DC twins (consider by 37 
weeks’ gestation) and MCDA twins (consider by 36 
weeks’ gestation) are to be balanced against the risk 
of neonatal morbidity.25 
While MA twins represent one of the highest risk 
groups, as per the MBRRACE-UK report,11 there were 
no cases of perinatal deaths associated with MA 
twins in Ireland over the last five years, with only one 
case in 2013. These data reinforce the national effort 
in compliance with guidance regarding heightened 
prenatal surveillance and timing of delivery of MA 
twins under the specialised care for high-risk multi-
ple pregnancy.19-21,25 






















SB END SB END SB END SB END SB END SB END SB END SB END SB END
<24 4 4 0 7 4 7 3 8 1 6 2 5 3 6 1 6 18 49
24-27 0 11 5 9 8 8 3 6 1 7 1 5 6 6 5 6 29 58
28-31 4 1 3 1 1 1 1 4 2 0 5 5 0 4 1 4 17 20
32-36 11 5 7 4 8 2 21 8 7 3 8 5 3 6 4 2 69 35
37 + 2 1 1 4 2 2 5 1 4 0 3 1 2 2 1 0 20 11
Total 21 22 16 25 23 20 33 27 15 16 19 21 14 24 12 18 153 173
Twin births refers to individual babies born following a twin delivery. 
In 2019, the majority of cases of twin early neona-
tal deaths delivered at < 28 weeks (12/18, 66.6%, 
comprising 6 cases delivering < 24 weeks and 6 at 
24-27 weeks (Table 2.6a, Figure 2.6). Similarly, ac-
cording to the recent MBRRACE-UK, almost two-
thirds of twin deaths delivered before 28 weeks.11 
There appears to be decreasing numbers of 
deaths in very preterm twins delivering between 
24-27 weeks (11/22, 50% in 2012 versus 6/18, 33% 
of cases in 2019). The highest reported number 
of early neonatal deaths in twins <24 weeks was 
reported in 2015 (eight cases of a total of 27 twin 
NND). Table 2.6a details the gestational age at de-
livery broken down by stillbirths and early neona-
tal deaths from twin births, 2012-2019. 
Gestational age at delivery in relation to chori-
onicity is highlighted in Table 2.6b. 
Gestational age at delivery 
 
Figure 2.6. Gestational age at delivery in early neonatal twin deaths, 2012-2019. Though numbers 
are small, there appears to be decreasing numbers of deaths in very preterm twins delivering 




Though numbers are small, there 
appears to be decreasing numbers 
of deaths in very preterm twins 








Chorionicity DCDA	(N) MCDA	(N) MCMA	(N) DCDA	(N) MCDA	(N) MCMA	(N)
<24 10 8 0 33 11 0
24-27 10 17 1 36 22 0
28-31 9 8 0 12 8 0
32-36 40 24 0 26 5 0
37 + 13 4 0 9 2 0
Total 82 61 1 116 48 0
Note: *Data unknown/missing for 9 stillbirths and 9 early neonatal deaths in 2012-2019. Dichorionic diamniotic (DCDA),  
Monochorionic diamniotic (MCDA) and Monochromic Monoamniotic (MCDA). 
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According to MBRRACE-UK, in the case of four of 
19 pregnancies following preterm vaginal birth of 
the first twin, the second twin was augmented, and 
birth expedited without clear clinical indication.11 
Furthermore, the report found that neither antena-
tal corticosteroids nor magnesium sulphate were 
considered and/or offered in nearly a third of eligi-
ble pregnancies. Following spontaneous birth of a 
first twin at less than 24 weeks’ gestation, consid-
eration should be given to delaying the birth of the 
surviving second twin, provided there are no con-
traindications such as infection, fetal compromise, 
bleeding or coagulopathy. Echoing MBRRACE-UK, 
the importance of early involvement of senior ob-
stetric and midwifery staff when faced with rare 
complications of twins, and particularly those pre-
senting at the threshold of viability, is highlighted. 
Screening and prevention of preterm delivery in 
twins remains an important obstetric and neonatal 
agenda. A cervical length of <or= 25mm at 20-24 
weeks’ gestation has been found to be associated 
with an increased risk of preterm birth before 28 
weeks’ gestation.26 However, screening by means of 
cervical length assessment in twins underperforms 
that of singleton pregnancies, although a single 
cervical length performed at 20-24 weeks appears 
to be a potential candidate and is endorsed by In-
ternational Society of Ultrasound in Obstetrics and 
Gynaecology (ISUOG).27 However, there is a lack of 
international consensus on the topic; those against 
screening cite a lack of effective treatment to pre-
vent preterm delivery in twins mitigating the suc-
cessful implementation of a screening program. 
However, some would argue that corticosteroids 
and magnesium sulphate are effective and impact-
ful forms of treatment when administered in a time-
ly manner to those at risk of preterm delivery, and 
therefore any means of identifying these patients 
may be important.8 New evidence supports a role 
for physical examination-indicated cerclage, com-
bined with indomethacin and antibiotics in women 
with twin pregnancies and asymptomatic cervical 
dilation before 24 weeks of gestation, being asso-
ciated with a 50% reduction in early preterm birth 
< 28 weeks’ gestation and an 8% decrease in per-
inatal mortality.28 Further study on interventions to 
prevent twin-related preterm birth, and their appli-
cability to our population are required. 
Referring to Table 2.3 outlining the main causes of 
SB in twins, IUGR was not found to be the main 
cause of death in any twin SB in 2019. For the time 
period spanning 2012-2019, IUGR was the main 
cause of SB in a total of only 4 cases of 153 twin 
stillbirths. 
A diagnosis of growth discordance is frequent-
ly encountered in twins, with discordance in fetal 
growth affecting 20% of twin pregnancies and ap-
proximately a third of all triplet pregnancies.29,30 Se-
verely growth discordant MCDA twins (≥25%) are 
more likely to be delivered before 30 weeks’ ges-
tation and have a longer neonatal intensive care 
stay (> 10 days) than their DCDA counterparts.31-33 
Overall, the reported incidence of intrauterine fetal 
death (IUFD) in the growth restricted twin is report-
ed between 14-40%.33-37 Data on chorionicity and/or 
a diagnosis of growth restriction was available for 
300 of the 326 perinatal twin deaths in 2012-2019. 
Although not the main cause of death, a diagnosis 
of growth restriction (either suspected antenatally 
or observed at delivery or post-mortem) was made 
in 23.3% (45/193) of DC twin deaths and 20.6% 
(22/107) MCDA twin deaths (Table 2.7). Further in-
dividual chart review will clarify timing of diagnosis, 
the degree of intertwin growth discordance, and the 
contribution of IUGR to single IUFD in these cases. 
IUGR and growth discordance in multiple pregnancy 
Table	2.7	Growth	restriction	associated	with	perinatal	death	in	twins	by	chorionicity,	2012-2019
DCDA MCDA MCMA Total
Growth 
restriction
Suspected antenatally 39 18 0 57
Observed at delivery or post-mortem 6 4 0 10
No diagnosis 148 85 1 233
Total 193 107 1 300
Note: Data unknown/missing for 26 of 326 cases in 2012-2019. Data represented in this table include cases where perinatal deaths 
in twins had an associated diagnosis of IUGR, though not the main cause of death. Dichorionic diamniotic (DCDA), Monochorionic 
diamniotic (MCDA) and Monochromic Monoamniotic (MCDA). 
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The prospective multicentre ESPRiT study conduct-
ed in Ireland with completed perinatal outcome on 
1,001 twin-pairs established that the threshold for 
significant birth weight discordance, i.e. that which 
is associated with an increase in composite perina-
tal morbidity, is 18% for both DC and MCDA twins.29 
Overall, the absolute risk of adverse perinatal out-
come was found to be higher in MCDA versus DC 
twins at every level of discordance.29 Cases of sig-
nificant IUGR and inter-twin growth discordance 
presenting at previable gestations represent high 
risk cases mandating specialist input from fetal 
medicine and neonatology as part of multi-disci-
plinary team (MDT) care. The importance of MDT 
care and documentation of discussions and deci-
sions in twin care is a key recommendation from 
MBRRACE-UK.11 
Twin-twin transfusion syndrome (TTTS) compli-
cates between 5-15% of MC twin pregnancies.37-39 
Without treatment with fetoscopic laser ablation 
of the communicating placental vessels responsi-
ble for the disease in severe cases, the condition 
is associated with 90% perinatal mortality.37 Since 
2006, the Irish National Fetal Laser Programme, 
consisting of fetal surgical teams at the Nation-
al Maternity Hospital and the Rotunda Hospital, 
Dublin, have jointly collaborated for the manage-
ment of TTTS. Cases of suspected or confirmed 
TTTS from all 19 maternity units in the country 
are typically reviewed within 24-48 hours in either 
site. 
In 2019, a total of 11 cases of severe TTTS requiring 
intervention were managed by the Irish National 
Fetal Laser Programme. Amongst these 11 preg-
nancies, 7 (64%) resulted in survival of both fetus-
es, and 4 (36%) resulted in survival of one fetus. 
This included two sets of triplets with a monocho-
rionic pair. The overall survival was 20 of 24 fetus-
es (83%). As of 2019, the group have completed 
186 cases of laser surgery for severe TTTS, with 
at least one survivor occurring in 84% of cases 
(157/186). These results are comparable with sur-
vival outcome data from the major international 
centres providing fetal intervention in twins.39 Im-
portantly, audit data from the national laser group 
indicate improving survival rates over time in cas-
es of TTTS that have undergone intervention.40
Perinatal mortality associated with TTTS for the 
purpose of this report is reported for monocho-
rionic twin perinatal deaths. It is worth mention-
ing the totality of the burden of outcome in TTTS 
is not described in this report, as data regarding 
total fetal loss in TTTS are not captured in these 
perinatal mortality figures. TTTS was found to be 
the main cause of death in two cases of a total 
of eight MCDA twin deaths in 2019. In 2018 there 
were no perinatal deaths due to TTTS. Over the 
timeframe from 2012-2019, TTTS was noted to be 
the main cause of death in a total of 29/106 (27%) 
of MCDA twin deaths (Table 2.3). This is compa-
rable with international outcome data on survival 
in TTTS.39 
As outlined in the recent MBRRACE-UK report, 
TTTS is the most common cause of perinatal loss 
in MC twins.11 Furthermore, it highlighted the un-
der-recognition of women presenting with ‘red 
flag’ symptoms and signs of TTTS, and it was felt 
that this may be related to a general knowledge de-
ficiency in monochorionic-related complications. It 
was noted that the gap in the care of some women 
with TTTS-associated perinatal mortality may be a 
consequence of centralisation of specialist servic-
es. It would be the collective experience in Ireland 
that cases of severe TTTS are generally recognised 
and referred for specialist input in a timely manner. 
The hub and spoke Irish maternity model, in addi-
tion to the collaboration of the Irish National Fetal 
Laser Programme with all 19 units in the country, 
alongside the provision of sonographers trained in 
the recognition of early signs of TTTS, contribute 
to a high standard of twin care in this country. 
The total numbers of cases and deaths associated 
with TTTS each year are notably small, and overall 
survival outcome is improving. There are multiple 
factors associated with the observed improving 
overall outcome in MCDA twins with TTTS, name-
ly the roll-out of first trimester dating ultrasounds 
in all obstetric units, clear guidance on timing of 
assignment of chorionicity, such that TTTS is iden-
tified earlier, clear TTTS referral pathways to the 
Irish National Fetal Laser Programme and increas-
ing collaborative operator experience over time. 
Twin-twin transfusion Syndrome
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Post-mortem in twin perinatal deaths
The proportion of stillbirths and early neonatal deaths of twins pregnancies undergoing post-mortem 
examination over the timeframe 2012-2019 are detailed in Table 2.8. Post-mortem examinations are per-
formed in twice as many cases of twin stillbirths without congenital anomaly (55/116, 47%) compared 




Pooled data 2012-2019 Cause of death: major congenital anomaly Cause of death: major congenital anomaly
Yes (n=30)  
N
No (n=116)  
N
Yes (n=49)  
N
No (n=110)  
N
Performed 10 55 20 29
Offered 17 51 24 72
Not offered 3 10 5 9
Total 30 116 49 110
*Data on whether autopsy was performed and/or offered was incomplete for seven cases of stillbirth and 14 cases of early 
neonatal deaths. 
•  In Ireland we have among the highest twin and 
higher-order multiple pregnancy birth rates in 
Europe. This is despite a steady year-on decline 
in the overall birth rate. 
•  Multiple pregnancy contributes significantly to 
perinatal mortality, with overall PNM three times 
that of singletons (2012-2019).
•  Increasing maternal age is protective against 
perinatal mortality in twins, with mothers aged 
<25 years having twice the rate of twin deaths 
compared to women aged over 40 years.
•  Regarding causes of perinatal mortality in twins 
in 2019, placental factors were found to be the 
main cause of stillbirth in 7/12 cases, with the 
main cause of NND being due to respiratory 
disorders (10/18).
•  Since 2012, there has been a reduction in PNM 
associated with MCDA twins and there have not 
been any cases of perinatal deaths associated 
with MA twins in Ireland over the last five years.
•  Over the time period 2012-2019, two thirds of 
the cases of early neonatal deaths in twins were 
associated with very preterm deliveries <28 
weeks’ gestation.
•  TTTS was noted to be the main cause of PNM 
in a total of 29/106 (27%) of MC twins over the 
time period 2012-2019. Increasing survivor out-
come is being reported for cases undergoing 
fetosocpic laser ablation for TTTS. 
Summary of the key findings
Key recommendations
In light of the findings of this report and that of 
the recent MBRRACE-UK report on twin perina-
tal mortality, the following focuses on current key 
recommendations to limit perinatal morbidity and 
mortality through the identification of early com-
plications. The goal of antenatal surveillance and 
optimum timing of delivery in multiple pregnan-
cies is aimed at reducing the risk of in-utero de-
mise, balanced against minimising perinatal mor-
bidity. Recommendations on the comprehensive 
management pathways of multiple pregnancy is 
out of the scope of this commentary and is readily 
available through established guidelines. 
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Recommendation for the NPEC 
audit
•  Expansion of NPEC audits to include more de-
tailed information regarding perinatal mortality 
in twins and higher-order multiple pregnancies. 
This report has highlighted a high rate of PNM in 
our youngest mothers delivering twins. Addition-
al information pertaining to fetal characteristics 
in twins (for example capturing timelines in rela-
tion to gestational age of occurrence of a single 
intrauterine fetal demise) are important in un-
derstanding impact on survival in the other twin. 
For cases of TTTS-associated perinatal mortality, 
documenting within NPEC if fetal intervention 
occurred is encouraged. 
•  Consideration to the establishment of a National 
Working Group in relation to Perinatal Mortality 
in Multiple Pregnancy. On the foot of the inau-
gural MBRRACE-UK enquiry into stillbirth and 
early neonatal death in twins, and in an effort to 
address perinatal mortality in twins, it would be 
prudent to establish an Irish group of specialists 
to investigate, on a rolling basis, twin and high-
er-order multiple deaths through a confidential 
individual chart review.
•  Auditing of all fetal loss in relation to TTTS <24 
weeks as a means of identifying factors leading 
to the under-recognition of TTTS.
Recommendations for clinical care 
that should assist a reduction in 
twin mortality
•  Continued emphasis on additional resources, 
recruitment and retention of highly trained ob-
stetric sonographers to continue to deliver the 
mandated highly specialised multiple pregnancy 
services across all 19 maternity units.
•  Hospital-based antenatal care delivered by a 
specialised group of obstetricians, midwives, so-
nographers, and neonatologists. 
•  Commencement of aspirin by 16 weeks’ gestation 
in multiple pregnancies with additional risk fac-
tors for the development of preeclampsia.
•  Adherence to national standards in relation to 
timing of assignment of chorionicity of twins, 
adherence to the schedule of twin-specific sono-
graphic assessments, and ensuring referral to fe-
tal medicine specialists in the event of specified 
twin complications:
•  Indications for referral for specialist fetal medi-
cine input in a tertiary unit:
 – TTTS (suspected or confirmed)
 –  IUGR (EFW of one or both twins <10th percen-
tile, and/or intertwin growth discordance of 
>18%)
 – Structural anomalies 
 – Single intrauterine fetal demise 
 – Monoamniotic twins
 – Higher-order multi-fetal gestations
•  Adherence to guidance regarding optimal timing 
of delivery in twin pregnancies to include:
 –  Delivery of uncomplicated MCDA twins from 36 
weeks’ gestation and no later than 37 weeks’ 
gestation (accepting a residual risk of 1.5% of 
late IUFD in twins)
 –  Delivery for uncomplicated DCDA twins, con-
sider at 37 weeks’ gestation, no later than 38 
weeks’ gestation. 
•  Addressing the risk of preterm birth in multiple 
pregnancy
•  Placental examination by dedicated perinatal pa-
thologists remains an essential part of the inves-
tigation of any twin mortality.
•  Continued investment in bereavement care.
Recommendations for education to 
enhance care that should assist a 
reduction in twin mortality 
•  Widespread education in relation to the identifi-
cation of twin-specific complications for all clin-
ical staff responsible for the care of women with 
multiple pregnancy. 
•  Education of all clinical staff regarding peri-via-
ble counselling in twin gestations with clear guid-
ance regarding escalation of care and early MDT 
involvement in cases at risk of extreme prema-
ture delivery.
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3. Stillbirths: Specific findings
Major congenital anomaly was the most common 
cause of death in both 2018 and 2019 (2018; n=67 
of 217, 30.9% and 2019; n=74 of 242, 30.6%) (Fig-
ure 3.1a and Figure 3.1b). This is in contrast to find-
ings in 2017 when specific placental conditions 
was the most common cause of death (Table 3.1). 
There was a chromosomal disorder in over half of 
the stillbirths in the combined reporting years due 
to congenital anomaly (2018; n=37 of 67, 55.2% 
and 2019; n=40 of 74, 54.1%), as shown in Figure 
3.2a and Figure 3.2b. In these cases with a chro-
mosomal disorder, almost sixty percent were di-
agnosed by cytogenetic analysis in 2018 and sev-
enty percent in 2019 (2018; n=22 of 37, 59.5% and 
2019 n=28 of 40, 70.0%).
In 2018, anomalies of the central nervous system 
(n=9), multiple anomalies (n=7), cardiovascular 
system (n=5), musculo-skeletal system (n=2), res-
piratory system (n=2) and urinary tract (n=1) col-
lectively leading to 26 stillbirths (38.8 % of 67). 
The remaining four cases were due to ‘other’ ma-
jor congenital anomalies (n=4). In 2019, multiple 
anomalies (n=8), anomalies of the cardiovascular 
system (n=11), central nervous system (n=4), res-
piratory system (n=3), urinary tract (n=2), muscu-
lo-skeletal (n=2) and gastro-intestinal (n=1) sys-
tems collectively led to 31 (41.9% of 74) stillbirths. 
The remaining three cases were due to ‘other’ 
major congenital anomalies. Data on whether the 
diagnosis of a major congenital anomaly was con-
firmed/suspected by a consultant fetal medicine 
specialist was recorded for all but twelve of the 
141 stillbirths that occurred across both reporting 
years, 2018 and 2019.  In the vast majority of these 
cases a diagnosis was confirmed/suspected by a 
consultant fetal medicine specialist (n=110 of 129, 
85.3%).
Table 3.1 shows further detail of the cause of death 
for stillbirths. Specific placental conditions was 
the second most common cause of death in still-
births in both 2018 and 2019 (2018; n= 57, 26.3% 
and 2019; n= 73, 30.2%). The most commonly 
occurring placental condition was maternal vas-
cular malperfusion in both reporting years (2018; 
n=16 of 57, 28.0% and 2019; n=25 of 73, 34.2%). 
Antepartum or intrapartum haemorrhage, most 
commonly involving placental abruption, was the 
next most common cause of stillbirth in 2018 and 
2019 (2018; n=12, 5.5% and 2019; n=22, 9.1%). Spe-
cific mechanical cause of death, most commonly 
due to the umbilical cord around the baby’s neck 
or another entanglement or knot in the umbilical 
cord, accounted for 9 stillbirths (4.1%) in 2018 and 
18 stillbirths (7.4%) in 2019.
Similar to 2017, infection was the main cause of 
death in just over two percent of stillbirths in 2018 
(n=6, 2.8%). However, the rate of stillbirth due to 
infection increased in 2019 (n=16, 6.6%).
In 2018, for twenty percent of stillbirths (n=45, 
20.7%), the cause of death was unexplained. This 
is higher than the proportion in 2016 (n=38, 15.2%), 
2017 (n=26, 11.1%) and 2019 (n=23, 9.5%), the latter 
year having the lowest rate since 2014. As detailed 
in Table 3.1, in 2018, for almost forty percent of the 
stillbirths with an unexplained cause of death, it 
was reported that there were no antecedents or 
associated obstetric factors (n=17, 37.8%). Similar-
ly, in 2019, for thirty-five percent of the stillbirths 
with an unexplained cause of death it was report-
ed that there were no antecedents or associated 
obstetric factors (n=8, 34.8%). 
In over forty percent of these cases where there 
were no antecedent or associated obstetric fac-
tors in 2018, an autopsy was performed (n=7 of 17, 
41.2%) or was offered to over half of cases (n=9 of 
17, 52.9%). In 2019, of the eight cases where there 
was no antecedent or associated obstetric fac-
tors, all but one case had an autopsy performed 
(n=6 of 8, 75.0%) or offered (n=1 of 8, 12.5%).
In almost sixteen percent of cases in 2018 (n=7, 
15.6%) and over twenty percent of cases in 2019 
(n=5, 21.7%) the maternity unit was pending 
post-mortem results or other investigations for 
these cases. In the majority of these cases where 
the unit was pending post-mortem results or oth-
er investigations, almost all became Coronial cas-
es (2018; n=4 of 5, 80.0%, unknown for two cases 
and 2019; 4 of 5, 80.0%).
Cause	of	death	in	stillbirths
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Specific placental conditions (26.3%)
Major congenital anomaly (30.9%)
Unexplained (20.7%)
Antepartum or intrapartum haemorrhage (5.5%)










Central nervous system (13.4%)































Specific placental conditions (30.2%)
Major congenital anomaly (30.6%)
Unexplained (9.5%)
Antepartum or intrapartum haemorrhage (9.1%)
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Chromosomal disorders 57 51 50 38 37 40
Central nervous system 9 3 5 3 9 4
Cardiovascular system 5 3 3 5 5 11
Urinary tract 4 2 3 5 1 2
Multiple anomalies 3 3 6 6 7 8
Gastro-intestinal system 2 0 3 2 0 1
Musculo-skeletal system 1 3 3 1 2 2
Respiratory system 0 0 1 0 2 3
Metabolic disorders 0 0 0 1 0 0














Maternal vascular malperfusion 32 26 24 28 16 25
Fetal vascular malperfusion 16 18 15 17 13 12
Cord pathology 17 15 15 15 10 11
Cord pathology with distal disease 0 0 9 0 7 14
Delayed villous maturation2 7 8 2 5 6 3
Chorioamnionitis 1 0 0 0 0 0
Villitis 5 3 0 1 4 2














Prolapse cord 3 3 2 0 1 0
Cord around neck 17 11 10 8 4 11
Uterine rupture before labour 1 0 1 0 3 0
Mal-presentation 0 0 0 0 0 0
Shoulder dystocia 0 0 0 0 0 1














Praevia 0 1 0 0 1 0
Abruption 31 20 18 21 10 21
Uncertain haemorrhage 1 0 0 0 0 1














Bacterial 2 0 1 0 0 1
Syphilis 0 0 0 0 0 0
Viral diseases 0 0 1 0 0 0
Group B Streptococcus 2 0 1 0 0 1
Other maternal infection 0 2 0 0 0 1
Chorioamnionitis 15 23 4 5 5 13
Other ascending infection 3 0 2 1 1 0
Note: 1The main placental pathology associated with perinatal death is reported.
 2  The term ‘Delayed villous maturation’ (DVM) has replaced conditions previously reported as ‘Placental maturation defect’. 
DVM includes distal villous immaturity and delayed villous maturation.



























Twin-twin transfusion 6 10 1 5 2 2
Feto-maternal haemorrhage 6 7 3 8 3 7
Non immune hydrops 2 4 3 4 1 1
Iso-immunisation 1 0 0 0 0 0














IUGR-Suspected antenatally 5 5 4 1 3 3
IUGR-Observed at delivery 2 0 0 0 0 0














Premature rupture of membranes 0 0 0 1 1 1
Prolonged rupture of membranes >24 hrs 1 0 0 1 1 0
Intrapartum asphyxia 0 0 2 3 1 0
Intracranial haemorrhage 0 0 0 0 0 0
Birth injury to scalp 0 0 0 0 0 0
Fracture 0 0 0 0 0 0
Other birth trauma 0 0 0 0 0 0
Polyhydramnios 0 0 0 0 0 0
Oligohydramnios 0 0 0 0 0 0
Spontaneous premature labour 0 0 0 1 0 0














Pre-existing hypertensive disease 0 0 0 0 0 0
Diabetes 0 1 0 2 1 0
Thrombophilias 1 0 0 0 0 0
Uterine anomalies 1 0 0 0 1 0
Other maternal disorder 1 1 0 1 1 1
Other endocrine conditions 0 0 0 0 0 0
Obstetric cholestasis 0 0 0 0 1 0














Pregnancy induced hypertension 2 0 1 0 0 0
Pre-eclampsia toxaemia 0 0 1 2 0 0
HELLP syndrome 0 0 0 0 0 0














No antecedents or associated obstetric factors 26 19 17 10 17 8
Antecedents or associated obstetric factors present 18 24 15 15 21 10
Pending post mortem or other investigation 3 1 5 1 7 5
Very limited information available 0 0 1 0 0 0
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Factors influencing the delivery management of 
women experiencing antepartum stillbirths in-
clude maternal choice, maternal wellbeing, risk 
of developing severe medical complications and 
previous obstetric history. Management of clini-
cal care may involve planned induction of labour, 
awaiting spontaneous labour or in some cases 
elective delivery by caesarean section.64
In the reporting years 2018 and 2019 combined, 
410 women experienced antepartum stillbirth 
(89.3% of all the stillbirths) (Table 3.3). The man-
agement of clinical care (i.e., whether the care 
involved planned induction of labour or awaiting 
spontaneous labour, elective delivery by caesarean 
section) was recorded for all the 410 women who 
experienced antepartum stillbirth. Labour was in-
duced for over seventy percent of the women who 
experienced antepartum stillbirth (n=299, 72.9%) 
whereas labour was spontaneous for 15.9% (n=65). 
As shown in Figure 3.3, the time from diagnosis of 
fetal demise to delivery was different for women 
whose labour was induced from the delivery time 
for women whose labour was spontaneous for 
the combined reporting years 2018 and 2019. The 
confirmation of death and delivery took place on 
the same day for 66.2% (n=43 of 65) of the wom-
en whose labour was spontaneous. For women 
whose labour was induced, it was common for 
up to three days to pass between diagnosis and 
delivery. As can be observed from Figure 3.3, a 
very small number of antepartum stillbirths were 
delivered more than two weeks after confirmation 




64 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of 
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Vaginal birth is the recommended mode of de-
livery for most women experiencing antepartum 
stillbirth, but caesarean section may be clinically 
indicated in some cases.65 Vaginal cephalic deliv-
ery was the most common mode of delivery in 
cases of antepartum stillbirth in 2018 and 2019 
(n=262, 64.1%, mode of delivery unknown for one 
case).
In 23 cases of antepartum stillbirth the intended 
mode of delivery was a planned caesarean section 
and ultimately, caesarean section was the mode of 
delivery for 56 women (45 pre-labour caesarean 
sections and 11 caesarean sections performed af-
ter onset of labour). The indication for caesarean 
section was known for 55 of these 56 women. Of 
these 55 women, the indication was classified as 
‘elective’ in 41.8% of the cases, 27.3% were ‘urgent’ 
and 30.9% were ‘emergency’ (Table 3.2). One third 
(n=19, 33.9%) of the 56 women who delivered by 
caesarean section had previously had a caesar-
ean section and thirty percent (n=17, 30.4%) had a 
multiple delivery, both of these were factors that 




Elective: At a time to suit the woman or the maternity team 23(41.8)
Urgent: Maternal or fetal compromise which is not immediately life threatening 15(27.3)
Emergency: Immediate threat to life of woman or baby 17(30.9)
Note: Values are N (%) unless otherwise stated. The indication for caesarean section was not known for one case.
It has been suggested that the comparatively low 
proportion of intrapartum stillbirths in high-in-
come countries indicates that fetal deaths occur-
ring in labour, in non-anomalous babies, are most 
likely preventable with quality intrapartum care.66 
Intrapartum deaths in this audit were identified by 
a specific question on the NPEC Perinatal Death 
Notification Form (Appendix E) as to whether the 
baby was alive at the onset of care in labour. This 
was not known in 23 cases in 2018 and 2019 (Table 
3.3). Of these 23 cases, one case was not booked 
to a maternity unit, and six cases were born before 
arrival at the maternity unit. Of the remaining 16 
cases, the cause of death was attributed to major 
congenital anomaly in 14 cases (and presumably 
not monitored in labour), one case was associat-
ed with prematurity (at 22 weeks gestation on a 
background of cervical incompetence) and one 
case involved cord prolapse.
There were 26 cases of stillbirths where the baby 
was known to be alive at the onset of care in la-
bour. Thus, intrapartum deaths accounted for 
5.7% of stillbirths in the Republic of Ireland in 2018 
and 2019 (Table 3.3). This was slightly lower than 
the proportion of intrapartum deaths reported in 
Ireland in 2017 (6.8%) and 2016 (7.2%) and also 
lower than the most recently published 2016 fig-
ures in the United Kingdom, ranging from 8.8% in 
both England and Wales, to 8.5% in Scotland. In 
Northern Ireland, the rate of intrapartum deaths 
was similar (6.3%).67
Intrapartum	stillbirths
65 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of 
Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive. 
66 Darmstadt G, Yakoob M, Haws R, Menezes E, Soomro T and Bhutta Z. Reducing stillbirths: interventions during labour. BMC 
Pregnancy and Childbirth 2009;9 (Suppl 1):s6
67 Draper ES, Gallimore ID, Kurinczuk JJ, Smith PW, Boby T, Smith LK, Manktelow BN, on behalf of the MBRRACE-UK Collaboration. 
MBRRACE-UK Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 2016. Leicester: 
The Infant Mortality and Morbidity Studies, Department of Health Sciences, University of Leicester. 2018.





Baby not alive at onset of care in 
labour (Antepartum Stillbirth)
384(83.6)
Never in labour 26(5.7)
Intrapartum Baby alive at onset of care in labour  26(5.7)
*Not	known/Unattended 23(5.0)
Note: *Some of these cases were not booked to a maternity unit or were born before arrival (BBA) at maternity unit.
Major congenital anomaly was the main cause of 
death for over fifty percent of the 26 intrapartum 
deaths (n=14, 53.8%). The second most common 
cause of death was infection due to chorioamni-
onitis accounting for three cases (11.5%) of the 26 
intrapartum deaths. There was no clustering by 
hospital in the intrapartum deaths due to causes 
other than congenital anomaly. 
Section 5 of this report provides further details 
on perinatal deaths associated with intrapartum 
events in babies with a gestational age of at least 
34 weeks gestation and a birthweight of at least 
2,500g who were alive at the onset of labour and 
whose death was not due to congenital anoma-
ly or infection. However, while the NPEC perina-
tal mortality audit provides the best national data 
available on intrapartum deaths and unexpected 
neonatal deaths, a more formal confidential in-
quiry based system is necessary to fully appraise 
these cases.68 As in previous reports, we make a 
recommendation in this area.
68 McNamara K, O’Donoghue K, Greene RA. Intrapartum fetal deaths and unexpected neonatal deaths in the Republic of Ireland: 
2011 - 2014; a descriptive study. BMC Pregnancy Childbirth. 2018 Jan 4;18(1):9. doi: 10.1186/s12884-017-1636-6. PMID: 29301489; 
PMCID: PMC5755435.
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4. Early neonatal deaths: Specific findings
The cause of early neonatal deaths in 2018 and 
2019 was classified using both the NPEC Neona-
tal Classification System and the NPEC Maternal 
and Fetal Classification System in order to identify 
both the primary neonatal condition causing the 
death and the underlying main antecedent or ob-
stetric factor associated with the death.
Major congenital anomaly was the most common 
cause of early neonatal death in both 2018 and 
2019 (2018; n=62 of 108, 57.4 % and 2019 n= 64 
of 118, 54.2%) followed by respiratory disorder, 
accounting for more than one in five of early ne-
onatal deaths (2018; n=25, 23.1% and 2019 n=28, 
23.7%) (Figure 4.1a and Figure 4.1b). Neurologi-
cal disorder was the next most common cause of 
death in both reporting years (2018; n=13, 12% and 
2019 15, 12.7%), which was slightly higher than the 
rate (8.1%) in 2017. Three deaths in 2018 (2.7%) and 
2 deaths in 2019 (1.7%) were unexplained pend-
ing post mortem or other investigation. A detailed 
listing of the main cause of death for 108 and 118 
early neonatal deaths occurring in 2018 and 2019 
respectively is given at the end of this section of 
the report (Table 4.3).
Cause	of	early	neonatal	death




Major Congenital Anomaly (57.4%)
Respiratory disorders (23.1%)
Neurological disorder (12%)
Other specific causes (0.9%)
Unexplained (3.7%)
Infection (1.9%)
Sudden unexpected deaths (0.9%)
Chromosomal disorders (19.4%)
Cardiovascular system (14.5%)
Central nervous system (19.4%)





Severe pulmonary immaturity (72%)
Surfactant deficiency lung disease (12%)
Pulmonary hypoplasia (8%)
Primary persistent pulmonary hypertension (4%)
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Major Congenital Anomaly (54.2%)
Respiratory disorders (23.7%)
Neurological disorder (12.7%)
Other specific causes (4.2%)
Unexplained (2.5%)
Infection (1.7%)
Gastro Intestional Disease (0.9%)
Chromosomal disorders (23.4%)
Central nervous system (12.5%)






Severe pulmonary immaturity (71.4%)
Pulmonary hypoplasia (10.7%)
Meconium aspiration syndrome (3.6%)
Primary persistent pulmonary hypertension (3.6%)
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The types of major congenital anomalies which 
caused 62 of the 108 neonatal deaths in 2018 are 
illustrated in Figure 4.2a. Figure 4.2b illustrates the 
types of major congenital anomalies causing 64 
of the 118 neonatal deaths in 2019. 
In 2018, multiple anomalies were the most com-
mon type of major congenital anomaly, occurring 
in over one in five neonatal deaths (n=14, 22.6%). 
The second most frequent anomalies were chro-
mosomal disorders and anomalies of the central 
nervous system, each disorder occurring in nine-
teen percent of the cases within the major congen-
ital anomaly group (n=12, 19.4%). Other occurring 
anomalies included anomalies of the cardiovascu-
lar system (n=9, 14.5%), urinary tract (n=7, 11.3 %), 
musculo-skeletal system (n=4, 6.5%) and respira-
tory system (n=2, 3.2%). Two cases were catego-
rised as having ‘other’ major congenital anomalies 
(3.2%).
In contrast, in 2019 chromosomal disorders was 
most common type of major congenital anoma-
ly, occurring in over twenty three percent of ne-
onatal deaths (n=15, 23.4%). The second most 
frequent anomalies within the major congenital 
anomaly group were multiple anomalies (n=12, 
18.8%). Anomalies of the central nervous system 
and the urinary tract each accounted for eight 
(12.5%) of deaths in this cohort. Other occurring 
anomalies included anomalies of the cardiovascu-
lar system (n=7, 10.9%) and the respiratory system 
(n=5, 7.8%). Six cases were categorised as having 
‘other’ major congenital anomalies (9.4%).
Data on whether the diagnosis of a major con-
genital anomaly was confirmed/suspected by a 
consultant fetal medicine specialist was recorded 
for all but one of the 126 neonatal deaths that oc-
curred across both reporting years, 2018 and 2019. 
In almost all of these 125 cases a diagnosis was 
confirmed/suspected by a consultant fetal medi-
cine specialist (n=119 of 125, 95.2%). Furthermore, 
the vast majority of the 27 neonatal deaths attrib-
uted to a chromosomal disorder were diagnosed 
by cytogenetic analysis (n=21, 77.8%). 
Major	congenital	anomalies	






















Respiratory disorder 45(86.5) 0(0) 5(9.6) 0(0) 2(3.8) 0(0)
Major congenital anomaly 16(12.7) 0(0) 22(17.5) 42(33.3) 45(35.7) 1(0.8)
All Other 15(31.9) 0(0) 9(19.1) 4(8.5) 18(38.3) 1(2.1)
Note: Values are n (%) unless otherwise stated. 
Figure 4.3a and Figure 4.3b detail causes of death 
in cases of respiratory disorders in neonatal deaths 
for the reporting years 2018 and 2019 respectively. 
Of the early neonatal deaths caused by respiratory 
disorder in both 2018 and 2019, the majority (2018; 
n=18, 72.0% and 2019; n=20, 71.4%) were due to 
severe pulmonary immaturity. Surfactant deficien-
cy lung disease occurred in three cases (12.0%) in 
2018 with no cases being reported as the leading 
respiratory cause of death in 2019. Pulmonary hy-
poplasia occurred in five cases across the com-
bined reporting years (2018; n=2, 8% and 2019; 
n=3, 10.7%). 
Table 4.1 shows the gestational age distribution in 
neonatal deaths in 2018 and 2019 by broad main 
cause of death. All but two of the 53 early neona-
tal deaths in 2018 and 2019 attributed to respira-
tory disorder occurred in babies delivered before 
28 weeks gestation. This pattern of gestational 
age was in marked contrast to the early neonatal 
deaths due to major congenital anomaly and to 
those due to all other causes. 
Respiratory	disorders
A neurological disorder was attributed as the main 
cause of death in 28 early neonatal deaths in 2018 
and 2019, thirteen of which occurred in 2018 and 
fifteen occurred in 2019. For sixteen of these 28 
cases, the condition involved was hypoxic ischae-
mic encephalopathy (HIE) and for twelve cases 
death was due to intraventricular/periventricular 
haemorrhage (IVH/PVH). Table 4.2 details the 
gestational age, customised birthweight centile 
and main antecedent or obstetric factor associat-
ed with the 28 early neonatal deaths attributed to 
neurological disorders. Thirteen of these 28 cases 
occurred in babies with a gestational age of 37-41 
weeks. Fifteen of these 28 early neonatal deaths 
had an autopsy performed and these 15 cases be-
came Coronial cases. 
Neurological	disorders	












HIE 40 4.8 Other birth trauma
Autopsy performed 
(Coroner case)
HIE 41 43.4 Fetal vascular malperfusion
Autopsy performed 
(Coroner case)
HIE 40 92.7 Cord pathology
Autopsy performed 
(Coroner case)
HIE 31 33 Abruption
Autopsy performed 
(Coroner case)
HIE 40 43.4 Group B Streptococcus
Autopsy performed 
(Coroner case)








HIE 41 7.7 Other birth trauma
Autopsy performed 
(Coroner case)
HIE 40 16.7 Uterine rupture during labour
Autopsy performed 
(Coroner case)
HIE 39 48.8 Abruption
Autopsy performed 
(Coroner case)
HIE 37 50.2 Uterine rupture during labour
Autopsy performed 
(Coroner case)
HIE 40 38.1 Other maternal disorder
Autopsy performed 
(Coroner case)








IVH/PVH 23 27.3 Spontaneous premature labour
Autopsy not performed 
and not offered
IVH/PVH 25 15.6 Spontaneous premature labour
Autopsy not performed 
but offered
IVH/PVH 25 67.1 Spontaneous premature labour
Autopsy not performed 
but offered
IVH/PVH 27 20 Spontaneous premature labour
Autopsy not performed 
but offered
IVH/PVH 24 15.9 Spontaneous premature labour
 Autopsy not performed 
but offered
IVH/PVH 24 97.6 Spontaneous premature labour
Autopsy not performed 
but offered
IVH/PVH 23 77.9 Spontaneous premature labour
Autopsy not performed 
but offered
IVH/PVH 24 20.4 Spontaneous premature labour
Autopsy not performed 
but offered
IVH/PVH 23 38.2 Spontaneous premature labour
Autopsy not performed 
but offered
IVH/PVH 27 3.1 Spontaneous premature labour
Autopsy not performed 
but offered
HIE 41 2.1 Abruption
Autopsy not performed 
but offered
HIE 30 57.9 Cord pathology
Autopsy not performed 
but offered
IVH/PVH 24 44.9 Spontaneous premature labour Autopsy performed
IVH/PVH 23 24.5 Spontaneous premature labour
Autopsy not performed 
but offered
Note: IVH/PVH = Intraventricular/periventricular haemorrhage; HIE = hypoxic ischaemic encephalopathy. 














Major	congenital	anomaly 68(47.9%) 98(59.0%) 68(54.8%) 62(55.9%) 62(57.4%) 64(54.2%)
Chromosomal disorders 25 17 18 26 12 15
Cardiovascular system 7 16 9 10 9 7
Central nervous system 7 11 7 7 12 8
Urinary tract 10 19 11 4 7 8
Multiple anomalies 8 11 8 4 14 12
Musculo-skeletal system 4 5 6 3 4 3
Respiratory system 2 1 3 2 2 5
Gastro-intestinal system 1 4 0 1 0 0
Metabolic disorders 0 1 3 0 0 0
Other major congenital anomaly 4 13 3 5 2 6
Pre-viable	(<22	weeks) 1(0.7%) 1(0.6%) 0(0%) 2(1.8%) 0(0) 0(0)
Respiratory	disorders 47(33.1%) 41(24.7%) 36(29.0%) 24(21.6%) 25(23.1%) 28(23.7%)
Severe pulmonary immaturity 36 31 25 13 18 20
Surfactant deficiency lung disease 5 1 4 6 3 0
Pulmonary hypoplasia 4 4 5 3 2 3
Primary persistent pulmonary 
hypertension
0 1 0 0 1 1
Meconium aspiration syndrome 0 0 0 0 0 1
Chronic lung disease/
bronchopulmonary 
0 0 0 0 0 0
Other respiratory disorder 2 4 2 2 1 3
Gastro-intestinal	disease 2(1.4%) 0(0%) 1(0.8%) 4(3.6%) 0(0%) 1(0.8%)
Necrotising enterocolitis 2 0 1 4 0 1
Other gastro-intestinal disease 0 0 0 0 0 0
Neurological	disorder 9(6.3%) 17(10.2%) 8(6.5%) 9(8.1%) 13(12%) 15(12.7%)
Hypoxic ischaemic encephalopathy 7 13 5 6 7 9
Intraventricular/periventricular 
haemorrhage
2 4 3 3 6 6
Other neurological disorder 0 0 0 0 0 0
Infection 12(8.5%) 3(1.8%) 4(3.2%) 1(0.9%) 2(1.9%) 2(1.7%)
Sepsis 7 0 4 1 1 1
Pneumonia 2 1 0 0 1 0
Meningitis 1 0 0 0 0 0
Other infection 2 2 0 0 0 1
Injury/trauma 0 0 0 0 0 0
Other	specific	causes 0(0%) 2(1.2%) 2(1.6%) 5(4.5%) 1(0.9%) 5(4.2%)
Malignancies/tumours 0 0 0 0 0 0
Other specific causes 0 2 2 5 1 5
Sudden	unexpected	deaths 1(0.7%) 1(0.6%) 0(0%) 1(0.9%) 1(0.9%) 0(0%)
Sudden infant death syndrome 
(SIDS)
1 1 0 1 1 0
Infant deaths - cause unascertained 0 0 0 0 0 0
Unexplained 2(1.4%) 3(1.8%) 5(4.0%) 3(2.7%) 4(3.7%) 3(2.5%)
Pending post mortem or other 
investigations
2 3 5 2 3 2
Antecedents or associated obstetric 
factors present
0 0 0 1 1 0
No antecedents or associated 
obstetric factors present
0 0 0 0 0 1
Very limited information available 0 0 0 0 0 0
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The NPEC Perinatal Death Notification Form (Ap-
pendix E) records the condition, in terms of res-
piratory activity and heart rate shortly after deliv-
ery, of babies who die in the early neonatal period. 
For most of these early neonatal deaths that oc-
curred during the years 2018 and 2019 (n=114 of 
226, 51.8%, unknown for six cases) spontaneous 
respiratory activity was absent or ineffective at 
five minutes following delivery and for over one 
third (n=81, 35.8%) the heart rate was persistently 
less than 100 beats per minute.
In 2018 and 2019, active resuscitation was offered 
in the delivery room in over half of early neonatal 
deaths (n=126 of 223, 55.8%, unknown for three 
case). Of the early neonatal deaths not receiving 
resuscitation (n=97), the majority (n=75, 77.3%) 
were associated with a major congenital anomaly 
(Table 4.4). More early neonatal cases born with-
out major congenital anomaly and not offered re-
suscitation were delivered prematurely less than 
27 weeks gestation compared to those born with-

























offered	resuscitation 0(0) 26(26.8) 12(12.4) 30(30.9) 28(28.9) 1(1.0) 97
Death	due	to	major	congenital	
anomaly	not	offered	resuscitation 0(0) 8(10.7) 10(13.3) 30(40) 26(34.7) 1(1.3) 75
Note: Values are n(%) unless otherwise stated. 
In 2018 and 2019, over fifty percent of early neona-
tal babies were admitted to a neonatal unit in the 
hospital of delivery (n=116, 51.3% of 226) and thir-
teen percent (n=30, 13.3%) were transferred to an-
other unit. Such admission and transfer depended 
on whether active resuscitation had been offered 
in the delivery room. Admission to a neonatal unit 
followed over eighty percent of the cases offered 
active resuscitation (n=106 of 126, 84.1%) com-
pared to nine percent not offered active resuscita-
tion (n=9 of 97, 9.3%) (Table 4.5). Over one in five 
cases offered active resuscitation were transferred 




Yes (n = 126) 106(84.1) 29(23.0)
No (n = 97) 9(9.3) 0(0)
Note: Values are N (%) unless otherwise stated. Active resuscitation in the delivery room includes BMV, PPV, intubation, cardiac 
massage. Data on active resuscitation was unknown for three cases. 
Age	of	neonate	at	death	
Over sixty percent of the early neonatal deaths occurred within 24 hours of delivery (Table 4.6). Major 
congenital anomaly and respiratory disorders (mainly severe pulmonary immaturity) were the main 
cause of death in 64.4% (n=93) and 23.6% (n=34) of these cases, respectively. 
Table	4.6:	Age	of	neonate	at	death	in	2018	and	2019
Completed	days 0 1 2 3 4 5 6
Number 144 28 20 13 14 2 5
% 63.7 12.4 8.8 5.8 6.2 0.9 2.2
Cumulative % 63.7 76.1 85 90.7 96.9 97.8 100
Note: Age of neonate at death unknown for one early neonatal death.
Condition	and	management	at	birth
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Location	of	neonatal	death	
The vast majority of early neonatal deaths in 2018 and 2019 occurred either in the neonatal unit, the 
labour ward, or in another maternity unit ward (Table 4.7). A very small proportion of deaths occurred 









Note: Values are n(%) unless otherwise stated. 
All but one of 71 neonatal deaths that occurred 
in the labour ward occurred within 24 hours of 
delivery. These 70 deaths in the labour ward ac-
counted for under half of the neonatal deaths 
that occurred within the first day of the birth 
(48.6%). In 2019, just under twenty percent of 
the 36 deaths in the labour ward that occurred 
within the first day resulted from a TOP (n=7 of 
36, 19.4%). A further 26.4% (n=38) of first day 
neonatal deaths occurred in a neonatal unit. As 
detailed in Table 4.6, the daily number of neo-
natal deaths was significantly lower once 24 
hours had elapsed after delivery. The majority 
of the neonatal deaths that occurred between 
1-6 completed days happened in a neonatal unit 
(Figure 4.4).
Figure	4.4:	Place	of	neonatal	death	0-6	complete	days	after	birth	in	2018	and	2019
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5.  Perinatal deaths associated with  
intrapartum events 
The investigation of perinatal deaths due to intra-
partum events is valuable in assessing quality of 
care. These deaths are unexpected and include 
stillbirths alive at the onset of professional care in 
labour and neonatal deaths. Traditionally intrapar-
tum deaths referred to babies who were alive at 
onset of labour but stillborn. The inclusion of neo-
natal deaths facilitates the assessment of all peri-
natal deaths that may have an intrapartum origin.
As in previous reports, we reviewed perinatal 
deaths reported in both 2018 and 2019, focus-
ing on cases with a gestational age of at least 34 
weeks and a birthweight of at least 2,500g who 
were alive at the onset of care in labour and whose 
death was not due to major congenital anom-
aly (or infection). Babies who were delivered by 
pre-labour caesarean section were not included. 
In 2018 and 2019, there were 30 and 29 cases re-
spectively, of perinatal death with a gestational 
age of at least 34 weeks and a birthweight of at 
least 2,500g who were alive at the onset of care in 
labour (2018, n=5 stillbirths and 25 early neonatal 
deaths and 2019, n=2 stillbirths and n=27 early ne-
onatal deaths). In 2018, there were two cases with 
death due to infection (Group B Streptococcus 
and Cytomegalovirus) and 18 cases due to major 
congenital anomaly (n=18 of 30, 60.0%). In 2019, 
there was two cases where the death was due to 
infection (Chorioamnionitis and Group B Strep-
tococcus) and 15 cases due to major congenital 
anomaly (n=15 of 29, 51.7%). A further two cases 
were excluded from this cohort in 2019, one case 
was excluded as the cause of death was sudden 
infant death at home with no maternal or fetal as-
sociated factors, for the other remaining case the 
cause of death was unexplained following Coronal 
investigation.
In total, for the reporting year 2018, there were ten 
perinatal deaths (five stillbirths and five early neo-
natal deaths) associated with intrapartum events 
with a gestational age of at least 34 weeks and 
a birthweight of at least 2,500g who were alive 
at the onset of labour and whose death was not 
due to major congenital anomaly or infection. All 
of the ten deaths were Coronial cases. In order to 
preserve confidentiality, limited details of the cas-
es are outlined in Table 5.1a on the following page. 
For the reporting year 2019, there were ten cas-
es of perinatal deaths (one stillbirth and nine ear-
ly neonatal deaths) associated with intrapartum 
events, (meeting the gestational age and birth-
weight criteria as above), who were alive at the 
onset of labour and not delivered by pre-labour 
caesarean section. Further, these deaths were not 
due to major congenital anomaly or infection. All 
ten perinatal deaths were Coronial cases. At time 
of writing, two cases are pending results of a Cor-
oner’s post mortem. Details of the cases are pro-
vided in Table 5.1b.

















SB 37 – 40 <10th Prolapsed Cord Not Applicable Yes (Coroner case)
SB 40 – 43 10th – 49th
Complication Breech 
delivery out with maternity 
unit
Not Applicable Yes (Coroner case)
SB 37 – 40 >90th
Pending results of coroner’s 
post mortem
Not Applicable Yes (Coroner case)
SB 37 – 40 < 10th
High grade placental 
disease
Not Applicable Yes (Coroner case)
SB 37 – 40 50 – 89th
Pending results of coroner’s 
post mortem
Not Applicable Yes (Coroner case)
END 40 – 43 10 – 49th Placental disease HIE Yes (Coroner case)
END 37 – 40 10 – 49th Uterine rupture in labour HIE Yes (Coroner case)
END 40 – 43 < 10th
Meconium aspiration 
syndrome
HIE Yes (Coroner case)
END 37 – 40 50 – 89th
Uterine rupture before 
labour
HIE Yes (Coroner case)
END 37 – 40 10 – 49th Maternal viral infection HIE Yes (Coroner case)

















SB 40 – 43 >90th Shoulder dystocia Not Applicable Yes (Coroner case)
END 40 – 43 10 – 49TH Placental disease HIE Yes (Coroner case)
END 37 – 40 10th – 49th Maternal epileptic seizure HIE Yes (Coroner case)







END 37 – 40 <10th 
Meconium aspiration 
syndrome
HIE Yes (Coroner case)
END 40 – 43 10th – 49th
Pending results of coroner’s 
post mortem
Pending results 
of coroner’s post 
mortem
Yes (Coroner case)




END 40 – 43 50th – 89th
Meconium aspiration 
syndrome
HIE Yes (Coroner case)
END 37 – 40 10th – 49th
Pending results of coroner’s 
post mortem
Pending results 
of coroner’s post 
mortem
Yes (Coroner case)





Note: SB=Stillbirth; END=Early neonatal death; HIE=hypoxic ischaemic encephalopathy. 
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6. Late neonatal deaths: Specific findings
Data relating to 62 late neonatal deaths occurring in 
2018 and 2019 (n=30 and n=32 respectively) were 
reported to the NPEC for the purposes of this clinical 
audit. For the year 2018 the Central Statistics Office 
(CSO) reported 31 late neonatal deaths. At the time 
of writing, finalised figures for late neonatal deaths 
in 2019 were not yet published by the CSO. However, 
in their provisional data, it was reported that 34 late 
neonatal deaths had occurred in 2019. 
In each of the preceding four years there has been 
some variation between the number of late neona-
tal deaths reported by the CSO and the number re-
ported to the NPEC. For 2014, 2015, 2016 and 2017 
respectively, the CSO reported 38, 32, 31 and 38 late 
neonatal deaths while 34, 28, 33 and 35 were report-
ed to the NPEC. Maternity hospitals may not be no-
tified of the late neonatal death of a baby delivered 
in their unit if the baby was transferred to a paedi-
atric unit or discharged home. The NPEC is working 
with colleagues in the relevant hospitals (maternity 
and paediatric) to address this issue. Further, it is 
envisaged that future collaboration with the NOCA 
National Paediatric Mortality Register (NPMR) will 
provide a validated, robust data source to inform the 
NPEC audit on late neonatal deaths.
Given the notification issue and the limited number 
of late neonatal deaths reported, this section of the 
report provides a brief summary of the submitted 
data as well as the detailed listing of the main cause 
of the 62 deaths, occurring in both 2018 and 2019, 
according to the NPEC Classification System.
Table 6.1 describes a range of characteristics of the 
babies who died in the late neonatal period. While 
values fluctuate from year to year, slightly more ba-
bies who died in the late neonatal period were male 
for the reporting years 2013 to 2018. This was not the 
case in 2019 when slightly more babies who died in 
the late neonatal period were female. 
For the reporting year 2018, over one third of the ba-
bies who died in the late neonatal period were born 
by vaginal cephalic delivery (n=12, 40%) and thirty 
percent were delivered by pre-labour caesarean sec-
tion (n=9, 30%). Most had a gestational age between 
22-27 weeks or 37-41 weeks at birth (n=21, 70%) and 
over three quarters of the babies (n=23; 76.7%) had 
a birthweight less than 2,500 grams. Forty percent 
of babies were small for gestational age (SGA; <10th 
centile n=12, 40%).
For the reporting year 2019, one third of the babies 
who died in the late neonatal period were born by 
vaginal cephalic delivery (n=10, 31.3%) and forty per-
cent were delivered by pre-labour caesarean section 
(n=13, 40.6%). The majority of babies had a gesta-
tional age between 22-27 weeks or 37-41 weeks at 
birth (n=28, 87.5%) and over sixty percent (n=22, 
62.9%) had a birthweight less than 2,500 grams. One 
third of babies were small for gestational age (SGA; 
<10th centile n=10, 31.3%).
Similar to previous reports, the proportion of late 
neonatal deaths was found to decrease across the 
second, third and fourth weeks of life in 2018. For 
example, in 2018, the proportion of late neonatal 
deaths decreased from 56.7% in week two to 23.3% 
in week three and 20% in week four. In contrast, for 
the reporting year 2019, the majority (75%) of late 
neonatal deaths occurred in week two and a further 
12.5% of deaths occurred in both week three and 
week four.
Seventy percent of late neonatal deaths in 2018 oc-
curred in the neonatal unit and almost seventeen 
percent died in a paediatric centre (n=21, 70.0% and 
n=5, 16.7%, respectively). In contrast, half of the late 
neonatal deaths in 2019 occurred in the neonatal unit 
and forty percent died in a paediatric centre (n=16, 
50.0% and n=13, 40.6%, respectively). The rising 
number of late neonatal deaths occurring in paedi-
atric centres, coupled with the notification issues of 
late neonatal deaths to the NPEC perinatal mortality 
audit as previously discussed, highlight the need for 
good communication between the referring materni-
ty units and paediatric centres, specifically in relation 
to cause of late neonatal death and autopsy uptake. 
Feedback from maternity units have indicated a need 
for improvement in communications with paediatric 
centres. 
As shown in Table 6.2, major congenital anomaly was 
the most common cause of death in 2018 and 2019 
(n=12, 40.0% and n=12, 37.5% respectively). The next 
most common causes in 2018 were gastro-intestinal 
disorders (n=5, 16.7%), neurological disorders (n=4, 
13.3%), and infection (n=4, 13.3%). In 2019 the sec-
ond most common cause of death was respiratory 
disorders (n=6, 18.8%). Other causes of death in 2019 
included gastro-intestinal disorders (n=3, 9.4%), neu-
rological disorders (n=3, 9.4%), infection (n=3, 9.4%) 
and sudden infant death syndrome (n=2, 6.3%). Two 
deaths were unexplained pending post-mortem or 
other investigation (n=2, 6.3%) in 2019.















Male 22(64.7) 19(73.1) 19(57.6) 18(51.4) 18(60) 14(43.8)
Female 12(35.3) 7(26.9) 14(42.4) 17(48.6) 12(40) 18(56.3)
Mode	of	delivery
Vaginal cephalic delivery 10(32.3) 11(42.3) 11(33.3) 13(37.1) 12(40) 10(31.3)
Vaginal breech delivery 1(3.2) 1(3.8) 3(9.1) 3(8.6) 4(13.3) 3(9.4)
Pre-labour caesarean section 10(32.3) 9(34.6) 9(27.3) 11(31.4) 9(30) 13(40.6)
Caesarean section after onset of labour 9(29) 3(11.5) 6(18.2) 6(17.1) 4(13.3) 3(9.4)
Forceps 0(0) 0(0) 1(3) 1(2.9) 1(3.3) 0(0)
Assisted breech 1(3.2) 1(3.8) 2(6.1) 0(0) 0(0) 2(6.3)
Ventouse 0(0) 1(3.8) 1(3) 1(2.9) 0(0) 1(3.1)
Gestational	age	at	delivery
22-27 weeks 12(35.3) 8(28.6) 12(36.4) 15(42.9) 13(43.3) 13(40.6)
28-31 weeks 9(26.5) 2(7.1) 3(9.1) 3(8.6) 5(16.7) 1(3.1)
32-36 weeks 4(11.8) 7(25) 6(18.2) 4(11.4) 4(13.3) 3(9.4)
37-41 weeks 9(26.5) 10(35.7) 12(36.4) 13(37.1) 8(26.7) 15(46.9)
42+ weeks 0(0) 1(3.6) 0(0) 0(0) 0(0) 0(0)
Birthweight
<500g 2(5.9) 1(3.6) 1(3) 0(0) 2(6.7) 2(6.3)
500<1000g 10(29.4) 8(28.6) 14(42.4) 15(42.9) 13(43.3) 10(31.3)
1000<1500g 6(17.6) 2(7.1) 2(6.1) 2(5.7) 3(10) 2(6.3)
1500<2000g 2(5.9) 2(7.1) 2(6.1) 2(5.7) 4(13.3) 0(0)
2000<2500g 2(5.9) 4(14.3) 5(15.2) 3(8.6) 1(3.3) 6(18.8)
2500<3000g 3(8.8) 3(10.7) 1(3) 4(11.4) 2(6.7) 1(3.1)
3000<3500g 4(11.8) 5(17.9) 6(18.2) 4(11.4) 3(10) 5(15.6)
3500<4000g 4(11.8) 3(10.7) 2(6.1) 4(11.4) 2(6.7) 5(15.6)
4000g+ 1(2.9) 0(0) 0(0) 1(2.9) 0(0) 1(3.1)
Customised	birthweight	centile	
category
<3rd 6(17.6) 10(35.7) 10(30.3) 7(20.0) 10(33.3) 6(18.8)
<10th* 8(23.5) 11(39.3) 11(33.3) 11(31.4) 12(40) 10(31.3)
10-49th 12(35.3) 8(28.6) 15(45.5) 13(37.1) 7(23.3) 9(28.1)
50-89th 9(26.5) 9(32.1) 6(18.2) 8(22.9) 7(23.3) 11(34.4)
90th+ 5(14.7) 0(0) 1(3) 3(8.6) 4(13.3) 2(6.3)
Timing	of	death
2nd week of life 19(59.4) 17(60.7) 15(45.5) 17(48.6) 17(56.7) 24(75)
3rd week of life 6(18.8) 7(25) 9(27.3) 11(31.4) 7(23.3) 4(12.5)
4th week of life 7(21.9) 4(14.3) 9(27.3) 7(20.0) 6(20) 4(12.5)
Location	of	death
Neonatal unit 25(73.5) 14(50) 22(66.7) 21(61.8) 21(70) 16(50)
Ward of the maternity unit 0(0) 0(0) 1(3) 0(0) 0(0) 1(3.1)
Paediatric centre 9(26.5) 9(32.1) 7(21.2) 10(29.4) 5(16.7) 13(40.6)
Home 0(0) 4(14.3) 3(9.1) 3(8.8) 4(13.3) 2(6.3)
In transit home 0(0) 1(3.6) 0(0) 0(0) 0(0) 0(0)
Note: 2013-2014 figures published in previous reports included late neonatal deaths only if the death occurred during the calendar 
year. The figures presented here have now been revised and are based on perinatal mortality for a birth cohort. For example, deaths 
are presented for births from 1 January 2013 to 31 December 2013; thus allowing early neonatal deaths of December 2013 births which 
occurred in January 2014 to be included in 2013 figures. Furthermore, data was missing for the following variables: In 2017, place of death 
not known for one case, in 2015 gender not known for two cases and mode of delivery was not known for two cases, in 2014 mode of 
delivery was not known for three cases and age of neonate not known for two cases. *Includes cases from the category <3rd Centile. 















Major	congenital	anomaly 19(55.9%) 15(53.6%) 15(45.5%) 13(37.1%) 12(40.0%) 12(37.5%)
Central nervous system 3 1 1 0 0 0
Cardiovascular system 5 5 2 5 3 5
Respiratory system 0 1 0 0 1 0
Gastro-intestinal system 0 1 1 0 0 0
Musculo-skeletal system 1 0 0 0 1 0
Multiple anomalies 0 0 2 2 0 0
Chromosomal disorders 1 0 1 0 6 2
Metabolic disorders 7 7 6 6 1 0
Urinary tract 2 0 1 0 0 1
Other major congenital anomaly 0 0 1 0 0 4
Respiratory	disorders 8(23.5%) 3(10.7%) 10(30.3%) 5(14.3%) 3(10.0%) 6(18.8%)
Severe pulmonary immaturity 2 3 3 3 1 2
Surfactant deficiency lung disease 6 0 6 1 1 2
Pulmonary hypoplasia 0 0 0 0 0 0
Meconium aspiration syndrome 0 0 0 0 0 0
Primary persistent pulmonary hypertension 0 0 0 0 0 0
Chronic lung disease/bronchopulmonary 
dysplasia
0 0 0 0 0 0
Other respiratory disorder 0 0 1 1 1 2
Gastro-intestinal	disease 3(8.8%) 3(10.7%) 3(9.1%) 8(22.9%) 5	(16.7%) 3(9.4%)
Necrotising enterocolitis 3 3 3 7 4 3
Other gastro-intestinal disease 0 0 0 1 1 0
Neurological	disorder 1(2.9%) 2(7.1%) 4(12.1%) 5(14.3%) 4(13.3%) 3(9.4%)
Hypoxic-ischaemic encephalopathy 0 1 3 5 1 2
Intraventricular/periventricular haemorrhage 1 1 1 0 3 1
Other neurological disorder 0 0 0 0 0 0
Infection 2(5.9%) 4(14.3%) 0(0%) 1(2.9%) 4(13.3%) 3(9.4%)
Sepsis 2 1 0 1 4 3
Pneumonia 0 0 0 0 0 0
Meningitis 0 2 0 0 0 0
Other infection 0 1 0 0 1 0
Injury/Trauma 1(2.9%) 0(0%) 0(0%) 0(0%) 0(0%) 0(0%)
Other	specific	causes 0(0%) 0(0%) 0(0%) 0(0%) 0(0%) 1(3.1%)
Malignancies/tumours 0 0 0 0 0 0
Other specific cause 0 0 0 0 0 1
Sudden	unexpected	deaths 0(0%) 1(3.6%) 1(3.0%) 1(2.9%) 1(3.3%) 2(6.3%)
Sudden infant death syndrome (SIDS) 0 1 1h 1 1 2
Infant Deaths - Cause Unascertained 0 0 0 0 0 0
Unexplained 0(0%) 0(0%) 0(0%) 2(5.7%) 0(0%) 2(6.3%)
No antecedents or associated obstetric factors 0 0 0 0 0 0
Antecedents or associated obstetric factors 
present
0 0 0 0 0 0
Very limited information available 0 0 0 0 0 0
Pending results of post mortem or other 
investigations
0 0 0 2 0 2
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7.  Early neonatal deaths with a birthweight <500g 
and a gestational age at delivery <24 weeks
While not included in the calculation of perinatal 
mortality rates in the Republic of Ireland (ROI), we 
ask for notification of deaths in the early neona-
tal period of babies born before 24 weeks gesta-
tion and weighing less than 500g. The collation of 
this data on these perinatal events by the NPEC 
provides vital information surrounding adverse 
pregnancy outcomes in all registered live births in 
the ROI. For 2018, 48 such deaths were reported, 
and a further 39 cases were reported in 2019. This 
gives a total 87 neonatal deaths occurring before 
24 weeks gestation and weighing less than 500g 
for the combined reporting years of 2018 and 
2019. Given the limited number of such deaths, a 
brief summary of the submitted NPEC audit data 
for 2018 and 2019 are provided in Table 7.1a and 
Table 7.1b respectively.
For the reporting year 2018, the majority (n=29) 
of the 48 deaths occurred in babies born between 
20- and 22-weeks gestation, 17 deaths occurred 
in babies born less than 20 weeks gestation and 
two deaths occurred in babies born after 22 weeks 
gestation. The birthweights of babies born in 2018 
were in the range of 80g to 490g. Details of the 
48 early neonatal deaths born in 2018 before 24 
weeks gestation and weighing less than 500g are 
provided in Table 7.1a.
Likewise, in 2019, the majority (n=21) of the 39 
deaths that occurred in babies born between 20- 
and 22-weeks gestation, 14 deaths occurred in ba-
bies born less than 20 weeks gestation and four 
deaths occurred in babies born after 22 weeks 
gestation. In 2019, the birthweights of babies born 
were in the range of 90g to 495g. Details of the 
39 early neonatal deaths born in 2019 before 24 
weeks gestation and weighing less than 500g are 
provided in Table 7.1b.
Similar to previous reports, using the NPEC Neo-
natal Classification System, the assigned neona-
tal cause of death was pre-viable (<22 weeks) for 
the majority of cases in 2018 and 2019 (n= cases 
36, 75.0 % and n=20, 51.3% respectively). The sec-
ond most common neonatal cause of deaths was 
severe pulmonary immaturity in both 2018 and 
2019 (n= 10, 20.8% and n=11, 28.2% respectively). 
Additionally in 2018, one case was attributed to 
major congenital anomaly and another is pending 
post-mortem results in. In 2019, the main cause of 
neonatal death was attributed to major congenital 
anomaly in 8 cases (20.5%). 
In 2018 and 2019, all 68 babies died within 24 
hours of being delivered, most commonly in the 
labour ward (n=28, 58.3% and n=24, 61.5% respec-
tively). In a smaller number of cases, the location 
of death in 2018 and 2019 was in another ward of 
the maternity unit (n=16, 33.3% and n= 14, 35.9% 
respectively) or out-with the hospital setting 
(n=3, 6.3% and n=1, 2.6% respectively). In 2018, 
one baby (2.0%) died in theatre. As such, location 
of delivery and location of death remains consist-
ent across reporting years since 2013.
In both 2018 and 2019, an autopsy was performed 
in only a small number of cases. In 2018, an autop-
sy was performed in just 14.6% of cases, data on 
autopsy uptake unknown for 2 cases. Similarly, in 
2019 an autopsy was only performed in 15.4% of 
cases, data unknown autopsy uptake in 4 cases. 
However, an autopsy was offered in a further 27% 
and 28.2% of cases in 2018 and 2019 respectively. 
A recurrent issue raised by maternity units relates 
to the registration of live babies born before the 
age of viability. Correspondence from the General 
Registers Office (GRO) has confirmed the current 
legislation on registration of such births: if an in-
fant is born with signs of life, regardless of birth-
weight or gestational age at delivery, the birth is 
registered as a live birth and if the subsequent 
death of the infant occurs during the perinatal pe-
riod, the death should then also be registered as a 
neonatal death.69
69 Smith B, Assistant Registrar General 2016, personal communication, 12th October. 
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Ongoing communication between the NPEC and 
maternity units identified a need for clarification 
on two counts: (1) reportable perinatal deaths to 
the NPEC audit following termination of pregnan-
cy (TOP) and (2) in light of recent guidelines on 
the resuscitation of normally formed babies at the 
cusp of viability, the calculation of perinatal mor-
tality rates at unit level. In response to these que-
ries, the NPEC disseminated a communique to all 
maternity units following communication with the 
NWIHP (see Appendix J). Briefly summarised, all 
perinatal deaths meeting the inclusion criteria for 
this audit and are registerable with the Civil Reg-
istration System by law, should be notified to the 
NPEC perinatal mortality audit.
In Ireland, the legal definition of stillbirths is not 
consistent with international definitions in the de-
veloped world. This not only has economic and 
psychosocial ramifications but impacts on po-
tential learning for clinicians and hampers robust 
international comparison.70,71 As an initial step, 
perhaps there is a need to align data collection 
on perinatal deaths with international findings. 
A review of current legal definitions of perinatal 
deaths in the ROI should also be considered. 
70 Kelly K et al. A review of stillbirth definitions: A rationale for change. European Journal of Obstetrics & Gynaecology and 
Reproductive Health. 256 (2021) 235-245
71 LK Smith et al. Producing valid statistics when legislation, culture and medical practices differ for births at or before the 
threshold of survival: report of a European workshop. BJOG (2019). DOI: 10.1111/1471-0528.15971. Available at: www.bjog.org
• Recommendation: Defining and auditing perinatal loss.
  (a) To allow for international comparison of stillbirths, a move towards collecting data on fetal deaths 
>22 weeks and < 24 weeks should be considered in the audit of perinatal mortality in Ireland.
  (b) A national working group should be convened to review the definition of perinatal mortality in 
the Republic of Ireland (ROI). This working group should include the NWIHP, NPEC, the General Reg-
isters Office (GRO), the Institute of Obstetrics and Gynaecology, the National Clinical Programme for 
Paediatrics and Neonatology and the Department of Health. 







22 442 In Transit Pre-viable (<22 weeks) No (and not offered)
18 165 Labour Ward Pre-viable (<22 weeks) No (and not offered)
21 490 Labour Ward Pre-viable (<22 weeks) No (but offered)
20 350 Ward Pre-viable (<22 weeks) Yes
21 450 Labour Ward
Pending results of post mortem 
or other investigations
Yes
20 330 In Transit Pre-viable (<22 weeks) No (and not offered)
19 180 Ward Pre-viable (<22 weeks) No (but offered)
19 310 Home Pre-viable (<22 weeks) No (and not offered)
19 260 Ward Pre-viable (<22 weeks) No (but offered)
19 380 Labour Ward Pre-viable (<22 weeks) No (and not offered)
20 351 Ward Pre-viable (<22 weeks) No (and not offered)
21 220 Labour Ward Chromosomal disorders No (and not offered)
21 350 Labour Ward Pre-viable (<22 weeks) No (and not offered)
21 350 Labour Ward Pre-viable (<22 weeks) No (and not offered)
20 337 Ward Pre-viable (<22 weeks) No (and not offered)
18 180 Labour Ward Pre-viable (<22 weeks) No (and not offered)
18 80 Labour Ward Pre-viable (<22 weeks) No (and not offered)
19 350 Labour Ward Pre-viable (<22 weeks) No (but offered)
22 400 Ward Severe pulmonary immaturity No (and not offered)
22 400 Theatre Severe pulmonary immaturity Yes
21 410 Ward Pre-viable (<22 weeks) No (but offered)
17 134 Ward Pre-viable (<22 weeks) No (and not offered)
22 440 Labour Ward Severe pulmonary immaturity No (and not offered)
18 200 Labour Ward Pre-viable (<22 weeks) No and not offered)
21 367 Labour Ward Pre-viable (<22 weeks) No (and not offered)
22 495 Labour Ward Severe pulmonary immaturity No (and not offered)
22 480 Labour Ward Severe pulmonary immaturity No (but offered)
20 240 Labour Ward Pre-viable (<22 weeks) No (but offered)
20 220 Labour Ward Pre-viable (<22 weeks) No (but offered)
21 405 Labour Ward Pre-viable (<22 weeks) No (but offered)
18 205 Ward Pre-viable (<22 weeks) No (and not offered)
20 . Labour Ward Pre-viable (<22 weeks)
No autopsy  
(unknown if offered)
21 485 Labour Ward Pre-viable (<22 weeks) No (and not offered)
20 240 Labour Ward Pre-viable (<22 weeks) No (and not offered)
19 320 Labour Ward Pre-viable (<22 weeks) No (and not offered)
23 430 Labour Ward Severe pulmonary immaturity No (and not offered)
20 420 Labour Ward Pre-viable (<22 weeks) Yes
23 490 Labour Ward Severe pulmonary immaturity Yes
20 305 Ward Pre-viable (<22 weeks) No (and not offered)
22 490 Labour Ward Severe pulmonary immaturity No (but offered)
17 120 Ward Pre-viable (<22 weeks) No (and not offered)
19 225 Ward Pre-viable (<22 weeks) Yes
20 240 Ward Pre-viable (<22 weeks) No (but offered)
22 407 Labour Ward Severe pulmonary immaturity Yes
17 160 Ward Pre-viable (<22 weeks)
No autopsy  
(unknown if offered)
22 365 Labour Ward Severe pulmonary immaturity No (but offered)
19 220 Ward Pre-viable (<22 weeks) No (but offered)
21 385 Ward Pre-viable (<22 weeks) No (and not offered)







23 350 Labour Ward Severe pulmonary immaturity No (and not offered)
22 480 Labour Ward Severe pulmonary immaturity No (but offered)
20 300 Labour Ward Pre-viable (<22 weeks) No (and not offered)
21 425 Ward Pre-viable (<22 weeks) Yes
19 237 Labour Ward Pre-viable (<22 weeks) No (and not offered)
19 268 Labour Ward Pre-viable (<22 weeks) No (but offered)
21 370 InTransit Pre-viable (<22 weeks) No (but offered)
22 490 Labour Ward Severe pulmonary immaturity Yes
20 320 Labour Ward Pre-viable (<22 weeks) No (but offered)
21 410 Labour Ward Pre-viable (<22 weeks) No (and not offered)
22 495 Labour Ward Severe pulmonary immaturity Yes
22 440 Labour Ward Severe pulmonary immaturity No (and not offered)
22 415 Labour Ward Severe pulmonary immaturity
No autopsy  
(unknown if offered)
19 300 Ward Pre-viable (<22 weeks) No (and not offered)
20 320 Ward Pre-viable (<22 weeks) No (and not offered)
22 450 Labour Ward Severe pulmonary immaturity No (and not offered)
22 420 Ward Severe pulmonary immaturity No (but offered)
23 470 Labour Ward Severe pulmonary immaturity No (and not offered)
22 362 Ward Pre-viable (<22 weeks) No (and not offered)
19 249 Labour Ward Cardiovascular system No (and not offered)
23 394 Ward Musculo-skeletal system
No autopsy  
(unknown if offered)
23 407 Ward Severe pulmonary immaturity No (and not offered)
18 240 Ward Pre-viable (<22 weeks) No (and not offered)
17 90 Ward Chromosomal disorders No (and not offered)
22 397 Ward Pre-viable (<22 weeks) No (and not offered)
19 121 Ward Pre-viable (<22 weeks)
No autopsy  
(unknown if offered)
19 300 Labour Ward Pre-viable (<22 weeks) No (but offered)
19 155 Labour Ward Pre-viable (<22 weeks) No (but offered)
22 490 Labour Ward Severe pulmonary immaturity No (but offered)
19 160 Labour Ward Pre-viable (<22 weeks) No (but offered)
18 210 Labour Ward Pre-viable (<22 weeks) Yes
17 126 Labour Ward Gastro-intestinal system
No autopsy  
(unknown if offered)
20 484 Ward Chromosomal disorders No (but offered)
22 475 Ward Cardiovascular system No (but offered)
22 440 Ward Chromosomal disorders No (and not offered)
22 380 Labour Ward Pre-viable (<22 weeks) Yes
20 320 Labour Ward Pre-viable (<22 weeks) No (and not offered)
18 210 Labour Ward Pre-viable (<22 weeks) Yes
19 160 Labour Ward Chromosomal disorders
No autopsy  
(unknown if offered)
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In Summary
•  The PMR was 5.30 per 1,000 births in 2018 and 6.04 per 1,000 births in 2019.
•  Corrected for congenital anomaly, the PMR was 3.20 per 1,000 births in 2018 
and 3.73 per 1,000 births in 2019.
•  There was a 17% increase in the corrected PMR in 2019 compared to 2018. 
However, this was not statistically significant.
•  The overall rate of perinatal mortality has remained flat for a number of years, 
in contrast to the decreasing rates observed in the decade prior to 2012.
•  Major congenital anomaly continues to be the most common cause of both 
stillbirths and neonatal deaths.
•  For the first time since the inception of this audit, hospitals are identified. 
This is a step towards greater transparency in the Irish maternity services.
•  Similar to previous NPEC perinatal mortality reports, low birth weight was as-
sociated with perinatal deaths, particularly stillbirths. This highlights the need 
for a standardised approach to improve antenatal detection of fetal growth 
restriction (FGR) as recommended in this report. 
•  Recommendations in previous NPEC perinatal mortality reports have been 
progressed by the NWIHP. This highlights the value of on-going PM audit to 
identify quality improvement initiatives to improve care of the women and 
babies in the Irish maternity services.
•  To allow for international comparison of stillbirths, a move towards collecting 
data on fetal deaths > 22weeks and < 24weeks should be considered in the 
audit of perinatal mortality in Ireland.
•  The establishment of an enquiry for stillbirths and neonatal deaths should 
be considered in order to enhance the lessons which may improve care. This 
could take the format of a standardized review of specific cohorts, such as:
 – Unexpected intrapartum related deaths
 – multiple pregnancies
 – term stillbirths (in normally formed babies)
These cohorts could be reviewed on a rolling basis.
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Appendix	B:	Perinatal Mortality Group Membership
Ms	Bridget	Boyd, Assistant Director of Midwifery, Coombe Women & Infants University Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Dr	David	Corcoran, Consultant Neonatologist, Rotunda Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Dr	Siobhan	Gormally, Consultant Paediatrician, Our Lady of Lourdes Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Professor	John	Morrison, Consultant Obstetrician & Gynaecologist, University Hospital Galway 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr	Eoghan	Mooney, Consultant Pathologist, National Maternity Hospital 
Nominated by the Faculty of Pathology, RCPI
Professor	Keelin	O’Donoghue, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Ms	Breda	O’Donovan, Clinical Midwife Manager III from 2017, University Hospital Waterford 
Nominated by the National Lead Midwife Office of the Nursing & Midwifery Services Director 
Ms	Ann	Rath, Assistant Director of Midwifery and Nursing, National Maternity Hospital  
Nominated by the Deputy Nursing Services Director, HSE 
Dr	Anne	Twomey, Consultant Neonatologist, National Maternity Hospital  
Nominated by the Faculty of Paediatrics, RCPI 
Ms	Patricia	Williamson, Assistant Director of Midwifery, Rotunda Hospital  
Nominated by the Deputy Nursing Services Director, HSE
Ms	Siobhan	Whelan, Patient Representative
Prof	Richard	Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital  
Chair, Director of the National Perinatal Epidemiology Centre 
Ms	Edel	Manning, Research Midwife, National Perinatal Epidemiology Centre  
Perinatal Mortality Project Manager 
Mr	Paul	Corcoran	PhD, Senior Lecturer in Perinatal Epidemiology, National Perinatal Epidemiology Centre  
National Perinatal Epidemiology Centre contributor 
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Appendix	C:	NPEC Governance Committee Members 
Chair: Dr	Michael	Robson, Consultant Obstetrician and Gynaecologist, National Maternity Hospital
Deputy Chair: Professor	Tom	Clarke, Consultant Neonatologist, Rotunda Hospital (Retired)
Dr	Sharon	Cooley, Institute of Obstetrics and Gynaecology Representative
Ms	Marie	Cregan, Patient Representative, University College Cork
Dr	Geraldine	Gaffney, Senior Lecturer, National University of Ireland, Galway
Professor	Richard	Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital, 
Director of the National Perinatal Epidemiology Centre
Professor	Shane	Higgins, Master, The National Maternity Hospital
Dr	Heather	Langan, Consultant Obstetrician and Gynaecologist, Sligo General Hospital
Professor	Fergal	Malone, Master, The Rotunda Hospital
Professor	Eleanor	Molloy, Professor of Paediatrics & Child Health, TCD, Faculty of Paediatrics Representative
Ms	Connie	McDonagh, Clinical Midwife Manager 3, St. Luke’s General Hospital
Ms	Ann	O’Byrne, Chair of the national Designated Midwifery Officer Group - Home Births 
Dr	Michael	O’Connell, Master, Coombe Women & Infants University Hospital 
Dr	Mary	O’Mahony, Specialist in Public Health Medicine, HSE
Ms	Margaret	Quigley, National Lead for Midwifery ONMSD, HSE 
Ms	Marina	Cronin, NOCA Head of Quality & Development, National Office of Clinical Audit 
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Appendix	D:	National Office of Clinical Audit (NOCA) endorsement 
of the Perinatal Mortality in Ireland Biennial Report 2018/2019
National Office of Clinical Audit 
2nd Floor 
Ardilaun House, Block B 
111 St Stephen’s Green 
Dublin 2, D02 VN51 
Tel: + (353) 1 402 8577 
Email: auditinfo@noca.ie 
Prof Richard Greene, 
Director,  
National Perinatal Epidemiology Centre (NPEC), 




Dear Prof Greene, 
I wish to acknowledge receipt of the Perinatal Mortality in Ireland Biennial Report 2018/2019.  
Following your presentation to the NOCA Quality Assurance Committee on the 30th July, 2021 we are 
delighted to endorse this report. 
On behalf of the NOCA Governance Board, I wish to acknowledge the work of NPEC on producing an 
excellent report.   Transparent public reporting is an essential cornerstone of a healthcare service 
focussed on patient safety and service improvement. This report has evolved, reflecting improved 
understanding, and continues to support improve outcomes for pregnant women and their families.  
Please accept this as formal endorsement from the NOCA Governance Board. 
Yours sincerely, 
Dr Brian Creedon 
Clinical Director 
National Office of Clinical Audit 
APPENDIX D 
The National Office of Clinical Audit (NOCA) was established in 
2012 to create sustainable clinical audit programmes at national 
level. NOCA enables those who manage and deliver healthcare to 
improve the quality of care through national clinical audit.
The NPEC aligns its audit governance structures to the NOCA 
audit governance standards for audit governance committees, 
monitoring & escalation of outliers and national reporting.
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Appendix	E:	Perinatal Death Notification Form 2019
1
Appendix E: PERINATAL DEATH
NOTIFICATION FORM 
2019
CHOOSE Type of Case (TICK)
 STILLBIRTH: A baby delivered without signs of life from 24 weeks’ gestation and/or with a birth weight of ≥
500g.
*If the birth occurred unattended and there was no lung aeration seen at Post Mortem (PM) and no other
circumstantial evidence of life at birth, it should be assumed that the baby was stillborn.
OR
 EARLY NEONATAL DEATH: Death of a live born baby occurring before 7 completed days after birth.
OR
 LATE NEONATAL DEATH:  Death of a live born baby occurring from the 7th day and before 28 completed 
days after birth.
* For the purpose of reporting, a ‘live born’ baby is defined as any baby born with evidence of life such as
breathing movements, presence of a heart beat, pulsation of the cord or definite movement of voluntary
muscles.
*If a baby born at <22 completed weeks is being registered as a neonatal death, please report same to
NPEC.
The National Perinatal Epidemiology Centre is sincerely grateful for your contribution to this 
audit.
Guidance for completing this form, with specific reference to Sections 11, 12 and 13 on Cause 
of Death, is outlined in the accompanying reference manual.
The National Perinatal Epidemiology Centre also acknowledges with thanks the Centre for Maternal and Child 
Enquiry (CMACE) UK for permission to modify and use its Perinatal Mortality Notification Proforma for use in the 
Irish context. 
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2 
SECTION 1.  WOMANS’ DETAILS  
       1.1. Mother’s age   
1.2. Ethnic group: 
     White - Irish                               Irish Traveller  
            Any other White background         Please specify country of origin ______________________________________  
      Asian or Asian Irish                    Black or Black Irish    
     Other including mixed ethnic backgrounds: Please specify  ______________________________________________      
            Not recorded 
         
 
        1.3. Marital status:      Married             Never married       Separated/Divorced     Widowed     Unknown    
 
         1.4. Living with partner / spouse?              Yes                        No                                   Unknown 
 
         1.5. Woman’s employment status at booking? 
 
             Employed or self-employed (full or part time)                      Unemployed (looking for work)            
 Student             Home maker                              Permanently sick/disabled     
Other________________       Unknown 
 
  
 1.7. Height at booking (round up to the nearest cm):  
 1.8. Weight at booking (round up to the nearest kg):    
 If weight is unavailable, was there evidence that the woman was too heavy for hospital scales?  Yes  No 
 1.9. Body Mass Index at booking (BMI):  . 
 
 1.10.a. Did the woman smoke at booking?      Yes, specify quantity smoked per day__________________ 
                                 No                     Unknown 
 1.10.b. Did she give up smoking during pregnancy?             Yes             No          Unknown     N/A 
 
 1.11. Is there documented history of alcohol abuse?  
        None recorded                  Prior to this pregnancy                  During this pregnancy  
 
           
       1.12. Is there documented history of drug abuse or attendance at a drug rehabilitation unit?  
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3 
SECTION 2.  PREVIOUS PREGNANCIES  
2.1. Did the woman have any previous pregnancies?    If yes, please complete questions 2.2-2.4                 Yes        No 
2.2. No. of completed pregnancies ≥24 weeks and or with a birth weight ≥ 500g (all live and stillbirths):   
2.3. No. of pregnancies <24 weeks and with a birth weight < 500g:         
2.4. Were there any previous pregnancy problems? If yes, please tick all that apply below  Yes  No 
       Three or more miscarriages  Pre-term birth or mid trimester loss         Stillbirth, please specify number   
       Infant requiring intensive care    Baby with congenital anomaly              Neonatal death, please specify number   
Previous caesarean section Placenta praevia               Placental abruption      
Pre-eclampsia (hypertension &  proteinuria)          Post-partum haemorrhage requiring transfusion 
Other, please specify_______________________________________   Unknown 
 
SECTION 3.  PREVIOUS MEDICAL HISTORY 
3.1. Were there any pre-existing medical problems? If yes, please  tick all that apply below    Yes  No Unknown 
Cardiac disease (congenital or acquired)  Epilepsy  
Endocrine disorders e.g. hypo or hyperthyroidism  Renal disease 
Haematological disorders e.g. sickle cell disease       Psychiatric disorders 
Inflammatory disorders e.g. inflammatory bowel disease  Hypertension  
Diabetes  Other, please specify  ________________________  
 
SECTION 4.  THIS PREGNANCY 
4.1. Final Estimated Date of Delivery (EDD):      //      Unknown 
  Use best estimate (ultrasound scan or date of last menstrual period) based on a 40 week gestation, or the final date agreed 
in the notes. 
4.2. Was this a multiple pregnancy at the onset of pregnancy?             Yes       No 
 
4.3. Was this pregnancy a result of infertility treatment?                          Yes     No             Unknown 
 
               If yes, please specify method of fertility treatment
  
       4.4 Gestation at first booking appointment:           Not booked    
 
 4.5 Intended place of delivery at booking:  Name of unit _________________________________ 
 
Please specify the type of unit  
  Obstetric Unit      Alongside Midwifery Unit               Home                   Unbooked 
 
 4.6 What was the intended type of delivery care at booking?  
         Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
         Home c/o Hospital DOMINO Scheme 
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        4.7a Was the care of the mother transferred from another unit with the fetus in utero?          Yes       No 
                 If yes please answer question 4.7 b  
       4.7b Gestation at time of in-utero transfer:                                        
       4.8 a Did the woman undergo an anatomy scan?                                  Yes       No 
                 If yes please answer question 4.8 b  
        4.8 b Gestation at time of anatomy scan:                                           
   
         
SECTION 5.  DELIVERY 
      
       5.1. Onset of labour: 
 Spontaneous          Induced  Never in labour  
 
5.2. Intended place of delivery at onset of labour:  Name of unit ____________________________ 
  
Please specify the type of unit 
 Obstetric Unit    Alongside Midwifery Unit     Home 
       
       5.3. What was the intended type of care at onset of labour?  
 Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
 Home c/o Hospital DOMINO Scheme 
 
5.4. Was the intended mode of delivery a planned caesarean section?    Yes    No  
 
5.5. Place of delivery: Name of unit ____________________________________  
 
Please specify the type of unit 
  Obstetric Unit             Alongside Midwifery Unit        Other, please specify___________________ 
 
5.6. What was the type of care at delivery?  
 Obstetric-Led Care        Midwifery -Led Care              Born Before Arrival (BBA) - Unattended      
 Self-Employed Community Midwife       Home c/o Hospital DOMINO Scheme                             
       5.7. Date and time of delivery/birth:  Date: //       Time:: 
 
5.8. What was the lie of the fetus at delivery?  
 Longitudinal                           Oblique                    Transverse   
5.9. What was the presentation at delivery?  
Vertex  Breech  Compound (includes transverse and shoulder presentations) Brow  Face    
 
5.10. What was the mode of delivery? (Please tick all that apply) 
 Vaginal cephalic delivery     Ventouse           Forceps            Assisted Breech delivery          
Vaginal Breech delivery           Pre-Labour Caesarean Section          Caesarean Section After Onset of Labour 
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5 
CAESAREAN SECTIONS ONLY 
 
5.11. What was the type of or indication for Caesarean Section? 
Elective - At a time to suit woman or maternity team Urgent - Maternal or fetal compromise which is not immediately life threatening    
Emergency - Immediate threat to life of woman or fetus          Failed instrumental delivery  
SECTION 6.  ALL BABY OUTCOME 
      6.1. Sex of fetus/baby:     Male    Female     Indeterminate  
      6.2. Number of fetuses/babies in this delivery: (all identifiable including papyraceous)                   
             Birth order of this fetus/baby:   
Singleton  
 Twin 1  Twin 2   
 Triplet 1  Triplet 2                 Triplet 3  
Other multiple birth pregnancy, please specify__________         Birth Order   
       
        6.3. If from a multiple delivery, what was the chorionicity? Please tick all that apply 
Dichorionic diamniotic  Monochorionic diamniotic   Monochorionic monoamniotic Trichorionic   
 Singleton Not known 
       
        6.4. Birth weight (kg):  .  
 6.5. Gestation at delivery:  weeks + days                        Unknown 
       6.6. Was this a termination of pregnancy?   Yes  No 
              Please refer to the reference manual  
 
       6.7. Was a local hospital review of this case undertaken?      Yes  No 
               Please refer to the reference manual 
 
 
SECTION 7. MATERNAL OUTCOME 
       7.1. Admission to HDU:                                                                                                                           Yes    No  
       7.2. Admission to ICU:                                                                                                                             Yes    No  
       7.3. Maternal Death:                                                                                                                                 Yes    No 
 
 
   
SECTION 8. STILLBIRTH (If not a stillbirth, please go to Section 9) 
      8.1. At what gestation was death confirmed to have occurred?  weeks + days  
      If known, what date was death confirmed?  // 
 
      8.2. Was the baby alive at onset of care in labour?   
Yes                    No                Never In Labour                    Unattended       Unknown 
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SECTION 9. NEONATAL DEATH ONLY 
       9.1. Was spontaneous respiratory activity absent or ineffective at 5 minutes?    Yes  No 
If a baby is receiving any artificial ventilation at 5 minutes, the assumption is absent/ineffective activity: a 0 Apgar score indicates 
absent activity.  
 
 
       9.2. Was the heart rate persistently <100bpm? ( i.e. heart rate never rose above 100bpm before death)  
                                                  Persistently <100bpm Rose above 100bpm 
      
       9.3. Was the baby offered *active resuscitation in the delivery room?                                             Yes  No 
        (*active resuscitation includes BMV, PPV, intubation, cardiac massage) 
 
 
        9.4. Was the baby admitted to a neonatal unit? (Includes SCBU and ICU)                                          Yes  No 
        9.5a. Was the baby transferred to another unit after birth?                                                                   Yes  No 
                  If yes please answer 9.5 b 
        
        9.5 b. Date and Time of Transfer to other unit after birth:    Date //         Time : 
 
   
        9.6. Date and Time of Death:                                                    Date //       Time : 
 
        9.7. Place of Death*:            Labour Ward               Neonatal Unit                 Ward          Theatre         
                                                In Transit                     Paediatric Centre           Home     
 
                                                           Name of unit:_____________________________________________ 
 
*This question refers to where the baby actually died, e.g. ‘ICU, ‘at home’ or ‘in transit’. 
 Babies are deemed to have died ‘at home’ if there are no signs of life documented in the home even if resuscitation is attempted. 
 A baby is deemed to have died ‘in transit’ if signs of life are documented prior to transfer but the baby was either declared dead on arrival to  
the hospital or showed no subsequent signs of life in the hospital, despite attempted resuscitation.. 
  
SECTION 10. POST-MORTEM INVESTIGATIONS  
       10.1. Was this a coroner’s case? If yes, please complete question 10.2.                                                   Yes   No  
10.2. Has the post-mortem report been received from the coroner’s office?                                   Yes   No 
                                                                                                                                                    
10.4. Was a post-mortem performed?                  Yes                        No 
         If no, please complete question 10.5. 
10.5. Was a  post-mortem offered?                                                                                                   Yes  No 
 
10.6. Were any of the following procedures carried out after death?  
               Please tick all that apply    
         MRI                      X-Ray                  CT           External Examination          Genetic testing         
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SECTION 11. CAUSE OF DEATH AND ASSOCIATED FACTORS - STILLBIRTH & NEONATAL DEATH  
  11. Please TICK ALL the maternal or fetal conditions that were present during pregnancy or were  
associated with the death.  PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        11.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases      
 
 Other major congenital anomaly, please specify ________________________________________________________________ 
 
 Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
           Clinically                               Genetic analysis *                  Ultrasound                 
                                                      *See reference manual 
11.1.1 (b) Was the diagnosis of major congenital anomaly confirmed/suspected before delivery by a Consultant Fetal  
Medicine Specialist?       

        11.1.2. HYPERTENSIVE DISORDERS OF PREGNANCY: 
 
Pregnancy induced hypertension    Pre-eclampsia  HELLP syndrome     Eclampsia  
 
        11.1.3. ANTEPARTUM or INTRAPARTUM HAEMORRHAGE:    
 
Praevia   Abruption    Other, please specify  _________________________________ 
 
        11.1.4. MECHANICAL:    
Cord compression:  Prolapse cord  Cord around neck    Other cord entanglement or knot 
Uterine rupture: Before labour During labour 
Mal-presentation: Breech                     Face  Compound  
 Transverse Other, please specify  ___________________________________  
        Shoulder dystocia:  
        11.1.5. MATERNAL DISORDER:       
    Pre-existing hypertensive disease   Diabetes     Other endocrine conditions (excluding diabetes)        
    Thrombophilias   Obstetric cholestasis  Uterine anomalies                       
    Connective tissue disorders, please specify______________________________________________________________________________ 
    Other, please specify_______________________________________________________________________________________________ 
 
        11.1.6. INFECTION: (confirmed by microbiology/placental histology)   
 
Maternal infection:  Bacterial    Syphilis    Viral diseases    
 Protozoal                                        Group B Streptococcus 
                                Other, please specify organism  _______________________________________________________ 
Ascending infection: 
                                                         Chorioamnionitis    Other, please specify  _________________________________ 
        11.1.7. SPECIFIC FETAL CONDITIONS:    
Twin-twin transfusion       Feto-maternal haemorrhage    Non-immune hydrops    Iso-immunisation    
Other, please specify _________________________________________________________________________________________________  
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        11.1.8. SPECIFIC PLACENTAL CONDITIONS:   
 
PLEASE NOTE THERE IS NO REQUIREMENT TO COMPLETE THIS SECTION SHOULD YOU WISH TO SUMIT AN ANONYMISED 
COPY OF THE PLACENTAL HISTOLOGY REPORT AS AN ATTACHMENT TO THIS FORM. 
   
 Please refer to the reference manual, page 10, for guidance on completing this section. 
 
No abnormal histology reported 
        
Chorioamnionitis              →           Mild                             Moderate                          Severe 
        
 Fetal vasculitis             →          Arterial                    Venous                        Both 
       
      
  Maternal vascular malperfusion (uteroplacental insufficiency) 
     Please specify pathology:   
   Distal villous hypoplasia                     Placental hypoplasia 
        Accelerated villous maturation         Ischaemic  villous crowding         
       Placental infarction           →           Please specify approximate percentage involved _______________ 
 
    Retroplacental haemorrhage    →    Please specify approximate percentage of maternal surface involved _______________ 
   
       Fetal vascular malperfusion: 
             Please specify pathology 
        Patchy hypoperfusion              Scattered avascular villi         Thrombosis in fetal circulation    Fetal thrombotic vasculopathy      
 
          
 
     Cord pathology as sole finding 
            Please specify pathology 
         Hypercoiled cord                      Hypocoiled cord                            Meconium associated vascular necrosis   
           Vasa praevia                       Velamentous cord                  Other , please specify__________          
    
    Cord pathology associated with distal disease 
                  please specify associated distal disease:   
          Delayed villous maturation                    Thrombosis in fetal circulation                     
    
    
     Delayed Villous maturation defect  (distal villous immaturity/ delayed villous maturation)           
    
    
     Villitis     →          Low grade                 High grade                        With stem vessel obliteration 
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        11.1.9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE:     YES   
         
          What was this based on? Please tick all that apply 
 Suspected antenatally                    Observed at delivery                         Observed at post-mortem      
 
 
        11.1.10. ASSOCIATED OBSTETRIC FACTORS: Please tick all that apply   
        Birth trauma             Intracranial haemorrhage                         Subgaleal haematoma    
                                  Fracture, please specify_____________________________________________________ 
                                  Other, please specify________________________________________________________________________________ 
 Intrapartum fetal blood sample result < 7.25       Yes     No 
 
      Polyhydramnios                  Oligohydramnios            Premature rupture of membranes     
      Prolonged rupture of membranes (> 24hours)                Amniocentesis                             
 
 



















SECTION 12.  MAIN CAUSE OF DEATH: STILL BIRTH & NEONATAL DEATHS 
 
     12.1. Which condition, indicated in Section 11 as being present, was the MAIN condition or sentinel event          
causing or associated with the death.  Please refer to the post-mortem and placental histology reports.   
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 
















12.2. Sources of information used to determine cause of death?  
               Please tick all that apply  
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SECTION 13. NEONATAL DEATH ONLY:  NEONATAL CONDITIONS ASSOCIATED WITH THE DEATH 
 
 
       13.1. Please TICK ALL the neonatal conditions causing and associated with the death.  
                PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        13.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases                              
  
Other major malformation, please specify ________________________________________________________________ 
 
 
Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
             Clinically                                     Genetic analysis *                  Ultrasound                 
                                                              *See reference manual 
 
 
13.1.1 (b) Was the diagnosis of major congenital anomaly confirmed/suspected before delivery by a Consultant 
Fetal  Medicine Specialist?                 No          Yes, in your unit     
                                                               Yes, in another unit, please specify name of unit  ___________________  
 
        13.1.2. PRE-VIABLE: (less than 22 weeks)           
 
        13.1.3. RESPIRATORY DISORDERS:    
 
   Severe pulmonary immaturity    Surfactant deficiency lung disease Pulmonary hypoplasia Meconium aspiration syndrome    
 
   Primary persistent pulm. hypertension          Chronic lung disease / Bronchopulmonary dysplasia (BPD)   




        13.1.4. GASTRO-INTESTINAL DISEASE:    
 
Necrotising enterocolitis (NEC)    Other, please specify __________________________________________________________________ 
 
 
        13.1.5. NEUROLOGICAL DISORDER:   
 
Hypoxic-ischaemic encephalopathy (HIE)                                                  
 
*Intraventricular / Periventricular haemorrhage, please specify highest grade (0 – 4) *           
    Hydrocephalus*, please tick all that apply: 
                   * Congenital              Acquired                     Communicating                   Obstructive       Other__________________            
 
 
Other, please specify______________________________________________________________________________________________ 
 
 
        13.1.6. INFECTION:   
 
Generalised (sepsis)    Pneumonia    Meningitis    Please  specify  specific organism _________________    
    Other, specify ______________       
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        13.1.7. INJURY / TRAUMA: (Postnatal)     
  
 
             Please specify_______________________________________________________________________________________________________ 
 
        13.1.8. OTHER SPECIFIC CAUSES:   
 
Malignancies / Tumours              In-born errors of metabolism, please specify ___________________________________ 
Specific conditions, please specify___________________________________________________________________________ 
 
 
        13.1.9. SUDDEN UNEXPECTED DEATHS:   
 
Sudden Infant Death Syndrome (SIDS)        Infant death – Cause unascertained 
 
        13.1.10. UNCLASSIFIED: (Use this category as sparingly as possible)   
 
 
      13.2. Which condition, indicated in Section 13.1 as being present, was the MAIN condition causing or 
associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem report, please 
refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 









     
      13.3. Sources of information used to determine cause of death?  
               Please tick all that apply  




SECTION 14. DETAILS OF REPORTING UNIT (Please print) 
        
   14.1. Name of reporting unit: ______________________________________________________________________ 
       14.2. Completed by 
          Name: _________________________________________________________________________________________ 
          Staff Grade: ____________________________________________________________________________________ 
          Work address: __________________________________________________________________________________ 
          _______________________________________________________________________________________________ 
          Telephone Number: ____________________     E-mail Address:_________________________ 
          Date of Notification: // 
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Appendix F: Terminology for placental pathology 
Pathology category Specific placental findings 
Maternal vascular malperfusion Refers to the spectrum of findings related to shallow implantation of the 
placenta, often found in conjunction with PET and IUGR and often called 
utero placental insufficiency. Placental findings that enable this category 
to be applied are: 
distal villous hypoplasia 
accelerated villous maturation 




Fetal vascular malperfusion Refers to thrombosis or decreased flow in the fetal circulation. It may 
be difficult to distinguish arteries from veins in the placenta and 
pathology may be present in both. Findings consistent with fetal 
vascular malperfusion are: 
patchy hypoperfusion 
villous stromal-vascular karyorrhexis       
scattered avascular villi      
thrombosis in fetal circulation    
fetal thrombotic vasculopathy / extensive avascular villi 
Cord pathology  Cord pathology may exist by itself, or may be accompanied by evidence 
of other disease. The findings of cord pathology include: 
hypercoiled cord (Umbilical coiling index (UCI) of ≥ 0.3) 
cord stricture 
hypocoiled cord  (UCI < 0.1)             
meconium associated vascular necrosis  
velamentous or marginal (<10mm) cord insertion   
Other 
Delayed villous maturation Delayed villous maturation is the recommended term instead of distal 
villous immaturity, placental maturation defect or villous maturation 
defect. 
Chorioamnionitis The maternal and fetal inflammatory response should be staged and 
graded where possible. 
Villitis The term is used to mean villitis of unknown aetiology and assumes that 
the reporting pathologist has excluded infection where appropriate. 
Villitis is graded as either low grade or high grade and can occur with 
stem vessel obliteration. 
Other 
Note: More than one placental category may be present. 
45 Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab 
Med. 
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Appendix G: Guidance and Definitions for Completion of 
Section 11 & 12 STILLBIRTHS AND NEONATAL DEATHS 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY 
Any genetic or structural defect arising at conception or during 
embryogenesis incompatible with life or potentially treatable but causing death 
Central nervous system   
Cardiovascular system 
Respiratory system 
Gastro-intestinal system  
Musculo-skeletal anomalies 
Multiple anomalies  
Chromosomal disorders 
Metabolic diseases  
Urinary tract 
Other 




ANTEPARTUM OR INTRAPARTUM HAEMORRHAGE 
After 20 w gestation, whether revealed or not. If associated with PET, APH will be a 
secondary diagnosis. Ignore minor degrees of haemorrhage (e.g. ‘shows’, cervical 
polyps etc). Recurrent bleeding of uncertain origin followed by preterm labour should 





Any death attributed to uterine rupture, deaths from birth trauma or intrapartum 
asphyxia associated with problems in labour such as cord compression, 
malpresentation, shoulder dystocia etc. 
Antepartum deaths associated with cord entanglement in the absence of strong 
circumstantial evidence that cord compression caused death should be classified as 
having no associated factor. 
Cord Compression  
Prolapsecord 
Cord around neck 
Other cord entanglement or knot 




Breech / Transverse 
 Face / Compound 
 Other  
Shoulder dystocia 
MATERNAL DISORDER.  
Specify hypertensive disease present before pregnancy or any other maternal disease 
or condition sufficient to jeopardise the baby such as diabetes, cardiac disease etc.  
Infection is classified separately. 
Pre-existing hypertensive disease 
Diabetes  
Other endocrine conditions 
Thrombophilias 
Obstetric cholestasis  
Drug misuse   
Uterine anomalies 
Connective tissue disorders / 
Other  
INFECTION. Confirmed by microbiology / placental histology. 
Specify maternal infections sufficient to have compromised the baby which may be 
associated with congenital infection of the baby. Trans-placental transmission may 
have occurred such as CMV, toxoplasmosis etc.  
Specify only those ascending infections that are a significant factor in death. 
Chorioamnionitis sufficient to cause preterm birth may be specified for some 
neonates but evidence of fetal infection may be required as an explanation of 
stillbirth.  
Maternal infection 
Bacterial / Viral diseases 
Syphilis  /Group B Streptoccus 
Protozoal 
Other 
Ascending infection  
Chorioamnionitis 
Other 
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Twin-twin transfusion   
Feto-maternal haemorrhage 
Non-immune hydrops   
Iso-immunisation 
Other 
SPECIFIC PLACENTAL CONDITIONS. Specific placental conditions sufficient to cause 
death or be associated with fetal compromise such as IUGR. Cord problems associated 
with compression will normally be classified under ‘Mechanical’.  
 
 
Chorioamnionitis              
Fetal vasculitis                 
Maternal vascular malperfusion  
Fetal vascular malperfusion 
Cord pathology 
 Other 
INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE. IUGR may be suspected 
antenatally by abdominal circumference (AC) less than the centile threshold used to 
define IUGR locally, or decreased AC growth velocity, +/- oligohydramnios. 
 
Suspected antenatally 
Observed at delivery 
Observed at post mortem 
ASSOCIATED OBSTETRIC FACTORS. Factors recorded as Other Associated Obstetric 
Factors will be important clinical or pathological features of the pregnancy or baby but 
may not be an explanation of the death; they will often be secondary to other 
maternal or fetal conditions. Birth trauma and/or Intrapartum asphyxia should 
normally be classified primarily by the underlying cause (e.g Mechanical ). Birth 
Trauma and/or other antenatal/intra-partum factors can be recorded here either as a 


















NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no explanation 
or significant associated factor. 
 
 
UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery 
and which cannot be fitted into any of the above categories.  
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Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY 
 Any genetic or structural defect arising at conception or during embryogenesis 
incompatible with life or potentially treatable but causing death. 







Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE 
Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS 
Severe pulmonary immaturity will encompass those babies where structural lung 
immaturity is so gross as to mean ventilatory support is unsustainable at the outset. 
Surfactant Deficient Lung Disease may include babies with clinical or pathological 
evidence of hyaline membrane disease.  
Please note that neonatal deaths previously attributed to prematurity, would most 
often be captured under the subcategory of ‘severe pulmonary immaturity’. 
 
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary 
hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary 
haemorrhage) 
GASTRO-INTESTINAL DISEASE 
Many babies with NEC will have associated sepsis which may be given as a secondary 
cause.  
 
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER 
HIE includes those babies with severe hypoxic-ischaemic brain injury before birth. If 
possible, please specify if HIE was primarily of intrapartum or antepartum origin. 
Specify periventricular leukomalacia only if this is a significant factor in the infant 









Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is 







INJURY / TRAUMA 
Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will usually be 
classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
 
OTHER SPECIFIC CAUSES 
Death due to specific fetal and neonatal conditions such as isoimmunisation or 
unexplained hydrops. Neonatal conditions will include aspiration, unexplained 








SUDDEN UNEXPECTED DEATHS.  
SIDS should conform to the accepted definition. Unascertained are those 
unexpected deaths that are not explained despite a full investigation including 
autopsy, but do not conform to the accepted definition of SIDS. 
 
Sudden Infant Death Syndrome 
(SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or 
delivery and which cannot be fitted into any of the above categories.  
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The 10 groups of the Robson Classification 35
35 Robson Classification: Implementation Manual. Geneva: World Health Organization; 2017. Licence: CCBY-NC-SA3.0IGO.
Appendix H 
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Data Quality Statement 
National Clinical Audit of Perinatal Mortality
Reference Number: NPEC-DQS-NCAoPM-01.18 
Revision Number: 01 
Author: National Perinatal Epidemiology Centre 
Approved by: Richard Greene, Director, National Perinatal Epidemiology Centre 
Effective from: March 2019 
Review date: March 2022
Signatures of all parties responsible 
Richard A Greene, Director, 
National Perinatal Epidemiology Centre 
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Data Quality Statement 







Perinatal mortality is a significant measure of obstetric and neonatal care. Regular audit of 
perinatal mortality (e.g. stillbirths, neonatal deaths, among other) may identify modifiable risk 
factors which decrease the risk of perinatal mortality and which inform clinical practise. The 
NPEC has provided an annual national assessment of perinatal mortality in Ireland from a 
clinical viewpoint since 2008.  It has done so with the guidance and collaboration of the NPEC 
Perinatal Mortality Governance Group, a specialist multidisciplinary group, having the aim to 
develop a comprehensive national clinical audit system of perinatal mortality in Ireland. 
 
 
2.0 Data collection for the National Clinical Audit of Perinatal Mortality  
 
Data on perinatal deaths from births that occurred between January 1 of each year and 
December 31 of the same year are pseudonymised and submitted to the NPEC by all 19 units 
using a standardised notification dataset either electronically, via the secure online NPEC 
database, or alternatively by paper format. The notification dataset is completed using data 
on fetal and maternal characteristics recorded in the clinical records. Implemented 
nationally in 2011, the NPEC notification dataset was based on the validated Centre for 
Maternal and Child Enquiries (CMACE) Perinatal Death Notification Form and has been 
endorsed by the Clinical Advisory Group at the Institute of Obstetrics and Gynaecology, the 
Faculty of Paediatrics and the HSE National Obstetric Programme Working Group. 
 
3.0 Dimensions of data quality for the National Clinical Audit of Perinatal 
Mortality 
 
The quality of data are defined and assessed here using the internationally accepted 
dimensions recommended by HIQA: 
1. Relevance  
2. Accuracy and reliability 
3. Timeliness and punctuality 
4. Coherence and comparability 





Processes are in place to regularly monitor the relevance and use of existing data in meeting 
the needs of data users and other stakeholders.  Regular consultation with data users and 
other stakeholders is undertaken.  These are structured consultation activities focussing on 
the content and the quality of the data collected, the outcomes, continuous operational 
improvements, future direction and potential needs. 
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Data Quality Statement 




3.2 Accuracy and reliability 
 
The population of reference is explicitly stated in all releases. Coverage rates are documented. 
Internal procedures and guidelines for data quality assessment exist and include data cleaning 
and validation procedures regarding data submitted through both the online and paper 
formats. The NPEC online database incorporates a suite of validation checks for accuracy. Data 
cleaning and correction processes are consistently applied: these include checks on the 
structure and integrity of the data, checks for missing data, checks that the data conforms to 
data source specifications and checks for outliers.  
 
 
3.3 Timeliness and punctuality 
 
The NPEC works closely with its data providers to ensure timely submission of data.  The NPEC 
makes data providers aware of submission dates, nevertheless, data collection is done on a 
by staff without specific protected time for this purpose. Thus, at times, an extension of the 
submission dates may be required so as to allow submission of complete and accurate data. 
Planned releases occur within a reasonable period of time from the end of the reference 




3.4 Coherence and comparability 
 
Assessments of compliance with terminology standards are regularly undertaken to ensure 
the data collection is compliant with international and national standards, including clinical 
guidelines and current best practise. The following are applied: 
 
 
3.5 Accessibility and clarity 
The Annual Report for the National Clinical Audit of Perinatal Mortality, its related lay 
summary and applied data collection forms are publically available on the NPEC website:  
https://www.ucc.ie/en/npec/npec-clinical-audits/perinatalmortalitysurveillance/ 
 
Research output from the audit is catalogued according to individual staff members and 
publically available on IRIS, ResearchGate, Linkedin or other research information systems. 
Methodologies are outlined in all published outputs. 
The NPEC operates a Data Access Policy in which clear policies and procedures are outlined 
for data users in relation to the process of accessing and requesting data. 
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4.0 Further information on the National Clinical Audit of Perinatal 
Mortality 
Further information on the NPEC’s Perinatal Mortality can be found at:  
https://www.ucc.ie/en/npec/npec-clinical-audits/perinatalmortalitysurveillance/ 
Alternatively please contact us at: 
npec@ucc.ie 
or 
National Perinatal Epidemiology Centre,  
Dept. of Obstetrics and Gynaecology,  
5th Floor Cork University Maternity Hospital,  
Wilton,  
Cork 
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Coláiste an Leighis agus na Sláinte 
College of Medicine and Health 
Roinn na Cnáimhseachas agus Liacht Bhan 
Department of Obstetrics and Gynaecology 
Cork University Maternity Hospital 
Wilton 
Cork, Ireland, T12 YEO2 
T 353 (0)21 420 5017 
F 353 (0)21 420 5025 
npec@ucc.ie 
www.ucc.ie/en/npec 
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National Perinatal Epidemiology Centre,  
Department of Obstetrics and Gynaecology,  
UCC, 5th Floor, Cork University Maternity Hospital,  
Wilton, Cork, Ireland
+353 21 4205017 
npec@ucc.ie 
www.ucc.ie/en/npec/
